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Abstract
Novel inorganic porous microspheres for drug delivery have been developed. Two 
types of inert bioceramic microspheres, dibasic calcium phosphate and tricalcium 
phosphate microspheres, were produced and tested.
The microspheres were produced by spray-drying suspensions of the ceramic powders. 
Initially, the feasible spray-drying conditions were explored, and then, the effects of the 
slurry compositions and the key parameters in the spray-dryer operating conditions 
were studied for their effect on the spray-dried products. It was demonstrated that 
ceramic microspheres having a range of properties (size; porosity; and morphology) 
could be produced by systematically varying the slurry composition (solids content; 
binder type and binder concentration; dispersant concentration; ceramic powder type; 
and powder particle size) and spray-dryer operational conditions (temperature; jet size).
The spray-dried microspheres were then sintered at temperatures in the range of 900 °C 
-  1300 °C. It was found that under controlled sintering conditions, microspheres with 
controlled porosity, pore size, and surface area were produced. The physical and 
chemical characteristics of these microspheres were studied using SEM, XRD, DSC, 
mercury intrusion porosimetry, surface area analysis, and density measurements, in 
order to optimise the combination of properties.
Subsequently, model drugs -  benzamide, propranolol hydrochloride and paracetamol -  
were incorporated into the microsphere systems using three methods, by direct co- 
spray-drying with the ceramic powder, by vacuum loading into the sintered 
microspheres and by cultivating drug crystals in the sintered microspheres. The in vitro 
drug release profiles of drugs from these systems were then studied by dissolution tests.
The optimised microspheres systems which have been developed are considered to have 
favourable characteristics to be used in bone implant, transdermal needle-free powder 
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1.1 Drug Delivery Systems
The average development time of a New Chemical Entity is ~ 10-15 years, and costs ~ 
$150-350 million1; while the development of new methods of delivery for existing 
drugs is generally less time consuming and costs considerably less1. New delivery 
methods may present the drugs with improved efficacy and bioavailability, and/or 
reduced dosing frequency to improve side effect profiles and enhance patient 
compliance. For example, Vectura Maxsol™ and Elan Nanocrystal® technologies 
improve the dissolution characteristics and bioavailability of poorly soluble drugs;
r y i w    m w
Shire Microtol and Yamanouchi Pharma Technologies OCAS are controlled 
release systems which allow reduced drug dosing frequency. New drug delivery 
systems may also open up new avenues for chemical entities that were not previously 
available for use because of their toxicity or poor bioavailability. For example, delivery 
of antineoplastic agents directly to tumour cells can greatly reduce toxic systemic side 
effects2.
Today, due to cost and competition, pharmaceutical companies are under pressure to 
maximise the full potential of a drug candidate at an early stage in its life cycle1,2. This 
aim can be achieved by incorporating the drug into various drug delivery systems. This 
exercise can also add economic value to drugs by providing product patent life 
extension, higher level of product differentiation and convenient dosage forms. 
Furthermore, companies can also make use of the regulatory exclusivities of the US 
Federal Food, Drug, and Cosmetic Act (FDCA) to effectively extend product franchises 
through the use of new delivery systems even where patent protections have expired3.
The future of gene therapy will also largely depend on innovative drug delivery 
techniques to deliver genes directly and precisely to their targets2’4, e.g. the cell nuclei. 
In addition, in the last twenty years, there has been a growing demand for more patient- 
compliant dosage forms, such as, dosage forms with controlled release properties to 
reduce dosage frequency, and dosage forms with improved organoleptic properties.1
1
As a result, there has been a boom in drug delivery corporations and medical device 
companies. The value of the drug delivery market is expected to increase 5 fold from 
$2.4 billion to nearly $12 billion in just 5 years3, and the demand for innovative drug 
delivery technologies is expected to grow continuously1.
1.2 The Concept of Controlled Release and Drug Carriers
The ideal drug delivery system is one that releases the drug into the appropriate part of 
the body when and where it is required, at the minimum dose level needed for the 
desired therapeutic effects. Such a system should have a programmable concentration­
time release profile or environmentally sensitive controls to enable it to achieve the 
optimum therapeutic results. However, such ideal systems are not always available. 
Nevertheless, scientists have moved closer to this goal by developing controlled release 
drug delivery systems. Controlled release describes a predictable and reproducible drug 
release kinetics5, i.e., a controlled drug concentration in the targeted tissue.
As the name implies, controlled-release drug delivery systems serve two functions. 
Firstly, ‘drug delivery’ indicates it involves the transport of the drug to a particular part 
of the body. This may be accomplished in a number of ways including intravenously, 
transdermally or orally. Secondly, ‘controlled release’ describes the rate at which the 
drug is made available to the body once it has been delivered.
Controlled release systems are particularly useful for drugs with narrow therapeutic 
windows where minimum fluctuation of blood concentration is desirable. Figure 1.1 
shows how the plasma drug concentration profile of a conventional oral delivery 
system, which requires multiple dose administration in a day, compares to the plasma 
drug concentration achieved using a controlled release system. For conventional 
therapy, the concentration of drug available to the body immediately peaks and then 
declines rapidly. At times, the drug concentration is very high, contributing to adverse 
side effects and compromised drug safety6. At other times, the concentration is too low 
to provide therapeutic benefit. Controlled release systems can provide sustained blood 
concentration, reduce side effects caused by the peak and trough effect, and reduce 
dosing frequency, therefore improve patient compliance.
2
The basic controlled release formulation consists of an active drug and a carrier, 
arranged to allow the drug to be released at the target over a period of time and at a 
controlled rate. The carrier, typically an organic polymer, serves as a barrier against 
drug release in order to achieve gradual drug release and/or to protect the drug from 
chemical or biological degradation. The drug particles are normally dispersed or 
encapsulated as solid solution or crystalline material in the carrier.
  Conventional tablet










Figure 1.1. Plasma drug level of a drug versus time profile when administered orally as 
a conventional tablet compared to a controlled release drug delivery.
Controlled release systems can be classified based on their controlling mechanism of 
drug release as chemically controlled systems or diffusional controlled systems7.
In chemically controlled systems, the drug is contained within a polymer membrane or 
matrix. The polymer is designed to degrade and release the drug at a specific location 
in the body. As the polymer degrades by hydrolysis or enzymatic cleavage, the drug is 




In diffusional systems, the drug is either encapsulated in a polymer membrane 
(membrane-reservoir systems) or suspended within a polymer matrix (matrix system). 
Typically the course of events is as follows: water diffuses into the membrane or 
matrix, the drug dissolves, and finally the dissolved drug diffuses out of the polymer. 
In a membrane system, the rate-determining step is the diffusion of a drug through the 
polymer. The rate of release is constant and proportional to the concentration of drug 
initially present. For these systems, before the establishment of a steady release rate, it 
is common that the initial release rate is much higher. This so called “burst effect” is 
due to the initial drug saturation of the membrane. In a matrix system, due to the 
increasing diffusional resistance and the decreasing area at the penetrating diffusion 
front as matrix diffusion proceeds, the rate of release depends upon the amount of drug 
present at a particular time, thus the rate of release is time dependent8,9.
There is also a sub-group of diffusion-controlled systems that depends on osmotic 
pumping mechanism. The drug is surrounded by a semi-permeable membrane that 
regulates the osmotic permeation of water. The membrane contains a small, laser- 
drilled hole. Within the membrane there is a high concentration of an osmotic agent, 
either the drug itself or a salt, which causes water to enter through the membrane. The 
drug is then forced out through the hole because of the increased pressure9. For a fixed 
reservoir, the device delivers a volume of drug solution equal to the volume of osmotic 
water uptake in a given time interval. The rate of drug release from these systems is 
generally regulated by the osmotic pressure of the drug core formulation and by the 
water permeablility of the semipermeable membrane7.
1.3 Microsphere Drug Delivery Systems
The term ‘microsphere’ or ‘microparticle’ is a general name used to describe spherical 
particles with a diameter between 1 pm - 1000 pm10. Microsphere/microparticulate 
delivery systems developed from organic polymeric materials have been widely 
investigated for controlled and targeted delivery of biologically active substances. The 
production technology mainly uses either the emulsion solvent evaporation/solvent 
extraction process11,12 or spray-drying13,14,15.
4
1.3.1 Organic Microspheres
Almost all microsphere drug delivery systems studied until today are made from 
organic materials. These are biodegradable and biocompatible polymers, which include 
lactic and glycolic acid derivatives11, polyanhydrides16, cellulose derivatives10’14, 
chitosan13’17, liposome18’19, gelatin20, acrylic polymers21 and silk22. They are mainly 
membrane-reservoir systems. The drug is surrounded by a rate-controlling membrane. 
A saturated reservoir maintains a constant rate of drug release. The kinetics of drug 
release depends on the diffusion of drugs across the membrane.
Pharmaceutical scientists welcome the concept of ‘microsphere drug carrier’ because 
by encapsulating drugs in microspheres, each particle is a delivery system itself. 
Therefore, the chance of dose dumping due to failure of one system is reduced. 
Furthermore, microspheres can be filled into containers of any size or shape and be 
formulated into various dosage forms.
Microsphere drug carriers also have the flexibility to be adopted for various delivery 
modes. Microspheres have been shown as promising drug delivery systems for
4^  A 4 0*5 4 4 4 ̂
oral ’ , vitreoretinal , parenteral , transdermal ’ , pulmonary , nasal and 
implants13 delivery. For example, poly-DL-lactic-poly(ethylene glycol) microspheres 
were studied as hepatitis B antigen carriers for oral and subcutaneous administration, 
and they were shown to induce a better immune response than conventional alum- 
absorbed antigens23; mucoadhesive hydroxypropylcellulose microspheres were 
prepared as powder for inhalation and were shown to enhance pulmonary drug 
absorption14; chitosan microspheres were studied as drug carrier for long acting 
injectable implants13 and were shown to be effective influenza vaccine carrier also via 
nasal delivery27; drug-loaded polylactic acid and poly(lactic-co-glycolic) microspheres 
have been used to treat diverse vitreoretinal diseases via intravitreous injection24; 
hollow microspheres were used as floating drug delivery systems to increase gastric 
retention of the drugs for oral delivery ; and acrylate/vinyl ester microspheres have 
been patented for use in adhesive transdermal delivery systems25.
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As explained earlier, the main advantages of using organic polymers microspheres are 
that they are biocompatible and bioerodible. However, there are limitations to these 
organic microspheres:
1. Toxicity -  Preparation of organic microspheres mostly involve the use of 
organic solvents, e.g. chloroform and glutaraldehyde, which are toxic. 
Therefore, there is a possibility of toxic contamination in the end products.
2. Stability problems -  Some organic microspheres are not stable. For example, 
liposomes are unstable unless the lipid bilayers are specifically stabilised. As a 
result, they have a very short shelf life. The exposure of protein drugs to 
organic solvent may have adverse effects on the stability of the proteins11.
3. Dependent on erosion kinetics -  For bioerodible organic microspheres, the 
incorporated drugs are released when the polymer erodes by hydrolysis or 
enzymatic cleavage. Therefore the release profile of the drug is dependent on 
the erosion kinetics of the matrix and in turn, the erosion kinetics is dependent 
on the environment.
4. Low drug loading -  The organic microspheres are usually non-porous and the 
carrier matrix makes up most of the content. Hence the drug loading capacity is 
correspondingly reduced.
1.3.2 Inorganic Microspheres
There are very few published reports about the use of inorganic microspheres as drug 
carriers. Kortesuo et al.29 studied the uses of spray-dried silica gel microspheres for 
controlled drug delivery. Silica xerogel had previously been studied in the form of 
monoliths or crushed particles and was found to show controlled release 
characterisitics30. The spray-dried silica gel microspheres produced had a smooth 
surface without pores on the external surface and were found to release toremifine 
citrate and dexmedetomidine HC1 in a period of 7 to 50 days. Compared to the 
production of monoliths, the production of spray-dried silica gel microspheres was 
simpler and less time consuming. Also, spray-dried silica gel microspheres were found 
to accommodate lower drug loading and degrade more slowly (-10 % degradation in 30 
days) than silica xerogel monoliths. This was probably due to the condensed structure 
of the silica gel microspheres compared to the monoliths.
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In this study, the potential of inorganic calcium phosphate microspheres, as drug 
delivery carriers was investigated. It is proposed that these calcium phosphate 
microspheres systems will have the following advantages over organic systems:
1. Non-toxic -  Preparation of microspheres does not require the use of toxic 
organic solvents.
2. Stability and strength -  Calcium phosphates are ceramic materials that provide 
the structural stability of a largely immutable solid. They can be used to protect 
and stabilise drugs that are embedded in their matrix. They can also be used as 
a skeleton for more complex systems. For example, as the basis for bone 
implants.
3. Controlled porosity -  The microspheres are porous and the drug release will be 
controlled by the porosity and pore-size of the microspheres. The drug release 
is not erosion kinetics-dependent; therefore, its drug release is not environment 
dependent.
4. Bone delivery -  Calcium phosphates are biocompatible with our bones. They 
can be absorbed by the bone to form the precursor of new bone31. Therefore, 
they are potentially suitable to be used as bone implants.
5. High drug loading -  The microspheres are porous and can accommodate high 
amounts of drug.
1.4 Calcium Phosphates for Drug Delivery
Calcium phosphates are inorganic materials found in most animals, often in appreciable 
quantities32. They are the main constituent of teeth and bone in human bodies, and 
calcium phosphate spherical particles have been found inside and outside bone cells32.
In this study, calcium phosphates were investigated because their biocompatible nature 
means that they may be applicable in various administration routes, including oral, bone 
implantation and transdermal delivery. Furthermore, they are well-studied 
pharmaceutical excipients.
Calcium phosphates are everyday ingredients in the pharmaceutical industry. The 
common forms are dibasic calcium phosphate (DCP), CaHPCU, in dihydrate or 
anhydrous form, beta-tricalcium phosphate (P-TCP), Ca3 (PC>4 )2 , and hydroxyapatite
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(HA), Caio(P0 4 )6 (OH)2 . The physicochemical properties of calcium phosphates are 
described in a recent monograph by de Groot et a l 35
DCP is one of the most widely used excipients for direct tableting, because it is cheap, 
has low hygroscopicity, a high bulk-density, and its aqueous dispersions33 are neutral in 
pH. P-TCP is widely used as a diluent in tablets and capsules, a calcium source in
<31
health supplement preparations, and an anticaking agent in food applications . Tablets 
prepared with DCP or P-TCP do not disintegrate readily, therefore, a disintegrant is 
always necessary33. DCP itself has been shown to retard drug release in controlled 
release tablets34.
HA is the most stable form of calcium phosphate at pH > 4.235. Its crystallography and 
chemical composition closely resemble those of bone and tooth mineral. Natural bone 
contains approximately 70% of HA by weight36. HA is a bioceramic that is now 
commercially used for bone repair, bone substitution, hard tissue implantation or as a 
coating on implants37.
Bioceramics are ceramic materials that are used for the repair and reconstruction of 
diseased, damaged or ‘worn out’ parts of the body. Calcium phosphate-based 
bioceramics, especially HA and P-TCP, have had a distinct place in the biomaterials 
research field for the last 30 years35. This is because they are biocompatible, non-toxic, 
non-immunogenic towards living tissue37, and most importantly, they exhibit bioactive 
behaviour.
Bioactive behaviour means that calcium phosphate bioceramics are integrated into bone 
tissue by the same ongoing processes active in remodelling healthy bone, through 
resorption and deposition of bone mineral. This leads to osseointegration - an intimate 
physicochemical bond between calcium phosphate implants and bone31. Calcium 
phosphates are also known to support osteoblast adhesion and proliferation. Porous HA 
implants have been found to promote the growth of soft connective tissues37, and bone 
and bone marrow cells were found inside HA implants pore structure ’ . p-TCP 
implants have also been found to be biocompatible and have connective tissue grown in
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their pore structure37. p-TCP implants are classified as resorbable35, and are designed 
to degrade gradually with time, whilst being replaced with tissue.
Calcium phosphates have also found increasing usage as drug delivery devices. 
Lasserre et al.40 recently published a comprehensive review on ceramic controlled drug 
delivery devices that include porous block ceramics, matrices, inserts, ceramic 
reservoirs and cements, mainly used as implants. The article discusses advantages and 
disadvantages of conventional drug delivery systems and different approaches used to 
deliver chemical and biological agents, by means of ceramic devices.
HA and P-TCP bioceramics have been investigated as drug delivery system for 
antibiotics, anticancers and analgesics. Itokazu et al.41 reported that antibiotics 
impregnated in porous HA cubic blocks, continue to release antibiotics and maintain 
their concentration levels above the minimum inhibitory concentration after 42 days. 
Seven patients with osteomyelitis have been treated using this system and no 
complications were observed during the follow up period of 8 - 36 months. Shinto 
et a/.38 demonstrated that the release of antibiotics from HA blocks, both in vitro and in 
vivo, was sustained and still effective at week 12. Martins et al.42 showed that a HA 
anionic collagen composite supports sustained released of ciprofloxacin and shows 
good biocompatibility associated with bone tissue growth.
Uchida et al.39 and Itokazu et a l 43 studied the release of anticancer agents (cis-platinum 
and methotrexate, respectively) from HA blocks. It was reported that drug release was 
maintained at high enough concentrations, up to as much as 12 weeks.
Otsuka et a/.44,45,46,47,48 investigated the in vitro and in vivo release characteristics of 
analgesics, indomethacin and aspirin, from self setting calcium phosphate cements and 
found that sustained release of drugs was achieved.
The apparent disadvantage of using calcium phosphates as drug carriers for bone 
delivery is the invasion treatment necessary to insert the materials into the body. Other 




Spray-drying is the transformation of feedstock from a fluid state into a dried product 
by spraying the feedstock into a hot drying medium, usually a gas49. The feedstock can 
be a solution, emulsion or suspension.
Spray-drying has long been an important processing step in the food, pharmaceutical 
and ceramics industries. It is a useful quick drying method, which results in weight and 
volume reduction. Some examples of spray-dried products are instant coffee, baby 
foods, powdered milk, fertilisers, plastics and structural ceramics.
In the pharmaceutical industry, spray-drying is widely used in the production of 
excipients, antibiotics, enzymes, and as an alternative to wet granulation for tablet 
formulations that cannot be directly compressed50. The advantages of spray-drying 
include:
1. It can produce powders with controlled flowability, bulk-density, moisture 
content, and particle size of narrow distribution.
2. It is applicable to both heat sensitive and heat resistant materials because the fast 
moisture evaporation keeps the particles cool.
3. It can be run continuously, adaptable to full automatic control and suitable for 
mass production.
There are four key steps in the spray-drying process:
1. Atomisation of feedstock into fine droplets
This is achieved by using a pneumatic/nozzle or rotating wheel atomiser. In 
pneumatic atomisation, a high-pressure air jet disintegrates a stream of 
feedstock that is pumped in at low-pressure. In rotary wheel atomisation, the 
feedstock flows onto a rapidly rotating wheel and is converted to a fine mist. 
Pneumatic atomisers are more suitable for producing very fine sprays (droplet 
size < 50 pm) but are more energy consuming.
2. Spray-air contact
The cloud of sprayed droplets meets a stream of hot drying air.
3. Moisture evaporation and particle shape formation
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When the droplets come into contact with the hot air, the liquid, usually water, 
evaporates leaving the dry solid behind.
4. Separation of dried product from the air
The dried product is passed into the cyclone where it is separated from the air 
stream. The resulting product is then collected in a collection bottle.
There are three types of airflow designs for spray-dryers51 as illustrated in Figure 1.2:
a) Co-current flow -  The feedstock is sprayed in the same direction as the flow of 
the hot air. The sprayed droplets meet the hottest part of the air when they are 
most moist.
b) Counter current flow -  The feedstock is sprayed in the opposite direction of the 
flow of the hot air. The sprayed droplets meet with increasingly hotter air in the 
chamber.
c) Mixed flow -  The feedstock is sprayed upwards, briefly encounters the hot 
drying air coming from the top. Then, due to gravity, the product falls 
downwards and travels through the cooler part of the chamber.
___ > ------ >
Feedstock spray Air flow
(a) Co-current flow (c) Mixed flow(b) Counter current flow
Figure 1.2 Various air-flow designs for spray-dryer.
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Co-current flow design is more suitable for thermally sensitive products because the 
droplets come into contact with the hot drying air when they are most moist. The 
moisture evaporation keeps the droplets temperature down. Product temperature on 
discharge from the dryer is lower than the exhaust air temperature. The counter current 
design is suitable only for thermally stable products which require a degree o f heat 
treatment during drying. The temperature o f  the powder leaving the dryer is usually 
higher than the exhaust air temperature. Therefore, the products contain less residual 
moisture in the case o f counter current design than in the co-current design. The mixed 
flow design has the advantages o f both co-current and counter current spraying 
methods. Due to the fact that the product is only in the hot zone for a short time, it is 
also suitable for both thermal sensitive and thermal stable products.
holding them together. When the droplet first comes into contact with the hot drying 
medium, evaporation o f  the solvent is immediate and rapid. Soluble materials, such as 
binders, are left behind forming a skin or film on the surface o f  the droplet (Figure 1.3). 
Due to the rapid evaporation process, the droplets are maintained at a relatively cool 
temperature even during the period they are exposed to the hot air.
1.5.1 Drying of a Single Droplet
















Figure 1.3 The drying o f a spray-dried droplet (adapted from Shaw52).
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The second stage of evaporation occurs at a slower rate52. The drying state proceeds at 
a constant rate as long as the surface remains saturated with liquid. The drying rate 
decreases as the liquid-vapour interface recedes into the porous material, until almost 
all liquid is evaporated.
Spray-drying produces particles of a variety of shapes, including hollow spheres, 
doughnut shaped particles and solid spheres.
The suggested mechanisms for the formation of hollow spheres are52,53,54:
(1) During solvent evaporation, the suspended solids are drawn to the droplet 
surface when the liquid at the interior of the droplet slowly diffuses to the 
surface to evaporate. As evaporation progresses, the skin grows inwards 
resulting in a hollow sphere. Internal pressure is built up in the droplet during 
this stage. If the shell is porous, this pressure could be released and a hollow 
sphere would be formed. If the shell is non-porous, a hollow sphere might erupt 
under the high internal pressure, and collapse (Figure 1.4).
(2) A low-permeability elastic film forms around the droplet. The internal pressure 
builds up during evaporation and causes ‘ballooning’.
(3) The presence of entrapped air in the slurry persists as voids.
Droplet of is porous
clear solution /*  w
If the crust —  Hollow  
structure
000*0
If the crust V  CollaPse
is solid
Figure 1.4 Illustration of hollow sphere formation (adapted from Luo et al.53).
S3The mechanisms suggested for the formation of doughnut shaped particles are ’ :
(1) In diluted slurries, the mobility of insoluble particles within droplets is high. 
These particles tend to travel to the bottom due to gravity, and elongated shape 
droplets are formed. This increases the surface area, which in turn increases the
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total surface energy of the droplet. When the droplet is detached from the 
stream, the strong effect of surface spring-back occurs to minimise the surface- 
to-volume ratio. This spring-back action results in the inward collapse of the 
opposite faces of the drop and a doughnut shaped particle is formed (Figure 1.5).
(2) Since droplets do not rotate as they travel through the drying air, one side of the 
droplet always meets the hotter gas. Therefore, evaporation is quicker on this 
side and the shell grows thicker more readily. The trailing side will have only a 
thin shell and the interior on this side will tend to stay wet and fluid. While the 
liquid and solids migrate to the hot side, the thin side is drawn inward, resulting 









Figure 1.5 Illustration of the mechanism of doughnut shaped particle formation 
(adapted from Luo et al.53).
Solid spheres are formed during the spray-drying of high solid content slurries. In these 
cases, the surface temperature of the spray droplet exceeds the boiling point of water 
during drying. Moisture rapidly flows to the droplet surface by capillary action. A 
thick shell of insoluble precipitation rapidly forms and hence heat transfer into the 
interior of the droplet becomes difficult and the temperature at the interior can never 
reach the boiling point. The drying process is thereby controlled by the outward
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diffusion process of water. The result is the formation of solid spheres53. The denser 
the starting slurry, the denser the solid spheres.
The properties of spray-drying products, such as appearance, particle size, particle 
density and porosity, can be altered by changing the spray-drying parameters, such as 
atomisation, spraying temperature, airflow, and the slurry composition, including 
concentration, rheology, additives and the dispersion state of the slurry55. Since the 
effects of each change on the final product are difficult to predict, development 
normally proceeds on a trial and error approach56.
1.5.2 Spray-drying of Ceramics (Inorganic Materials)
The spray-drying of inorganic materials is widely practised in the ceramic industry. 
The basic ceramics manufacturing techniques are: mill, dry, press, and fire. Spray- 
drying is a versatile process for producing the dry and free-flowing powders directly 
from milled ceramic slurries. It also incorporates a particle formation process. The 
process can control the powder characteristics produced in terms of particle size, 
flowability, bulk-density and moisture content. In the ceramic industry, the ability to 
control these powder characteristics during the drying stage is very important because 
the quality of the finished piece depends on them.
Spray-drying is used in the manufacture of powder for whitewares (tiles, dinnerware), 
structural ceramics (biomedical parts, wear parts), and more importantly in the 
advanced ceramic industry, electronic ceramics (semi-conductors, capacitors)57.
When making ceramic powders, the feed material is usually a water-based suspension, 
often called a slurry. To spray dry a slurry, the slurry must be pumpable. The 
homogeneity of the slurry and the solids content are critical for optimum atomisation. 
The air dispersing conditions are controlled to achieve reproducible powder quality.
Sometimes, additives are mixed in. In spray-drying for dry pressing, binders, 
dispersants and lubricants are often added to improve the subsequent pressing 
operation. Binders are added to increase particle strength. Dispersants are added to 
achieve higher total solid content for the control of powder density. Lubricants are
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added so that the dried product on pressing requires less applied pressure and also aids 
the release of the pressed item from the die.
All additives are soluble, hence spray-dried products consist of soluble additives and 
insoluble ceramics. During spray-drying, the soluble materials form an even coat 
around each ceramic particle, holding the submicron primary particles together. The 
additives are normally organic and are used in very small quantities, typically 1% - 2% 
by weight. Only small amounts of additives are needed because the homogenous 
coating of these materials on all particle surfaces is effective with spray-drying. By
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applying laser microscopy and immersion liquid technique, Zhang et al. reported that 
a binder was observed to effectively distribute itself onto the surfaces of spray-dried 
ceramic particles. Additives may have a negative effect on the properties of the final 
product. This is why organic additives, which are easily burned out in the subsequent 
firing process, are mainly used.
For most ceramic systems, spray-dried granules should ideally be uniform solid 
spheres. Solid spheres form the best compacts, which sinter well to form finished 
products with the least number of defects.
The spray-drying of hydroxyapatite was studied by Luo et al.53. It was reported that 
agglomerated spherical hydroxyapatite granules with controlled particle sizes and 
structures were produced. It was observed that by adjusting the spray-drying 
conditions, such as the volume fraction of feed slurry and the atomisation pressure, the 
granules produced were doughnut shapes, solid spheres or hollow spheres and of 
various sizes. The mechanisms of formation of these structures proposed by the authors 
are included in the discussion earlier in section 1.5.1.
Takami et al.59 produced granulated DCPA for direct tabletting by a restricted crystal 
growing synthesis of DCPA, followed by spray-drying of its aqueous dispersion. It was 
reported that the technique produced spherical DCPA with remarkably improved 
compressibility and flowability, higher specific surface area (~ 33 m2/g) and lower 
crystallinity, compared to conventional DCPA. Tablets prepared with spray-dried 
DCPA were also found to have a relatively higher tensile strength. It was proposed that 
the free-flowing properties of the spray-dried DCPA were due to a significant reduction
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in interparticle friction because of their spherical shape, and the higher tensile strength 
was due to an increase in interparticle bonding in the tablet as a results of plastic 
deformation of the spray-dried DCPA particles which were porous and had low 
crystallinity.
1.6 Sintering
A ceramic green body is a molded shape made from a multitude of ceramic particles. 
The assembly of these ceramic powder particles usually has pores filled with 
atmospheric gas. When the temperature increases, material flows from various sources 
within the green body to fill the pores between particles. This process is termed 
sintering and the new deformed particles are referred to as grains.
Sintering is a standard technique used in ceramic industry for strengthening the ceramic 
green body. During sintering, the ceramic is heated to very high temperatures that are 
close to its melting point. The results of sintering include:
a) Changes in grain-size and shape;
b) Changes in pore-size and shape.
In brief, sintering is a process where particles coalesce under heat without liquefaction. 
A schematic representation of sintering is illustrated in Figure 1.6. During sintering, 
particles coalesce, small pores disappear and shrinkage takes place (shrinkage is 








Figure 1.6. Process of sintering (adapted from de Groot et al. ).
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The driving force for sintering is the reduction of total surface area62, where the high 
surface energy solid-air interfaces of a powder are replaced by the lower energy solid- 
solid interfaces in the form of grain boundaries. The surface of a solid material usually 
consists of high energy chemical bonds, which are comparable to stretched springs. In 
nature, low energy state bonds are preferred. When particles touch each other, 
spontaneous joining does not occur because there is an energy barrier, the activation 
energy (Figure 1.7). During sintering, the activation energy is provided and this barrier 
is overcome62. Hence, the stretched springs relax, energy is released as heat, the 
surfaces merge, and the stretched bonds on the surface move into the lattice vacancies 
of nearby material becoming ordinary internal chemical bonds63. Since the newly 
formed grain boundary also represents an area of high energy in the system, there is 





Distance between atoms 
Figure 1.7 Activation energy (taken from Shanefield62).
Solid state sintering takes place in three stages as described in Table l . l 60. During 
sintering, materials migrate mainly due to surface curvature and vapour pressure36. In 
the initial stage, also referred to as neck growth, the system tries to minimise its surface 
free energy by migrating high energy bonds into existing lattice vacancies, as described 
in the previous paragraph. If there is a difference in the concentration of lattice 
vacancies, materials will move from areas of low concentration to areas of high 
concentration. Due to the surface curvature, the lattice vacancies near the neck are 
greater; as a result, during sintering materials migrate towards the neck area. This leads 
to increased particle contact, neck growth, and the grain centres moving closer together, 
resulting in interparticle shrinkage and an increase in density. Since the vapour
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pressure also changes with respect to the curvature, it also promotes material transfer64. 
The first grain growth represents the termination of the initial sintering stage and the 
beginning of the intermediate stage. At this point, pores are continuous, interconnected 
and intersected by grain boundaries. During the intermediate stage, the cylindrical 
pores shrink and break up into a string of spherical, closed pores (Figure 1.8)60 and the 
grain size grows slowly. In the final stage, these isolated pores shrink continuously 
until they disappear, and the sintering process is considered complete. An alternative 
final stage of sintering occurs when the discontinuous grain growth occurs before all the 
porosity is removed. Further heating results in the elimination of pores at the grain 
boundaries, but the pores situated within the grains still remain. Generally, small pores 
that are a fraction of the powder particle size will disappear during sintering, but larger 
pores cannot be sintered out62.
Table 1.1 Stages of microstructural characteristics during solid state sintering of 
powder compacts60.
Stage Observations
Initial Surface smoothing of particles 
Grain boundaries form, neck growth 
Rounding of interconnected, open pores 
Porosity decreases <12%
Intermediate Shrinkage of open pores intersecting grain boundaries 
Mean porosity decreases markedly 
Slow grain growth
Final (1) Closed pores containing kiln gas form when density is ~ 92% 
(>85% in heterogeneous material)
Closed pores intersect grain boundaries 
Pores shrink to a limited size or disappear 
Pores larger than grains shrink relatively slowly
Final (2) Grains of much larger size appear rapidly 





Figure 1.8 Break up of a cylindrical pore into a string of spherical pores (adapted from 
Ring60).
The higher the surface area per gram of powder, the more surface energy is available as 
a driving force for sintering. Hence, the specific surface area of the starting powder can 
be a good indicator of how well a powder will sinter under favourable conditions62. 
Different sintering conditions such as temperature, duration and atmosphere of sintering 
will cause the primary particles to ‘coalesce’ to different degrees36. Therefore, by 
modifying the starting powder and the sintering conditions, it is possible to tailor make 
ceramics with desired porosity and pore-size.
Sintering adds mechanical strength to a material but generally does not change the 
chemical nature of a material. Sintered calcium phosphates are biocompatible and 
sintered hydroxyapatite is commonly used as a bone substitute.
1 . 7  Project Background
As discussed earlier (section 1.5), under the right conditions spray-drying can produce 
inorganic free-flowing hollow centred agglomerates or microspheres (Figure 1.9). 
These microspheres are held together by a binder, which is mainly distributed on the 
surface of the microspheres. It is envisaged that these microspheres can be used as drug 
carriers. Their hollow centres can be used as drug reservoirs while their shells and the 
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Figure 1.9 Schematic of a microsphere.
It is proposed that microspheres of different sizes would release incorporated drug at 
various rates. Therefore, if a drug carrier system contains microspheres of two particle 
sizes, it is reasonable to expect that the drug might be released at two different rates. 
An extended or a biphasic drug release profile may be achieved. This concept is 
illustrated in Figure 1.10.
Release rate
Time
Figure 1.10. Microspheres of two different particle sizes may produce two different 
drug release rates. An extended release profile can be achieved.
If a drug carrier system contains two or more types of microspheres, and these 
microspheres are made from materials which have different dissolution rates (Figure 
1.11), two or more different release rates can be achieved (illustrated in Figure 1.12).
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Drug reservoir
Figure 1.11 A system with microspheres o f different solubilities.
Furthermore, by using binders o f  different solubilities, or by adding external coatings to 
the microspheres, the release o f drugs may be further delayed and targeted at different 
absorption sites o f  the gastrointestinal tract depending on the properties and solubility 
o f  the coatings.
The porosity and pore-size o f  these inorganic microspheres can be further modified by 
sintering. Different sintering conditions can produce microspheres with different pore- 
sizes, which may deliver drugs at different rates. Controlled pore-size may lead to 
controlled drug release. In short, different combinations o f the microspheres may be 
used to achieve desired patterns o f delivery.
Most soluble microspheres 
Medium soluble microspheres 
Least soluble microspheres
Time
Figure 1.12 Carrier materials with different dissolution rates could produce a 
multiphase drug release system.
Release rate
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There are several probable methods of loading a drug into the microspheres:
1. A drug is mixed with the slurry, and the drug-containing slurry is then spray- 
dried.
2. Microspheres are placed in a vacuum, and a drug, either as powder or solution, is 
then vacuum forced into the microspheres.
3. Drug crystals are cultivated within the microspheres by soaking the 
microspheres in supersaturated drug solution.
4. A drug is bound to a polymer and then the drug-containing polymer is loaded 
into the microspheres.
In summary, it is proposed that ceramic microspheres can be developed into a novel 
drug delivery system. The system is flexible and allows customised multiphase drug 
release profiles. It is envisaged that flexibility of the system to delivery drugs at 
various rates can be achieved by:
1. Using microspheres of various sizes;
2. Using microspheres made from materials of different dissolution properties;
3. Controlling the pore-size of the microspheres by sintering;
4. Further coating the microspheres with polymers (for example, acid resistant 
polymer for target release in the intestine).
Apart from being highly flexible, it is expected that the new system will also be 
attractive from the manufacturers’ viewpoint because:
1. The ingredients involved are low cost pharmaceutical materials;
2. No toxic solvents are needed in the process;
3. The process is suitable for automatic mass production;
4. Ceramic systems are stable, heat resistance, have long shelf life, and can be 
easily sterilised by either heat or gamma radiation.
1.8 Potential Usage of Calcium Phosphate Microspheres
1.8.1 Bone Delivery
Osteomyelitis is the infection of bone, usually of bacterial origin. Infections are 
chronic, painful and require urgent treatment. The success of the treatment depends on
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the delivery of bactericidal concentration of antibiotics to the infected bone. Currently, 
osteomyelitis is treated with antibiotic-impregnated polymethylmethacrylate (PMMA) 
beads/cement as implants in the infection site, and systemic antibiotics65.
Bone implants are effective in delivering high concentration of antibiotics. However, 
the main disadvantage of the PMMA systems is that they have to be changed at regular 
intervals, and they must also be removed before sound bone can re-grow in the defect. 
The reopening of the wound for changing is a very costly and painful process. Other 
disadvantages of PMMA systems include:
• During polymerisation of PMMA cement, antibiotics such as penicillin and its 
derivatives could be deactivated40;
• PMMA does not bond to living bones;
• PMMA toxicity poses a practical clinical problem. It has been reported that 
even at low concentrations, the polymer can seriously suppress the phagocytic 
and bactericidal activity of human leukocytes66.
As discussed earlier (section 1.4), calcium phosphates are biocompatible, resorbable, 
and can act as bone precursors. As a result, calcium phosphate microspheres would be 
ideal implant drug carriers for the treatment of osteomyelitis and other bone disorders. 
The main advantage of these systems is that they do not have to be surgically removed 
after the delivery of drug. They can either dissolve in the body or become part of the 
bone tissue by a natural growth process. In other words, after the delivery of antibiotic, 
the carrier forms the basis of a bone graft.
By using calcium phosphates of a range of solubilities, these drug carrier systems can 
be engineered to resorb at a known rate, part of the structure dissolving at a 
predetermined rate and part of the structure remaining insoluble to be integrated to the 
new bone structure. These microspheres can be antibiotic reservoirs, which release 
antibiotics directly at the site over a sustained period of time. By controlling the 
morphology and pore-size of these microspheres, precise control of drug delivery rates 
may also be achieved. Should very low rates of delivery be required, the drug might be 
incorporated into a polymer host and then be held in the ceramic host superstructure.
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1.8.2 Oral Delivery
Since calcium phosphates are usual excipients in tabletting, calcium phosphate 
microspheres can be taken orally. Potentially, the microspheres could be used in the 
pharmaceutical and food industries. For example, due to their robust nature, they could 
be used as a protective carrier to stabilise food substances or drugs in the digestive tract, 
or during the storage period. They could also be used as carriers to mask the bitter 
tastes or strong smells of drugs or health foods. This masking method could be 
advantageous over traditional methods of packing materials in capsules or using tablet 
coatings, as some capsules and coated tablets are difficult to swallow due to their size.
These microspheres could be coated with biopolymers of different properties, i.e., 
gelatin, chitosan, carrageenan or eudragits, to further delay the release of the drugs from 
the microspheres and to achieve controlled release, or to improve the taste masking 
property of the microspheres.
Spray-dried calcium phosphate microspheres are highly porous and therefore have the 
potential to accommodate high drug loading. High drug loading carriers could reduce 
the size of dosage forms, making them more acceptable to patients. Also, some drugs 
that are currently only feasible to be formulated as tablets could be formulated as 
capsules if they are to be incorporated into these microspheres.
By modifying the pore-size and structure of the microspheres, the release of drugs from 
them could be modified and controlled. Therefore, the microspheres themselves could 
be the basis of an oral controlled release system.
Sintered microspheres are not expected to dissolve in the intestine and therefore not be 
absorbed by the body through the gastro intestinal tract, but will leave the body as 
ghosts. Since these microspheres are in the micron size range (mainly < 30 pm in 
diameter), they should not be noticeable in the faeces.
1.8.3 Transdermal Delivery -  Needle-Free Injection
When the oral route is inappropriate, for example when the first pass mechanism needs 
to be avoided or the patient cannot ingest orally, alternative drug delivery routes are
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explored. Parenteral needle injections can be an effective alternative, however, such 
parenteral administration have the following disadvantages67:
1. Complexity of dose preparation and administration, therefore, professional skills 
are required for their application.
2. Due to stability issues after reconstitution, they have a limited shelf life.
3. Compromised patient compliance. Fear of injections can seriously affect patient 
compliance and needle phobia is common. Pain upon injection is also a factor 
for certain drugs and injection sites.
4. Health workers are at risk of injuries by patients’ needles, which may expose 
them to serious health hazards that include AIDS and hepatitis B.
To overcome the above issues, needle-free injections were invented. Needle-free 
injections eliminate ‘needle phobia’ and reduce patient anxiety. They also eliminate the 
risk of bloodbom pathogen transmission through accidental needlestick injuries. Hence 
the safety for health workers is much improved. The injection occurs in a fraction of a 
second and therefore is very time effective to immunise large numbers of people
/TO
quickly and economically .
Needle-free liquid jet injections have been used for many years69. However, needle- 
free powder injections have only recently been used. Professor Bellhouse at the 
University of Oxford discovered the possibility of using compressed gas to blast fine 
particles of a drug through the surface of the skin in 1992, and a patent was submitted 
for the use of the needle-free syringe using supersonic gas flow for particle delivery in 
199470.
Needle-free powder injection is also known as ‘high velocity powder injection’. It 
works by accelerating particles to a sufficiently high velocity such that they penetrate 
the outer layers of the target tissue and deposit the particles close to the site of action 
for uptake. The technology is based on the principle of supersonic gas dynamics. The 
driving force is compressed gas, helium, which is accelerated to high velocities through 
a specially designed convergent-divergent nozzle70. The drug particles are entrained 
within this gas flow and acceleration is generated by drag, a function of relative slip 
velocity between the particle and gas67. The particle acceleration and exit velocity
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depends on several factors related to the device, e.g., gas pressure, nozzle geometry, 
and the drug particles themselves, e.g., the density and size.
The skin is considered the largest organ of the human body. It is mainly classified into 
three layers: epidermis, dermis and hypodermis. The epidermis is the outermost layer 
and it can be subdivided into many layers including the stratum comeum. The stratum 
comeum, which is 10 -  25 pm thick75, is the principle diffusional barrier to 
percutaneous drug absorption. Powder injection typically delivers the particles into the 
skin to a depth not more than 100 pm. The particles cross the stratum comeum, but still 
stay predominantly in the epidermis. The drug molecules contained in the particles 
then dissolve to act locally or diffuse into the rich capillary beds of the nearby dermis to 
enter the systemic circulation.
Powder injection technology has been developed for the administration of a range of 
medicines, including local anaesthetics {e.g. lignocaine67), proteins and peptides {e.g. 
calcitonin, alprostadil71), and DNA vaccines {e.g. hepatitis B and influenza vaccines72).
The optimum particle characteristics required for powder injection are different from 
the conventional dosage forms. In addition to standard compatibility and stability 
parameters, particle quality and size distribution are also important. There is a strict 
requirement for physical stability in addition to chemical stability. The powder must 
retain its size distribution during transport and storage, and particles must also survive 
the unique action of the gas jet within the device and the impact with the skin at high 
velocity. Furthermore, the powder should also have dissolution characteristics 
appropriate for the given application.
The relatively small-volume of the target epidermis imposes a limitation on the mass of 
powder that can be delivered per unit area of skin. Current powder injection systems 
capable of delivering the drug payload over an area of up to 2 cm2 are generally 
restricted to doses in the low milligram range.
In the case of DNA delivery, the ultimate aim is to deliver the DNA into the cell 
nucleus. DNA has been precipitated onto dense gold particles (1 pm - 3 pm) and
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delivered via a powder injection system by PowderJect Pharmaceutical pic. The results 
showed that a much lower dose of vaccines, ~ 1000 fold less, was needed to produce a 
balanced immune response compared to direct syringe and needle injection73. This is 
because the system delivered the DNA vaccine directly to the intracellular 
compartment74. The use of smaller does of DNA vaccines means that the treatment cost 
can be dramatically reduced.
The depth of particle penetration depends on momentum, i.e. it is related to the particle 
size, mass and velocity (Equation 1.1) . Ideally, optimum momentum conditions will 
be achieved with large, dense particles. However, there is only a practical range of 
particles that can be used. Basic clinical experiments showed that organic particles of 
less than 20 pm have insufficient momentum to penetrate target tissues; particles of 
20 pm - 100 pm penetrated the skin75; particles of excessive size can cause minor 
subdermal haemorrhages and are not suitable for cosmetic reasons.
P = k 1+
I *
Equation 1.1
P  = depth of particle penetration (m)
k = Petry constant67, related to the biomechanical properties of the target tissue 
m = mass of particle (g)
A = plan area of particle (m2) 
v0 = impact particle velocity (m/s) 
vt = threshold particle velocity for penetration (m/s) 
d> = penetration coefficient (m/s)
Depending on the particle and density, formulations for intracellular or extracellular can 
be achieved via powder injection. To achieve intracellular delivery, DNA vaccines 
were precipitated onto high-density carriers, microscopic gold particles that are only 
1 pm - 3 pm in diameter76. These particles achieve the momentum needed to deliver 
the vaccine directly into cells. The average diameter of target epidermal cells is 20 pm, 
therefore the delivered particle does not interfere with cell viability. Once inside the 
cells, the DNA elutes off the gold and becomes transcriptionally active, producing the 
encoded protein to trigger an immune response77.
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For extracellular delivery, pharmaceutically acceptable sugars and polymers were used 
as excipients to aqueous vaccines to impart stability, density and hardness to the 
vaccine particles78. Particles in the 20 /xm - 70 /xm size range were used because 
particles smaller than these were stopped by the skin barrier, and these particles are too 
large to enter individual cells, resulting in extracellular delivery77.
Sintered calcium phosphate microspheres are potentially a better drug carrier than the 
currently used organic carriers (sugars, polymers) or gold for powder injection 
technology because:
1. Calcium phosphates bioceramics are much denser than most organic materials. 
They have a high density of ~ 3 g/cm3 and therefore have the capability of 
achieving high momentum to penetrate the skin.
2. Calcium phosphates bioceramics are much stronger mechanically than most 
organic materials. They can provide the physical strength and stability required 
for this technology.
3. Calcium phosphate microspheres can be manufactured to have high porosity to 
accommodate high drug loading. This is particularly beneficial because the 
small-volume of the viable target epidermis is a limiting factor for the amount of 
particles that can be delivered by powder injection. The high packing density of 
drugs inside the microspheres may also serve as a reservoir for drugs to achieve 
a sustained release profile of drug delivery.
4. Calcium phosphates are non-toxic, biocompatible and bioerodible. Calcium 
phosphate particles are commonly found in all vertebrates32 and they can be 
resorbed by the human body after drug delivery. This is a significant advantage 
over gold, which has been shown to cause severe side effects, especially when 
used in long-term disease management, e.g. in rheumatic arthritis.
5. For achieving intracellular delivery, calcium phosphates are much cheaper than 
gold.
It is possible that the injected sub-dermal calcium phosphate particulates may be 
encapsulated by fibrous tissue and formed a cyst under skin. However, it is more likely 
that the calcium phosphate particulates will be dissolved by the body tissue and any 
non-dissolved parts will be removed from the body together with dead skin cells in our 
natural skin shedding process.
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1.9 Aims of Study
The aim of the project is to develop novel inorganic microsphere drug delivery systems 
using calcium phosphates. The project can be divided into three sections:
1) To produce inorganic porous microspheres using spray-drying
2) To control the porosity and pore-size of the microspheres by sintering
3) To investigate the delivery profiles of drugs via the microspheres
Firstly, the feasibility and limitations of producing calcium phosphate microspheres by 
spray-drying were investigated. The effects of the composition of the slurries and the 
influence of key parameters in the spray-drying process were studied.
Secondly, the porosity and pore-size of the microspheres were modified and controlled 
by sintering. The effects of sintering conditions on the microspheres were investigated. 
The physical and chemical changes of microspheres after sintering were characterised 
by various analytical techniques.
Thirdly, methods of loading model drugs into these microspheres were studied, 
followed by the investigation of in vitro drugs release profile from these microspheres 
to evaluate the drug delivery potential of the systems.
30
2 Materials, Equipment and Methods
2.1 Materials
Material Batch/Lot no. Supplier
Calcium phosphate dibasic 38H0675 Sigma-Aldrich Chemical Co., Dorset, 
UK
Capsules, hard gelatin 
(natural transparent)
size 0: 200820699 
size 2: 30013721 
size 3: 200247099
Davcaps Ltd., Gloucester, UK
Deionised water (purified 
by reverse osmosis)
Freshly purified Millipore, Watford, UK
Dispex A40 00054742 Allied Colloids Ltd., Bradford, UK
Ethanol (99.7-100% v/v) L121307 BDH Laboratory Supplies, Poole, UK
Eudragit L100 03-80047 Rohm Pharma, Weiterstadt, Germany
Hydrochloric acid k28090152 031 BDH Laboratory Supplies, Poole, UK
Paracetamol 77H1805 Sigma-Aldrich Chemical Co., Dorset, 
UK
Polyethylene glycol 1000 17H0551 Sigma-Aldrich Chemical Co., Dorset, 
UK
Polyethylene glycol 6000 23265351 FSA Laboratory Supplies, 
Loughborough, UK
Polyethylene glycol 10000 02920EY Sigma-Aldrich Chemical Co., Dorset, 
UK
Polyethylene glycol 20000 2172A 8908869 BDH Chemicals Ltd., Poole, UK
Potassium dihydrogen 
orthophosphate
A224724 033 BDH Laboratory Supplies, Poole, UK
Propranolol hydrochloride 12896031 Cosma S.P.A. Ciserano (BG), Italy
Sodium
carboxymethylcellulose
60804 Honeywill & Stein Limited, Surrey, 
UK
Sodium hydroxide pellet B255950 828 BDH Laboratory Supplies, Poole, UK





94RH/L2756/1 Thornton and Ross, Huddersfield, 
UK




Accelerated surface area 
and porosimetry analyser
ASAP 2010 Micromeritics Instruments Co., 
Georgia, USA
Dilatometer 214 1 392 Netzsch Thermal Analysis, Bavaria, 
Germany
Dissolution bath Type PTWS3C Pharma Test Apparatebau GmbH, 
Hamburg, Germany
Dissolution software WinDiss Version 
4.106
Pharma Test Apparatebau GmbH, 
Hamburg, Germany
Furnace for sintering CWF 13/13 Carbolite, Sheffield, UK
Filter, sintered glass porosity 4 BDH Laboratory Supplies, Poole, UK
Magnetic Stirrer HI 190M Hanna Instruments Ltd, Bedfordshire, 
UK
Mastersizer Mastersizer X, 
Mastersizer 2000
Malvern Instruments Ltd., Malvern, 
UK
Oven OV-440 Gallenkamp, Loughborough, UK
pH meter Jenway pH meter 
3305
Spectronic Analytical Instruments, 
Garforth, Leeds, UK
pH papers,
(pH 8-10 and pH 4-7)
Fisherbrand Fisher Scientific UK Ltd, 
Leicestershire, UK




Jeol T330 and 
Jeol T6310
Japanese Electron Optics Ltd., Tokyo, 
Japan
Spray-dryer SD-05 LabPlant Ltd., West Yorkshire, UK
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Sputter coater, carbon Pirani Penning, 
Model 4
Edwards High Vacuum Ltd., Sussex, 
UK
Sputter coater, gold Model S150B Edwards High Vacuum Ltd., Sussex, 
UK
Surface area analyser Gemini 2360 Micromeritics Instruments Co., 
Georgia, USA
Tapped density tester J. Engelmann AG, Ludwigshafen a. 
Rh, Germany
Ultramicrotome OM U3 C. Reichert AG, Vienna, Austria




Unicam 8625 and 
Helios a
ThermoSpectronic, Cambridge, UK
Vacuum pump A-C motor, 
5KC48PN0202X
GE Motors, Halifax, UK
Water bath
(Refrigerated Circulator)
DC5-K20 Thermo Haake, Karlsruhe, Germany.
X-ray diffractometer Philips PW 1710 Philips Analytical, Cambridge, UK
2.3 Particle-Size Analysis
Particle-size distributions were determined using either a Mastersizer X or a 
Mastersizer 2000 (Malvern Instruments Ltd., Malvern, UK). Mastersizer instruments 
measure the Low Angle Laser Light Scattering (LALLS) pattern of particles as they 
come into contact with a laser beam. Assuming that particles are spherical in shape, 
Mastersizer's calculations are based on the Mie theory that solves the equations for 
interaction of light with matter. The fundamental measurement produced by Mastersizer 
instruments is a size/volume distribution.
On passing through the beam, samples scatter the laser beam at a low angle in a forward 
direction79. The angle at which the light is scattered by a particle is inversely 
proportional to the size of the particle. Small particles will give rise to large angles of 
scatter, and large particles will give rise to small angels of scatter80. A Fourier lens then
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focuses the scattered light onto a detector. The response is averaged and numerically 
inverted to produce the size distribution results. The instrument can be used to 
characterise particles in both liquid and gas suspending media.
The particle-size distribution results were expressed as volume mean diameter, as 
follows:
d(v, 0.1) = particle diameter, such that 10% of the total particle volume is composed of
particles of smaller diameter.
d(v, 0.5) = particle diameter, such that 50% of the total particle volume is composed of
particles of smaller diameter. This is the volume median diameter. 
d(v, 0.9) = particle diameter, such that 90% of the total particle volume is composed of
particles of smaller diameter.
2.3.1 Mastersizer X
The Mastersizer X uses a low power helium-neon laser beam (A, = 0.63 pm). It has 
three separate lenses: 45 mm, 100 mm, and 300 mm, which are capable of measuring 
particle-sizes in the range of 0.1 pm - 80 pm, 0.5 pm - 180 pm, and 1.2 pm - 600 pm 
respectively.
Obscuration is the amount of light being scattered. The concentration of the sample is 
best when the obscuration is within 10% - 30%. If too little sample is used, the sample 
signals are not clearly distinguished from the background noise; conversely, if too much 
sample is used, secondary scattering or multiple diffraction occurs and the conditions 
on which the sample analysis are based do not apply.
Particle-size distributions measured by Mastersizer X were obtained either by 
suspending the particles in a small-volume (15 ml) stirred cell (SVC), a large-volume 
(1 litre) circulating cell (LVC), or via a dry powder feeder (DPF). In this study, enough 
of a sample was added until an obscuration of 15% - 25% was obtained. It was 
assumed that solid and opaque particles of the calcium phosphate sample have a 
refractive index of 1.53.
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2.3.1.1 Small-Volume Stirred Cell (SVC)
Most measurements in this study were obtained using the SVC, in conjunction with the 
100 mm lens. The advantage of the SVC is that it only requires a small amount of 
sample and suspending medium. Firstly, the SVC was filled with ~ 15 ml of deionised 
water, the optics were then aligned. The diffracted light with no sample present was 
measured to establish a background reading. A 20 ml vial was filled v/ith ~ 5 ml 
deionised water and ~ 1 mg of sample was added into the vial, followed by a small 
amount of the dispersant, tetrasodium pyrophosphate. The vial was manually shaken to 
facilitate wetting of the sample, and then sonicated for the required period of time. The 
suspensions were then pipetted into the SVC. All samples were prepared and analysed 
in triplicate.
2.3.1.2 Large-Volume Circulating Cell (LVC)
The LVC was used when particle-size distributions below 0.5 pm were to be 
determined, as the 45 mm lens was designed to be used in conjunction with the LVC. 
The LVC allows for automated sample dispersion, with variable pump, stir and 
ultrasonication rates available. The LVC was first filled with deionised water and a 
small amount of the tetrasodium pyrophosphate dispersant was then added. The sample 
pump, stir and ultrasonication rates were all set to the LVC scale of 5. The sample was 
then added to the cell by a pipette. All samples were prepared and analysed in 
triplicate.
2.3.1.3 Dry Powder Feeder (DPF)
DPF allows dry powders to be measured directly. The powder is sucked through the 
laser beam by means of a vacuum cleaner (Electrolux Powder system 1500W, 
Bedfordshire, UK) to prevent dust being sprayed into the environment. DPF may result 
in poorer dispersion than using a liquid dispersing medium. However, in conjunction 
with a suspension analysis it can be valuable in determining the amount of 
agglomerated material in the dry state.
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2.3.2 Mastersizer 2000
Compared to the Mastersizer X, the Mastersizer 2000 is a more advanced model. It has 
two lasers: a red helium neon laser and a blue solid state laser. It can measure particle- 
sizes in the range of 0.02 /xm - 2000 fim  with a single lens. The particle refractive 
index of the calcium phosphate sample was determined using the Mastersizer 2000 and 
was found to be 1.30. This value was used for all calculations.
Samples (~ 1 mg) were suspended in cyclohexane using 0.1% lecithin, as suspending 
agent, in a 25 ml glass vial. This was stirred for 5 min, followed by sonication for 5 
min. The pre-dispersion was then added using a plastic pipette to the dispersant (pure 
cyclohexane) in a small-volume sample dispersion unit in the Mastersizer, until the




Tap density was measured using a tap density tester (J. Engelsmann AG, Ludwigshafen 
a. Rh, Germany). Approximately 10 ml of sample powder (3 g - 7 g) were poured into 
a 10 ml graduated cylinder. The accurate weight and volume of the samples were 
recorded and the bulk-density calculated. The graduated cylinder was tapped in a cycle 
of 500 taps. The volume of the sample was recorded after each cycle, and the cycle was 
repeated until no further decrease in volume was observed. A total of 6 cycles was 
performed for every sample (total tapping = 3000). The tap density was calculated 
from the final tapped volume recorded. Each sample was analysed in triplicate.
2.4.2 True Density
The true density was determined using a helium pycnometer (AccuPyc 1330, V2.01, 
Micromeritics Instruments Co., Georgia, USA). Approximately 2.5 g - 2.9 g of each 
sample was accurately weighed into the pycnometer sample cell on a 4-point balance. 
The sample was put in an oven (Size 2 incubator, model 1H150, Gallenkamp, 
Loughborough, UK) at 60 °C for two days to eliminate moisture. The sample was then
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placed into the pycnometer, and was purged with helium. Ten sequential density 
measurements were then collected and the mean density value was determined. The 
mean value of 3 experimental runs, using different powder samples, was calculated. 
Samples were oven treated before density measurements were carried out because 
preliminary experiments showed that oven treated samples were 3% - 4% less dense 
than untreated samples.
2.5 Surface Area Analysis
The surface area characteristics of powders are important because they greatly influence 
the behaviour and the processing methods that can be used.
2.5.1 Surface Area Analyser
The specific surface area of samples was determined using a 5-point BET N 2  adsorption 
apparatus (Gemini 2360 Analyser, Micromeritics Instruments Co., Georgia, USA). 
Nitrogen was used as the pressure gas or adsorbate; an empty balance tube of identical 
dimensions to the sample holder was used to measure the generated pressure 
differential.
An accurately weighed sample was loaded into a glass tube (12 cm3), and degassed 
(FlowPrep 060 Degasser, Micromeritics Instruments Co., Georgia, USA) at 105 °C for 
24 h to remove surface moisture and pre-adsorbed gases. This temperature (105 °C) 
was used to decrease the degassing time. After degassing, the sample was re-weighed, 
and the value obtained was used for the surface area determinations. The sample was 
cooled to the boiling point of the adsorbate gas (-196 °C) by immersing it in a Dewar 
flask filled with liquid nitrogen. The sample was then exposed to partial pressures of 
the adsorbate gas until the surface was covered by the gas. The liquid nitrogen Dewar 
was removed from the sample cell. The amount of the previously adsorbed gas was 
measured by a detector as the sample warmed to room temperature. Using the BET 
equation, the surface area was derived from the volume of gas adsorbed. This 
calculation was performed by the Gemini analyser. Five replicates were obtained for 
each sample.
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2.5.2 Accelerated Surface Area and Porosimetry Analyser
An Accelerated Surface Area and Porosimetry Analyser (ASAP) 2010 (Micromeritics 
Instruments Co., Georgia, USA) was used to determine the surface area of samples. 
This equipment can also provide information about pores in the nanometer range (pore 
diameter of 0.35 nm - 300 nm).
The basics of the analytical technique is that a sample contained in an evacuated sample 
tube is cooled to cryogenic temperature, then is exposed to analysis gas at a series of 
precisely controlled pressures. With each incremental pressure increase, the number of 
gas molecules adsorbed on the surface increases. The pressure at which adsorption 
equilibrium occurs is measured and the universal gas law is applied to determine the 
quantity of gas adsorbed. As adsorption proceeds, the thickness of the adsorbed film 
increases. Firstly, the micropores in the surface are quickly filled, then the free surface 
becomes completely covered, and finally larger pores are filled. The process may 
continue to the point of bulk condensation of the analysis gas. The desorption process 
may then begin in which pressure is systematically reduced allowing for the liberation 
of the adsorbed molecules. As with the adsorption process, the changing quantity of 
gas on the solid surface is measured. The two sets of data obtained describe the 
adsorption and desorption isotherms, respectively. Analysis of the isotherms yields 
information about the surface characteristics of the material.
An accurately weighed sample was placed in a standard glass sample tube (25 cm2). 
The higher total surface area available for measurement, the more reliable the analysis 
becomes. Therefore, a larger amount of sample was used for samples with predicted 
low surface area and vice-versa. Preliminary studies indicated that non-sintered 
samples have high surface areas, so ~ 1 g of powder was used in each experiment, 
whilst sintered samples have smaller surface area and ~ 9 g of powder was used.
Firstly, a sample was placed in a degas port of the analyser and degassed by vacuum 
pumping down to 1 mmHg with the heating jacket at 200 °C, overnight. The sample 
tube was then backfilled with nitrogen gas to atmospheric pressure, before it was 
transferred to an analysis port. This was to reduce the risk of mixing with atmospheric 
gases during the transfer. At the analysis port, the sample was cooled down to the
38
boiling temperature of nitrogen (-196 °C) by immersing the sample holder in the 
Dewar filled with liquid nitrogen. The sample was then exposed to increasing partial 
pressures of nitrogen. The volume of gas adsorbed was measured at each partial 
pressure. A series of pressure/volume measurements were made over a sequence of 
ascending relative pressures from 0.00001 to 0.97000. The procedure was then 
reversed by reducing the relative pressure over a sequence of descending relative 
pressures, back to 0.00001.
2.6 Mercury Intrusion Porosimetry
To investigate the pore-size and the porosity of the microspheres, a Micromeritics 
Autopore II Porosimeter (Type 9220 V3.03, Micromeritics Instruments Co., Georgia, 
USA) was used. The Autopore measures the volume distribution of pores in materials 
by mercury intrusion or extrusion. It operates in the pressure range of 3.4 kPa -  
413685 kPa that corresponds to pore analysis in the range of 360 pm- 0.003 pm, 
assuming 130° is the mercury wetting angle. Mercury has a high surface tension and is 
non-wetting to most materials; hence, pressure must be applied to introduce mercury 
into pores of solid materials. Mercury porosimetry is based on the capillary law that 
governs liquid penetration into small pores.
The Autopore has two pressure chambers: a low-pressure chamber, operating from 
3.4 kPa - 207 kPa; and a high-pressure chamber operating from 207 kPa - 413685 kPa. 
The filling pressure, i.e. the pressure at which mercury is introduced in the 
penetrometer, can be controlled between 3 kPa - 69 kPa. The pressure was generated 
by a hydraulic pump and the amount of mercury entering the head of the penetrometer 
from the penetrometer stem was tracked using a conductance detector. All aspects of 
the pressure analysis, data collection and data deduction were processed by a computer 
control module.
Samples ~ 0.2 g - 0.5 g were weighed into a 5 ml powder penetrometer that has a stem 
volume of 0.392 ml. They were then evacuated at a pressure of 50 pmHg for 5 min to 
remove any absorbed gases and moisture. The fill pressure was set to 68 kPa. After 
degassing, the penetrometer was filled with mercury and was transferred manually to a
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high-pressure port. The penetrometer, fill pressure and sample size were carefully 
selected so that the penetrometer stem volume used was between 25% and 90% to 
ensure reliable results. Measurements were carried out at room temperature using an 
equilibration time of 5 s. The surface tension, contact angle, and density of the mercury 
were taken to be 0.485 N/m, 130 °C and 13.5438 g/ml respectively.
2.7 Scanning Electron Microscopy (SEM)
In SEM, a finely focused electron beam is scanned across the sample’s surface. The 
diameter of the electron beam, at its point of impact on the sample, influences the 
microscope’s performance because this diameter is the finest resolvable detail in the 
image. To minimize the interaction of the electron beam with air, the SEM column and 
the sample chamber are evacuated to a pressure of ~ 1 x 10'5 Pa. Magnification of up to 
x 100 000 can be obtained. Due to enhanced contrast and large depth of field, surfaces 
can be sharply focused, even when relatively large height variations are present. SEM 
is a versatile technique for observation of surface and microstructure of a wide range of 
materials, including pharmaceutical drug crystals and drug delivery systems81.
The scanning electron microscopes used were the Jeol T330 (Japanese Electron Optics 
Ltd., Tokyo, Japan); and the Jeol T6310 (Japanese Electron Optics Ltd., Tokyo, Japan). 
The latter model allows for electronic collection and storage of images.
2.7.1 Topographic Imaging and Backscattered Electron Imaging
When a surface is bombarded with a high energy electron beam, secondary low energy 
electrons and backscattered high energy electrons are released from the surface. Both 
types of emergent electrons can be collected by detectors to construct an image.
During topographical imaging, secondary electrons are collected. The number of 
secondary electrons detected is affected by the geometrical orientation of the 
specimen’s surface. Therefore, topographical information can be obtained from these 
signals.
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During backscattered electron imaging, backscattered electrons are collected. The 
signals of backscattered electron increase with the mean atomic number of the sample. 
Therefore, areas with high atomic number elements are emphasised and displayed as 
bright regions in the image.
2.7.2 X-Ray Analysis
When an electron beam interacts with an element, characteristic secondary X-rays are 
emitted. If these X-rays are collected, a fingerprint spectrum can be produced.
Therefore, X-ray analysis can identify the presence of specific elements, provided that
their localised concentration exceeds ~ 0.1%. The relative intensities of the spectral 
peaks can be used as a rough guide of the relative concentration of each element in the 
specimen. To perform X-ray analysis, an energy dispersive spectrometer is fitted as an 
attachment to the SEM. The spectra produced by the energy dispersive X-ray 
spectrometer are plots of X-ray counts versus X-ray energy. The qualitative analysis 
may also be presented in a graphic format, called a dot map. In this technique, the 
brightness of the SEM beam at each point on the display is modulated by the X-ray 
output from the element of interest.
SEM combined with Energy Dispersive X-Ray Analysis (EDX) was used in this study. 
The set-up used was a Jeol T6310 (Japanese Electron Optics Ltd., Tokyo, Japan) fitted 
with Oxford Inst, AN 10 000 X-Ray Analyser (Gatan, UK). All images were taken at a 
voltage of 10 kV or 15 kV.
2.7.3 Conductive Coating
Ideally SEM requires specimens that are dry, mechanically stable, non-volatile and 
electrically conducting82. However, most pharmaceutical powders do not have these 
characteristics. Non-conducting or poorly conducting samples accumulate electrons 
during electron irradiation and cause local electrical charges. These charges on the 
samples result in distortion of the beam, over brightness, and poor focus of the image. 
To avoid the charging effects, samples are usually sputter coated with a fine conductive 
layer of gold for topographic imaging. The coating becomes the main source of 
secondary electrons, and also protects the specimen against heat generated on exposure
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to the electron beam. One disadvantage of gold coating is that it absorbs X-rays. Also, 
Large gold peaks on the spectra may overlap with specimen’s peaks. Therefore, 
specimens for X-ray analysis are usually coated with carbon, which is lighter and less 
absorbent of the X-rays. Backscattered imaging specimens are also normally coated 
with carbon because gold, being a high atomic number element, produces high 
backscattered electrons that may interfere with the specimen’s signals.
In this study, samples for topographical imaging were coated with gold using a sputter 
coater (Model S150B, Edwards High Vacuum Ltd., Sussex, UK) while samples for 
backscattered electron imaging were coated with carbon (Edwards coating unit, Pirani 
Penning, Model 4, Edwards High Vacuum Ltd., Sussex, UK).
2.7.4 Sample Preparation for the Investigation of Surface 
Morphology of Microspheres
Microsphere samples were sprinkled onto adhesive carbon pads and then placed in an 
oven at 60 °C overnight. The sample surfaces were then gold coated with a sputter 
coater for 10 min at a voltage of 1.4 kV.
2.7.5 Sample Preparation for the Investigation of Internal 
Morphology of Microspheres (Resin-Embedded Technique)
Preliminary experiments indicated that the calcium phosphate microspheres could be 
sectioned by firstly embedding them in an epoxy resin (Hard Grade, Taab Resin, Taab, 
Reading, UK). This resin provided a strong support for sectioning of the hard sintered 
calcium phosphate. The microsphere samples were mounted in the resin by the 
following procedure. About 2 ml of resin was added to a small amount of 
microspheres. The resin/microspheres mixture was put under vacuum to eliminate 
trapped gas and facilitate the penetration of resin into the microspheres. They were 
then placed on a rotatory mixer rotating slowly for ~ 3 h to further allow the resin to 
penetrate into the samples. The resulting mixtures were poured into plastic moulds. 
The samples were placed in an oven at 60 °C overnight for the resin to set. The 
samples were then allowed to cool and the moulds were removed. The resin-embedded 
samples were then manually trimmed on an ultramicrotome (Om U3, C. Reichert AG,
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Vienna, Austria) using a razor blade, followed by a glass knife (freshly prepared), and a 
diamond knife, when necessary, to obtain a flat and smooth surface that exposed the 
internal structure of the samples. The resin blocks were then coated with colloidal 
graphite (Agar Scientific, Stansted, UK) to ensure good electron conductivity, leaving 
only the freshly trimmed surface free of carbon. For topographical imaging, the 
samples were then sputter coated with gold for 3 min; for backscattered electron 
imaging, the samples were coated with carbon for 3 min.
2 . 8  Low-Temperature Scanning Electron Microscopy (LTSEM)
In this study, LTSEM was employed for imaging samples containing drug crystals to 
overcome image distortion associated with conventional SEM. A schematic of a low- 
temperature scanning electron microscope is shown in Figure 2.1. The equipment 
consists of a cold-stage (C) fitted inside the microscope’s specimen chamber. The cold- 
stage is cooled with nitrogen gas that circulates within a Dewar flask (D l). The 
cryopreparation chamber, attached to the side of the microscope and evacuated by a 
vacuum pump, has a second cold-stage (P) which is thermally cooled down by liquid 
nitrogen from a second Dewar flask (D2). A sputter head for gold coating (S) is placed 
above the sample. The two chambers are separated by a gate valve (G). The 
microscope used was a Jeol T6310 (Japanese Electron Optics Ltd., Tokyo, Japan).
D2
Dl
cryopreparation chamber specimen chamber
o o
Figure 2.1 Low-temperature SEM (adapted from Potter et a l. ).
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2.8.1 Sample Preparation for LTSEM
Each sample was sprinkled onto an adhesive carbon pad that was then attached to a 
metal stub on the end of a transfer rod (T). The sample was transferred to cold stage (P) 
in the cryopreparation chamber and allowed to cool down to — 180 °C for 10 min to 
freeze water molecules contained in the sample. The sample was then transferred into 
the specimen chamber for 5 min for sublimation of contaminating surface frost at 
— 180 °C. The process of surface frost sublimation/disappearance could be observed 
under the microscope at this stage. The sample (e) was then placed back in the 
cryopreparation chamber to be sputter coated, with gold, for 3 min in a low-pressure 
atmosphere of argon at — 180 °C. The sample was then placed back into the specimen 
chamber and the final examination of the sample was performed at — 170 °C.
2.9 Thermal Analysis - Differential Scanning Calorimetry
Differential Scanning Calorimetry (DSC) is a thermal analysis technique that is widely 
used in pharmaceutical applications for the investigation of the purity, crystallinity and 
polymorphism of materials. In DSC, the sample and reference are maintained at the 
same temperature as heat is supplied to the system. The heat flow required to keep the 
equity in temperature is measured. Therefore, the heat exchange as physical and 
chemical changes occur during a heating process is recorded. The energy input per unit 
time is recorded as a function of temperature. Hence, DSC plots are obtained as the 
differential rate of heating against temperature. The area under a DSC peak is directly 
proportional to the heat absorbed or evolved by the thermal event.
A differential scanning calorimeter (DSC 2910, TA Instruments Ltd., Leatherhead, UK) 
with a liquid nitrogen cooler attached was used to investigate the change of crystallinity 
of model drugs before and after drug loading experiments. The calorimeter was first 
calibrated using indium (mp = 156.6 °C) as a standard reference material. A sample of 
~ 5 mg - 8 mg was accurately weighed in an aluminium pan that was then hermetically 
sealed. An empty sealed aluminium pan was used as a reference. The heat flow rate 
was recorded from 30 °C - 250 °C at a rate of 10 °C/min. The samples were purged 
with nitrogen at a feeding rate of 25 ml/min. The collected data were then analysed 
using the Universal VI.8M software (TA Instruments Ltd., Leatherhead, UK).
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2.10 X-ray Diffraction (XRD) Studies
X-ray powder diffraction studies are widely used for the identification of solid phases. 
The X-ray powder pattern of every crystalline form of a compound is unique, making 
this technique particularly suited for the identification of different polymorphic forms 
of a compound. When a material is irradiated with a parallel beam of monochromatic 
X-rays, the atomic lattice of the material acts as a 3-dimensional diffraction grating, 
causing the X-ray beam to be diffracted to specific angles, related to the inter-atomic 
spacing. By measuring the angles of diffraction, the inter-atomic spacing of the 
material can be determined and used to identify the crystallographic structures of the 
material84.
The phase changes of calcium phosphate after sintering and the possible change of 
model drugs after drug loading experiments were investigated by X-ray diffraction 
studies. The XRD patterns were obtained on a Philips powder diffractometer, using 
monochromatic Cu-Ka, Ni-filtered radiation, at 20, and a scanning speed of 
approximately l°/min. Powder samples were placed in an aluminium sample holder, 
and pressurised to ascertain that the sample surface was flat and level with the surface 
of the holder. The crystalline phases were then compared to the standard reference 
pattern from the International Centre for Diffraction Data.
The equipment used was Philips PW1730/00 4kW X-ray generator; Philips PW2273/20 
long fine focus 2kW copper target X-ray tube, operated at 40 kV & 25 mA; Philips 
PW1820/00 computer controlled vertical diffractometer goniometer; Philips 
PW1711/00 xenon proportional counter with PW1752/00 graphite monochromator & 
PW1368/55 automatic divergence slit assembly; Philips PW1710/00 microprocessor 
diffractometer control; and Philips PW1877 PC-APD, version 3.5b, diffraction 
software.
2.11 Dissolution Studies
To investigate the in vitro release of drugs from the microspheres, the dissolution tests 
that comply with BP 1998 standard - apparatus II (paddle) method, were carried out.
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Experiments were performed in a Pharmatest dissolution bath (Type PTW S3C, 
Pharmatest Ltd., Frankfurt, Germany) at 37 °C ± 0.5 °C. Paddles were positioned at 
25 mm from the inside bottom of the vessel, and their rotating speed was set to 50 rpm. 
The dissolution medium was 900 ml of BP phosphate buffer, pH = 6.8. Samples to be 
studied were placed in gelatin capsules, which in turn were individually placed in a 
sinker to allow the capsules to sink to the bottom of the vessels. Sinkers were hand- 
coiled tin-plated copper wire. The capsule size chosen in each experiment was the 
smallest size which could hold the required amount of sample. The percentage of drug 
release from the dissolution test was calculated using the equation below:
2.12 Determination of Drug Contents
The loading efficiency of model drugs was determined as follows: 100 mg or 150 mg 
of accurately weighed drug-loaded microsphere sample were placed in a 250 ml 
volumetric flask containing around 200 ml of freshly prepared 0.1 M HC1. These were 
then sonicated for ~ 5 min, or until full dissolution was achieved as verified by visual 
examination. This was then made up to the designated volume. Each sample was 
tested in triplicate. The UV absorbance of drug in the final acid solution was 
determined by spectrophotometry (Unicam Helios a, Cambridge, UK), and compared 
to the drug absorbance and concentration calibration plot. Dilutions were performed if 
the measurements were outside the calibration plot. The calibration plots for model 
drugs can be found in Appendix IV. DCPA and P-TCP dissolved in 0.1 M HC1 were 
found not to interfere with the drug identification peaks for all model drugs chosen.
The percentage drug loading was calculated using the equation below:
% drug release at time t =
f amount of drug release at time t '
x 100 % Equation 2.1
mean total drug loading
% Drug Loading =
weight o f drug
xl00% Equation 2.2
^weight o f drug -  loaded microspheres}
46
3 Manufacture of Novel Drug Carrier 
Systems by Spray-drying
3.1 Introduction
The overall aim of this study was to obtain porous inorganic microspheres to be used as 
drug carriers. To produce the microspheres, the spray drying method was investigated.
Spray-drying has a wide range of applications within the pharmaceutical, food, and 
ceramic industries57,49. The spray-drying process usually produces free-flowing 
spherical powders in a short time. By modifying the spray-drying conditions, it is 
possible to alter and control the properties of spray-dried powders, such as morphology, 
bulk-density, porosity, moisture content, flowability, stability, friability, particle-size 
and size distribution50,85,86.
This chapter describes the development process of establishing feasible spray-drying 
conditions to produce bioceramic microspheres using pharmaceutical grade calcium 
phosphates. The desirable characteristics of the microspheres include being highly 
porous, free-flowing, and well-formed spherical particles with narrow size distribution. 
Two types of calcium phosphates, dibasic calcium phosphate anhydrous (DCPA) and 
beta-tricalcium phosphate (p-TCP) were studied. These were chosen mainly because 
they are orally acceptable pharmaceutical excipients, and they are cheap.
In the preparation of ceramic slurries for spray-drying, a few points should be 
considered54:
1) Binder addition
Binders are used in ceramic processing to provide enough strength to the ceramic 
green body (see section 1.6) to maintain its shape until it is sintered. The 
desirable characteristics of binders are63:
- Ease of thermal removal;
Strong adhesion and cohesive strength;
Solubility in fluidising liquid;
- Low cost.
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Organic binders, such as polyvinyl alcohol (PVA), polyethylene glycol (PEG), 
and polyethylene oxide (PEO), are commonly used (Figure 3.1). The method of 
adding binder to the slurry is important. Adding binder as a prepared solution is 
desirable so that the required solids content is consistent. This also allows for 
preliminary screening of undissolved or undispersed binder materials. The 
presence of organic agglomerates exposes defects to the final product87 which
oo
persist during sintering . Typically, powders contain 0.5% - 4.0% (weight) 











Figure 3.1 Molecular structures of PVA, PEG and PEO. RO specifically depends 
upon initiator/terminator. PEO is typically more monodisperse than PEG.
2) Powder dispersion
To produce good spray-dried products, the powders must be homogeneously 
dispersed. Since most powders to be spray-dried are several micron in diameter, 
the slurry can be considered a colloidal system. The DLVO theory regarding 
colloidal stability suggests that the stability of colloidal system depends on the 
particle surface charge, and stable systems are deflocculated54. Dispersants are 
commonly used in the preparation of ceramic slurries to produce deflocculated 
systems. The dispersants such, as organic polymers, adjust the surface charges of 
the ceramic particles by being adsorbed on the surface of the particles by van der 
Waals forces or hydrogen bonding54.
3) Solids content
A high solids content slurry is desired for economic and technical reasons. Since 
dryer capacities are specified by the quantity of water that can be evaporated per 
hour, a higher solids content slurry means an increased powder output. When 
formulating a slurry for spray-drying, it is valuable to estimate the approximate 
maximum solids content achievable. A reduction in the mean particle-size of the
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powder will decrease the maximum solids content that can be achieved. This is 
because the distance between particles decreases with decreasing particle-size, 
and agglomeration and flocculation can happen readily when the particles are 
close together54. The viscosity of the slurry increases, and operation difficulties 
arise. The maximum concentration of solids that can be achieved for micron­
sized ceramic powders is normally 40% - 50%. However, for the slurries to be 
fluid enough to be sprayed, the maximum concentration of solids is 30% - 40% 
even in the presence of dispersants. This is due to the viscosity becoming too 
high.
Initially, the spray-drying of DCPA was studied. The suitability of various excipients, 
slurry compositions and spray-drying conditions in producing DCPA microspheres 
were investigated.
The excipients investigated were:
a) Binders - PEG 1000; PEG 6000; PEG 10000; PEG 20000; Plasdone K-90;
Polyplasdone XL-10; Eudragit L100; and Maltodextrin;
b) Surfactant -  Sodium Lauryl Sulphate (SLS);
c) Suspending agent -  Tragacanth;
d) Dispersant -  Dispex A40.









The spray-drying of p-TCP was then investigated, followed by a search of the optimal 
conditions to obtain free-flowing p-TCP microspheres.
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Due to time constraints, the full range of variables was not studied, and replicates were 
limited to a small number of conditions. The sets of experiments chosen were based on 
the best knowledge derived from the experience acquired with preliminary tests.
3.2 Spray-dryer
A bench-top SD-05 Laboratory Scale Spray-dryer (LabPlant Limited, West Yorkshire, 
UK) (Figure 3.2) was used in this study.
The SD-05 spray-dryer has co-current airflow, i.e., the liquid is sprayed in the same 
direction as the flow of the air (section 1.5). The liquid is sprayed into the drying 
chamber (500 mm x 215 mm) through a two-fluid nozzle. Two-fluid nozzles are 
nozzles in which atomisation is achieved using high-velocity air, gas or steam89. The 
stainless steel jet spray assembly of the SD-05 spray-dryer consists of an inner tube for 
the liquid sample leading to a close tolerance internal diameter jet. The outer tube 
directs the supply of compressed air to the nozzle, and the close tolerance gap between 
the nozzle and the jet ensures that the liquid jet is produced as a fine vaporised spray.
Various jet sizes, from 0.5 mm to 2.0 mm internal diameter are available. For two-fluid 
atomisers, the jet size (the diameter of the final discharge orifice) is an important 
dimension for atomisation because theory predicts that mean drop size is roughly 
proportional to the square root of the jet diameter89.
The jet spray assembly of the spray-dryer has an automatic plunger de-blocking device 
to remove blockages. The de-blocking device is a spring-restrained needle activated by 
an integral compressor. De-blocking is important especially when spraying high solids 
content slurry. In this study, the de-blocking frequency was set to maximum at all 




















Figure 3.2 The SD-05 Laboratory Scale Spray-dryer
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3.3 Spray-drying Parameters
The spray-drying conditions determine the characteristics of the powder produced. The 
important spray-drying parameters are:
a) Inlet temperature
The inlet temperature is the temperature of the heated drying air. The air used in 
the drying process is drawn in over a heater by the aspirator motor. The heated 
air temperature is measured prior to flowing into the drying chamber.
b) Outlet temperature
The outlet temperature is the temperature of the air with the solid particles before 
entering the cyclone. Unlike the inlet temperature, it cannot be set with a 
temperature regulator. The outlet temperature depends on the inlet temperature, 
the air-flow rate, the peristaltic pump setting and the concentration of the material 
being sprayed. Outlet temperature is an important parameter as it generally 
represents product quality, i.e. the bulk-density, colour, flavour, activity and
90moisture content .
c) Air-flow
The air-flow measures the amount of air flowing through the chamber. Because 
the amount of energy available for solvent evaporation depends on the amount of 
drying air present, air-flow has an important effect on the performance of a spray- 
dryer. The vaporisation performance is also influenced by other factors such as 
the concentration of the spray solution and the moisture content of the drying air.
d) Pump speed
The peristaltic pump delivers the feedstock to the nozzle. Increasing pump speed 
means more feedstock passes through the nozzle at any one time, i.e. increasing 
rate of sample feed. Keeping the inlet temperature constant, an increase in the 
pump speed will reduce the outlet temperature. This is because a higher amount 
of feedstock was fed into the system at any one time and this means more heat is 
removed in the vaporisation process. Therefore, the moisture content of the 
product normally increases.
e) Compressor air pressure
This is the pressure needed to convert the spray into fine mist. The higher the 
compressor air pressure, the smaller the size of the particles in the final product.
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The parameters described above are interdependent. Adjusting one parameter may lead 
to alteration of others. The characteristics of the spray-drying products not only depend 
on the spray-drying conditions, but also depend on the type and the physical dimension 
of the drying chamber. Therefore, the investigation of the spray-drying processing 
conditions relies mainly on trial and error.
In this study, before the start of each spray-drying experiment, the spray-dryer was 
allowed to warm up to the target temperature, followed by spraying of deionised water 
for -  5 min. This is to ensure that all the glassware reach the required temperature and 
the system is in equilibrium under the experimental conditions.
3.4 Expression of Concentrations
In this document, all the solids content (ceramic powders) of the slurries are expressed 
in weight percentage of the dry solids to the final slurry weight (%w/w); while all the 
concentrations of excipients (binders, surfactant and dispersant) are expressed in parts 
per hundred by weight (pph), based on the dry weight of the ceramic powder. The 
density of the ceramic powder used is ~ 3 g/cm3, therefore, readers should note that the 
values of the concentrations of excipients would be ~ 3 times higher if they were 
expressed in part per hundred by volume.
3.5 Preliminary Studies -  Slurry Preparation
Preliminary studies were performed using DCPA. Excipients that can be used for 
producing free-flowing calcium phosphate microspheres were investigated. The 
products of spray-drying experiments were examined under the SEM. The details of 
the SEM techniques used are detailed in section 2.7.
3.5.1 Water
Using deionised water as feedstock, complete water evaporation was observed in the 
SD-05 spray-dryer at the operating conditions below:
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Drying air flow rate
0.5 mm 
200 °C
350 ml/h (dryer scale =10)
62-64 m3/h (dryer scale = 41-44) (maximum setting)
Compressor air pressure 150 kPa (maximum setting)
Preliminary results indicated that by keeping other parameters in SDC Set 1 constant, 
lower inlet temperatures, lower air-flows, lower compressor air pressures, or higher 
pump speeds always resulted in incomplete water evaporation in the chamber.
3.5.2 Dibasic Calcium Phosphate Anhydrous (DCPA)
A slurry of 5% w/w DCPA (200 ml) in deionised water was prepared, and magnetically 
stirred to prevent the sedimentation of the solids. Spray-drying was carried out under 
SDC Set 1. The experiment produced a moderate yield and the product obtained was a 
free-flowing powder. Under the SEM, the spray-dried powder looked similar to the 
DCPA powder as-received. No microspheres were obtained.
3.5.3 Binders
To promote the agglomeration of DCPA particles and produce microspheres, a binder 
was added to the spray-drying slurry.
Polyethylene glycols (PEGs), a type of water-soluble organic binder, were initially 
chosen in this study because they are commonly used in the ceramic industry as 
binders91. PEGs are also widely used as excipients in a variety of pharmaceutical 
formulations including parenteral, topical, ophthalmic, oral, and rectal preparations. 
PEGs are easily removed during firing; therefore, they do not interfere with the 
subsequent sintering process.
3.5.3.1 Polyethylene Glycol (PEG) 1000
A 200 g slurry containing 5% w/w (10 g) of DCPA and 40 pph (4 g) of PEG 1000 was 
prepared by first dissolving the PEG in water, then adding the DCPA powder, and
finally adding more water to make up to the final weight. The resultant slurry was 
spray-dried at inlet temperatures of 150 °C, 200 °C, 220 °C and 245 °C. All other 
adjustable parameters of the spray-dryer were kept unchanged as in SDC Set 1 (see 
section 3.5.1). Very low yield obtained for all four experiments, and each 200 g slurry 
took ~ 30 min to spray dry.
3.5.3.1.1 Results and Discussion
During the experiments, two problems were encountered:
(a) The DCPA was poorly suspended. Sedimentation of DCPA occurred very 
readily, i.e. homogenous powder dispersion was not achieved.
(b) The spray-dried products were not free-flowing, but were wet and sticky 
instead. These products tended to deposit on the walls of the main chamber and 
the cyclone.
The practical highest inlet temperature that can be operated on the SD-05 spray-dryer is 
245 °C. Even spraying at this temperature the results showed that the products were 
sticky and free-flowing products were not obtained.
3.5.3.2 Other Binders
The use of other pharmaceutical excipients as binder, including PEGs of higher 
molecular weight (PEG 6000, PEG 10000, PEG 20000), and Plasdone K-90, 
Polyplasdone XL-10, Eudragit L100, and Maltodextrin were investigated. Slurries of 
5% w/w DCPA and 1 pph binder were spray-dried under SDC Set 1 (section 3.5.1).
3.5.3.2.1 Results and Discussion
None of the spray dried products were free-flowing. Slurries with PEGs produced 
products that were wet and had a clear gum texture. Slurries with Plasdone K-90, 
Polyplasdone XL-10, Eudragit L100 or Maltodextrin produced products which looked 
relatively drier than slurries with PEGs, judging by the powder flowed pattern in the 
cyclone. It was decided to define dry products as being white, free-flowing powders 
that flowed into the collection bottle, and wet products as being sticky gums which 
stuck to the walls of the main chamber and the cyclone wall. The yields for all
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experiments were low. Among all the binders, it was observed that Eudragit L100 
produced the best flow products, which are assumed to contain the least water content, 
but the water content was not determined. One particle of the products was selected 
and examined under the SEM. It was found that this was a doughnut-shape particle 
with a smooth surface (Figure 3.3).
Figure 3.3 SEM micrograph of spray-dried product obtained from the slurry of 5% w/w 
DCPA and 1 pph Eudragit L100.
3.5.4 Surfactant
Surfactants could improve the wetting of PEGs, therefore may assist the dispersion of 
the polymer. Aiming to produce free-flowing spray-dried products, i.e., the addition of 
a surfactant, sodium lauryl sulphate (SLS), to the spray-drying slurry was investigated.
SLS (20 pph; 60 pph; 80 pph) was added to slurries of 5% w/w DCPA and 40 pph PEG 
1000. (That is of I, 3 or 4 g of SLS was added to 5 g of DCPA, 2 g of PEG 1000 and 
water to produce a 100 g slurry,). The slurries were spray-dried under the SCD Set 1 
(section 3.5.1).
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The effect of SLS on other slurries containing different binders to PEG 1000 was also 
investigated. The experiments above were repeated replacing PEG 1000 with 20 pph of 
PEG 6000, PEG 10000, PEG 20000 and Maltodextrin.
3.5.4.1 Results and Discussion
Results showed that with the addition of SLS, powders with better flow characteristics 
were produced. This is probably because SLS assisted the wetting and spread of the 
PEGs, therefore local aggregation of PEGs was reduced and a more uniform dispersion 
of PEGs was achieved. For the slurries containing PEG 1000, it was also noted that 
with increasing concentration of SLS, the spray-dried products became less sticky and 
flowed better in the spray-dryer. However, products were mainly accumulated in the 
cyclone and did not reach the collection bottle.
The results for slurries containing other binders, namely, PEG 6000, PEG 10000, PEG 
20000 and Maltodextrin, followed a similar trend: spray-dried products from slurries 
containing SLS had improved flow properties compared to their counterparts which did 
not contain SLS. The appearance of products was that of a white powder instead of a 
clear gum. Under the SEM (Figure 3.4), all SLS containing products were irregular 
shaped agglomerates, small ‘bubble’ structures.
These experiments showed that the inclusion of SLS improved the flow characteristics 
of the spray-dried products. However, in the present of SLS, the desirable spherical 





Figure 3.4 SEM micrographs of spray-dried products obtained from slurries of 5% w/w 
DCPA, 40 pph of PEG 1000, and a) 20 pph; b) 60 pph; c) 80 pph of SLS.
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3.5.5 Suspending Agent
The DCPA powder was poorly suspended in water, and sedimentation occurred readily. 
To produce a stable suspension, the use of a suspending agent was investigated.
Tragacanth is a traditional pharmaceutical suspending agent. A slurry containing 
5% w/w DCPA, 40 pph PEG 1000 and 20 pph tragacanth was prepared and spray-dried 
under SDC Setl (section 3.5.1).
3.5.5.1 Results and Discussion
Tragacanth produced a thick, foamed DCPA suspension. However, the spray-dried 
products were of a waxy gum-like consistency that deposited on the top part of the 
cyclone. The use of the suspending agent was then discontinued.
3.5.6 Particle-Size Reduction
The possibility of using powders with smaller particle-size to produce more stable 
suspensions was then investigated. To reduce the particle-size of the DCPA powder, 
two ball-milling methods, wet-milling and dry-milling, were investigated:
a) Dry-milling: 200 mg of DCPA powder were placed in a 500 ml plastic container 
(7.5 cm x 11.5 cm) with 80 zirconia beads (1 cm x 1 cm zirconia cylinders, 
Coming Inc., New York, USA) and ball-milled for 10 h at an optimum speed to 
obtain cascading of the grinding media;
b) Wet-milling: 200 ml of 30% w/w of DCPA powder in deionised water was 
prepared, placed in a 500 ml plastic container (7.5 cm x 11.5 cm) with 80 
zirconia beads (1 cm x 1 cm zirconia cylinders, Coming Inc., New York, USA) 
and was ball-milled for either 10 h and 40 h at an optimum speed to obtain 
cascading of the grinding media. The experiment was repeated using 40% w/w 
and 50% w/w slurries.
The particle-size distribution of DCPA powders before and after milling, were 
determined using Mastersizer X. Details of particle sizing methods are described in 
section 2.3. Three measurements were performed for each sample.
59
3.5.6.1 Results and Discussion
Before milling, the DCPA powder and water mixture was a highly unstable suspension, 
sedimentation of the DCPA particles happened readily. After subjecting the mixture to 
ball-milling, the mixture became a relatively thick, viscous and stable slurry. SEM 
micrographs of DCPA powder as-received and after dry-milling for 10 h are shown in 
Figure 3.5. It can be seen that the size of agglomerates and primary particles had both 
decreased after ball-milling and the ball-milled powder looked more flat and flaky.
The results of particle-size analysis of DCPA powders as-received and after ball- 
milling, are shown in Table 3.1. The as-received powder was found to have a volume 
mean diameter, d(v, 0.5), of 4.56 pm. After 10 h dry-milling, no marked reduction in 
d(v, 0.5) was detected. For slurry with 50% w/w solids content, 10 h of wet-milling 
reduced the powder d(v, 0.5) to 2.01 pm; and 40 h of wet-milling further reduced the 
powder d(v, 0.5) to 1.45 pm. These results show that wet-milling was more effective 
than dry-milling in particle-size reduction of the DCPA powder, and a longer session of 
milling produced finer particles. Wet-milling is more effective because the lubrication 
of water prevents the fine particles from sticking together again after they break up. 
The water also neutralises the electronic charges on the newly formed particle surfaces.
The mean d(v, 0.5) for the 30%, 40% and 50% w/w solids content slurries after 10 h 
wet-milling was found to be 2.15 pm, 1.71 pm and 2.01 pm, respectively. No trend can 
be concluded from these results, indicating that the solids contents at these 
concentrations do not markedly affect the particle reduction in wet-milling.
Representative particle-size distributions of wet-milled (40% w/w solids) and dry- 
milled products are compared in Figure 3.6. The graph shows that wet-milling 
produces a single model particle-size distribution and almost all particles are below 
10 pm; while dry-milling produces a bimodal particle-size distribution and about half of 
the particles are above 10 pm. Since wet-milling produces single model particle-size 
distribution, and is more effective in particle-size reduction, it was the method chosen 
for the reduction of DCPA particle-size.
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The dry-milled powder was measured while suspending in liquid (using large-volume 
cell, dispersion medium = water) and in gas (using dry powder feeder, dispersant 
medium = air). The results showed that both methods produce similar results, the 
d(v, 0.5) obtained being 4.77 pm and 4.89 pm respectively.
(b)
Figure 3.5 DCPA powders (a) as-received, (b) after dry ball-milling.
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Table 3.1 The results of particle-size analysis for DCPA samples.








Run 1 Run 2 Run 3 Run 1 Run 2 Run 3 mean Run 1 Run 2 Run 3
Powder as-received SVC 100 mm 0.74 0.74 0.74 4.59 4.25 4.84 4.56 21.16 17.30 19.74
50% solids wet-milling (10 h) SVC 100 mm 0.68 0.66 0.67 2.21 1.79 2.03 2.01 7.21 5.23 7.76
50% solids wet-milling (40 h) SVC 100 mm 0.63 0.62 0.63 1.42 1.41 1.51 1.45 4.15 4.27 5.02
40% solids wet-milling (10 h) SVC 100 mm 0.64 0.65 0.65 1.66 1.71 1.76 1.71 5.66 6.48 7.09
LVC 45 mm 0.46 0.48 0.46 1.58 2.13 1.60 1.77 5.06 5.45 5.20
30% solids wet-milling (10 h) SVC 100 mm 0.65 0.65 0.66 2.19 2.12 2.15 2.15 10.89 9.49 8.88
Dry-milling (10 h) LVC 45 mm 0.60 0.61 0.60 4.72 4.76 4.84 4.77 27.32 27.01 27.55
DPF 45 mm 0.60 0.61 0.62 4.84 4.97 4.86 4.89 27.55 27.80 27.43
Note: SVC = small-volume cell (samples were sonicated ]or 5 min before analysis)
LVC = Large-volume cell 
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Figure 3.6 Particle-size distribution o f  dry ball-milled and wet ball-milled DCPA 
samples.
3.5.7 Solids Content
One o f  the reasons for lack o f success in producing free-flowing product was thought 
to be due the slurrie’s high water content or, in other words, their low solids content 
(5% w/w). Masters57 illustrated that, for a given production rate, increase in feed 
solids content from 10% to 25%, will result in a 66.6% reduction in heat input, even 
increasing solid content from 25% to 50% will result in a similar heat input 
reduction. Heat input is reduced because as the solid content increases, the water 
content is reduced. Hence, the amount o f moisture evaporation needed to produce a 
unit weight o f dry powder is reduced; the major factor being that the heat o f 
evaporation o f  water (~ 2300 J/g or ~ 540 cal/g at 100 °C) is so much larger than the 
specific heat o f ceramic particles, for example, oxides or phosphates. A high solids 
content also has the advantage o f  stabilising the ceramic powder mixture, so that 
sedimentation does not occur readily.
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3.5.7.1 Results and Discussion
DCPA slurries with a higher solids content were investigated. Slurries of ceramic 
powder with high solid contents (> 50% w/w) were found to be highly viscous, and it 
is not spray-drying feasible because:
1) The slurry was too viscous to be pumped through the tube to the nozzle;
2) When the slurries reached the nozzle, they blocked the nozzle instantly.
To reduce the viscosity so that the slurries could be processed using a spray-dryer, a 
dispersant was considered to be necessary.
3.5.8 Dispersant
Dispersants, sometimes called ‘deflocculants’, are commonly added to ceramic 
slurries for two main reasons63:
1) To lower the viscosity of the slurry;
2) To prevent particle agglomeration.
The most commonly used ceramic dispersants are polyacrylates63. These are 
powerful dispersants which can provide a low viscosity ceramic slurries even when 
only small amounts of solvent are present. In the ceramic industry, the concentration 
of dispersants used is typically ~ 0.2 - 2.0 pph of ceramic powder by weight. The 
viscosity of the ceramic slurry is normally found to be at a minimum when there is a 
monolayer of dispersant adsorbed onto the powder surface92.
In this study, the polyacrylate dispersant chosen in DCPA slurries is Dispex A40. 
Dispex A40 is anionic and performs best as deflocculating agent at pH 8 - 9  (for 
more information on dispersant refer to section 3.8).
A 200 g slurry of DCPA was prepared by ball-milling 50% w/w DCPA in water 
overnight. 2 pph PEG 1000 and 1 pph Dispex A40 were then added, followed by the 
addition of aqueous ammonia (2.7 M, ~ 2 ml) to adjust the pH to -  8. The slurry was 
then further ball-milled for 30 min before it was spray-dried under SDC Set 1 
(section 3.5.1).
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3.5.8.1 Results and Discussion
The initial mixture of 50% w/w DCPA powder in water was highly viscous. The 
addition of Dispex was found to markedly decrease the viscosity. The mixture was 
further ball-milled after the addition of the binder and the dispersant to ensure 
thoroughly mixing in of the excipients, and the elimination of any agglomerates 
formed. This high solids content slurry was pumpable, and was successfully spray- 
dried.
3.6 Spray-drying of Dibasic Calcium Phosphate Anhydrous 
(DCPA)
Following the success of ceramic slurry production for spray-drying in the 
preliminary studies, the optimum spray-drying conditions required to produce DCPA 
microspheres were further investigated.
Spray-drying slurries of DCPA for all experiments were prepared as follows:
1) DCPA powder, deionised water and zirconia beads were placed in a plastic 
container, and ball-milled for 10 h (as described in section 3.5.6);
2) A binder (either PEG 1000 or Eudragit L100) was added;
3) A dispersant, Dispex A40, was added;
4) Sufficient quantities of aqueous ammonia (2.7 M), typically ~ 2 ml for 200 g 
slurry, were added to adjust the slurry pH to 8 - 9. The increase of pH was 
monitored using pH paper (Fisherbrand, range pH 8.0 - 10.0, Fisher Scientific 
UK Ltd., Leicestershire, UK);
5) The slurry was then ball-milled for another 30 min before spray-drying.
During the spray-drying process, the DCPA slurries were continuously stirred with a 
magnetic stirrer. Air-flow and compressor air pressure were set to the maximum 
value in all experiments at 62 - 64 m3/h and 170 kPa, respectively.
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3.6.1 Effect of Temperature
To investigate the effect of spraying temperature on spray-dried DCPA products, 
slurries containing 40% w/w and 50% w/w DCPA were spray-dried at 240 °C -  
100 °C and 240 °C -  70 °C, respectively.
3.6.1.1 40% w/w Solids Content Slurries
Slurry containing 40% w/w DCPA, 2 pph PEG 1000; and 1 pph Dispex A40 were 
prepared and spray-dried at inlet temperatures 240 °C - 100 °C, with decrements of 
20 °C. 200 ml of slurry was spray-dryed at each temperature. The other spray-dryer 
conditions were kept constant as in SDC Set 1 (section 3.5.1).
3.6.1.1.1 Results and Discussion
As the inlet temperature dropped below 160 °C, wet products started to accumulate at 
the base of the main chamber. When the inlet temperature dropped further to below 
100 °C, water condensation was also observed in the cyclone and in the collection 
bottle. These temperatures were not suitable for spray-drying as the products were 
not dried properly. There were no obvious changes observed in the flow 
characteristics of the product in the spray-dryer in the range of inlet temperature 
investigated. Most products accumulated in the cyclone and did not flow into the 
collection bottle. However, it was interesting to note that with decreasing inlet 
temperature, relatively more product reached the collection bottle.
Products collected in the collection bottle were studied under the SEM (Figure 3.7). 
They consisted of spherical agglomerates, i.e. microspheres. On visual inspection, 
the products obtained at the spraying temperatures of 220 °C - 160 °C were found to 
be of better spherical shape, and therefore more desirable. The reason for this 
observation could be complicated and might be related to a number of factors 
including viscosity, and mass of the particles of the DCPA powder, water, and binder 
which were sprayed. If the water inside the particle "boiled", the sphere would first 
become hollow and then burst. Both the air flow rate and temperature affect the 
shape of the particle formed.
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Inlet temperature = 240 °C Inlet temperature = 220 °C
Inlet temperature = 160 °C Inlet temperature = 120 °C
t  5 K U
Inlet temperature = 100 °C
Figure 3.7 SEM micrographs of spray-dried products of 40% w/w DCPA produced 
at various inlet temperatures.
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3.6.1.2 50% w/w Solids Content Slurries
Slurries of 50% w/w DCPA, 2 pph PEG 1000; and 1 pph Dispex A40 were prepared 
and spray-dried at inlet temperatures of 240 °C - 70 °C, with interval decrements of 
20 °C.
All other spray-dryer conditions were kept constant as in SDC Set 1 (section 3.5.1), 
except for experiments with inlet temperatures > 100 °C, where the pump rate was 
increased from -350  ml/h to -500  ml/h (dryer scale = from 10 to 15). This was done 
because it was found that high solids content slurries readily caused nozzle blockage. 
A higher feeding rate helped preventing the blockage. All spray-dried products were 
examined under the SEM.
For SEM examination, initially the microsphere samples were sputter coated with 
gold for 3 min, 5 min or 8 min. However, these samples were found to have marked 
charging effects under the microscope. This was because the round shape of the 
microspheres only allows one point of contact with the support disc and the 
conduction of electrons was limited. The effect was exacerbated by the convoluted 
surface morphology of the microspheres, where breaks in the conducting coating 
were inevitable. Subsequently all the microsphere samples for SEM were gold 
coated for 10 min.
3.6.1.2.1 Results and Discussion
As the inlet temperature dropped below 90 °C, water condensation was observed in 
both the cyclone and the collection bottle, at 70 °C, it was almost impossible to 
produce a proper spray. At these temperatures there was insufficient energy available 
for moisture evaporation to produce ‘dry looking’ products.
In all experiments, apart from deposited in the collection bottle, products were also 
found to accumulated heavily on the cyclone wall. Products collected in the cyclone 
and collection in the collection tube from same batch of products were examined 
under the SEM. The results showed that the microspheres collected in the cyclone 
were generally smaller in size than those collected in the collection bottle.
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SEM micrographs of the spray-dried products are shown in Figure 3.8. By 
comparing the SEM micrographs of the microspheres obtained from the 50% w/w 
solids content slurries and the 40% w/w solids content slurries, it was found that 
higher solids contents slurries generally produced bigger microspheres.
3.6.2 Slurry Solids Content
To further investigate the effect of solids content of the DCPA slurry on the resultant 
spray-dried products, slurries with solid contents of 20%, 30% and 60% w/w DCPA, 
2 pph PEG 1000 and 1 pph Dispex A40 were spray-dried as before, SDC Set 1, 
section 3.5.1 (exception: pump speed of 60% w/w slurry were set to ~ 500 ml/h, 
dryer scale = 15, to prevent nozzle blockage). The spray-drying processes were 
observed and the products were compared under the SEM.
3.6.2.1 Results and Discussion
Slurries with 20% w/w solids content could not be spray-dried successfully. The 
products were ‘wet’ and sticky due to the high water content. It was noticed that the 
lower the solids content, the more products deposited in the cyclone and the fewer 
products reached the collection bottle. The higher the solids content, the better the 
spray-dried product flowed in the spray-dryer. Slurries with 60% w/w solids content 
produced free flowing powder that flowed smoothly into the collection bottle.
SEM micrographs of spray-dried products obtained from various slurries with 
various solid contents (20% - 60% w/w) are shown in Figure 3.9. The products of 
low solids content, 20% and 30% w/w, have high moisture content. They appeared 
to be relatively smaller sized microspheres and they clustered together. The higher 
the solids content, the bigger the microspheres obtained. 60% w/w slurry produced 
well-formed microspheres. A SEM micrograph of one of these microspheres is 
shown in Figure 3.10.
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Inlet temperature = 240 °C Inlet temperature = 220 °C
Inlet temperature = 120 °C Inlet temperature = 100 °C
Inlet temperature = 90 °C Inlet temperature = 70 °C
Figure 3.8 SEM micrographs of spray-dried products of 50% w/w DCPA produced 
at various inlet temperatures.
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(a) Solids content = 20% w/w
(b) Solids content = 30% w/w
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(c) Solids content = 40% w/w
(d) Solids content = 50% w/w
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(e) Solids content = 60% w/w
Figure 3.9 SEM micrographs of spray-dried products obtained from slurries of 
various solids content of DCPA, (a) 20% (b) 30%, (c)40%, (d) 50% and (e) 60%.




To investigate the effect of the dispersant concentration on the spray-dried products, 
200 g slurries of 30% w/w DCPA and 2 pph PEG 1000 were prepared with various 
amounts (1 pph, 2 pph or 3 pph) of Dispex A40 and sufficient quantity of aqueous 
ammonia to adjust the slurry pH to 8 -  9. These spray-dried under SDC Set 1 
(section 3.5.1). The experiments produced low yields. The spray-dried products 
were examined under the SEM.
3.6.3.1 Results and Discussion
SEM examination results (Figure 3.11) showed that at higher concentration of 
dispersant, microspheres of smaller size were produced. The decrease in microsphere 
size may be explained by the reduction of slurry viscosity due to the addition of 
dispersant. It is known that viscosity is one of the factors that influences the mean 
drop size of a spray, but the viscosity was not measured in the experiments. The 
results obtained are in agreement with the finding that an increase in feedstock 
viscosity results in an increase in mean drop size of the sprays, and therefore 
producing particles of bigger size50,93.
(a) Dispex concentration = 1 pph
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(b) Dispex concentration = 2 pph
(c) Dispex concentration = 3 pph 
Figure 3.11 Spray-dried products from slurries containing (a) 1 pph, (b) 2 pph, and
c) 3 pph of Dispex A40. (Magnification x 500)
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3.6.4 Binder Concentration
To investigate the effect of binder concentration, slurries (200 g) with 30% w/w 
DCPA and 2 pph of Dispex A40 were added with 2 pph or 3 pph of PEG 1000. The 
slurries were then spray-dried under SDC Set 1 (section 3.5.1) and the experiments 
produced a low yield. The spray-dried products were examined under the SEM.
3.6.4.1 Results and Discussion
The SEM results (Figure 3.12) showed that the morphology of the microspheres 
changed when the concentration of binder increased from 2 pph to 3 pph. 3 pph PEG 
1000 produced microspheres with smoother surfaces. This can be due to higher 
amount of binder accumulating on the surface of the microspheres. Zhang et a/.58 
have reported that a surface layer with a large amount of binder was formed in the 
ceramic spray-dried granule, and the binder segregation was influenced by initial 
binder concentration.
It was also noted that slurry with the higher concentration of PEG 1000 produced 
spray-dried products which flowed less well. The products accumulated mainly in 
the cyclone. The presence of PEG 1000 may have helped to retain moisture. 
Therefore, the products were dried less efficiently. It is concluded that the lesser the 
PEG the better the product flow; 2 pph PEG is more suitable concentration.
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(a) binder concentration = 2 pph
(c) binder concentration = 3 pph
Figure 3.12 Spray-dried product of 30% w/w DCPA, 2 pph Dispex A40 and PEG 
1000 (binder) concentrations of (a) 2 pph, and (b) 3 pph. (Magnification x 500)
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3.6.5 Jet Size
The effect of atomiser jet size was also investigated. The size of the spray droplets is 
closely linked to the jet size. Theory predicts that the mean drop size is roughly
QQ
proportional to the square root of the liquid jet diameter . With the aim of producing 
a larger spray-dried product, the use of a bigger jet size, 1.5 mm (vs. 0.5 mm used 
previously) was investigated.
A suspension (200 g) of 30% w/w DCPA, 2 pph PEG 1000 and 2 pph Dispex A40 
was sprayed under these following conditions:








350 and 500 ml/h (dryer scale = 10 or 15)
62-64 m3/h (dryer scale = 41 -44)(maximum setting) 
80 kPa (maximum setting)
Experiments were performed at two different pump speeds, 350 ml/h and 500 ml/h. 
The compressor air pressure was set to maximum as in SDC Set 1 (section 3.5.1), and 
the reduction in its values was due to the change of jet size. Both experiments 
produced a very low yield.
3.6.5.1 Results and Discussion
A jet with a bigger diameter decreases the velocity of the feed sprayed through the 
nozzle at any one time if the pump speed remains constant. At a pump speed of 350 
ml/h, the sprayed droplets landed mostly on the base of the main chamber because 
the sprayed products were wet, the moisture evaporation being far from complete. At 
an increased pump speed of 600 ml/h, slurry droplets were dribbling from the nozzle, 
because there was not enough energy to convert the slurry into a fine mist. It was 
therefore concluded that the 1.5 mm jet nozzle was not suitable for these studies.
78
3.6.6 Change of binder to Eudragit L100
As mentioned in the preliminary studies (section 3.5.3.2), Eudragit L100 was found 
to produce microspheres with smooth surfaces that flowed relatively well in the 
spray-dryer, compared to other binders tested. It was then decided to further 
investigate the use of Eudragit L100 as a binder, replacing PEG 1000, in the DCPA 
spray-drying slurry.
Eudragits are a variety of acrylic resins that are based on poly(ethylacrylate- 
methymethacrylate) esters33, and are widely used in the pharmaceutical industry as a 
coating material for oral dosage forms to prepare film-coated, enteric coated or 
sustained-release granules or tablets21. Films with different solubility characteristics 
can be obtained using different types of eudragits. For example, Eudragit E is used 
as a plain or insulating film coating because it is soluble in gastric fluid below pH 5. 
In contrast, Eudragit L and S types are used as enteric coating agents since they are 
resistant to acidic pH in the stomach, e.g., Eudragit L 100 is soluble at pH > 6.
Eudragits are also used in both aqueous and organic wet-granulation processes as 
binders. Larger quantities (5% - 20%) are used to control the release of active 
drugs33. Solid Eudragits may also be used in direct compression to produce 
controlled release tablets94.
Six slurries, containing Eudragit L100, with compositions listed in Table 3.2, were 
prepared and spray-dried at the inlet temperature given in the table. All other spray- 
drying conditions are as in SDC Set 1 (section 3.5.1).
Table 3.2 Slurry compositions and spray-drying conditions for formulation A - F.
Formulation
A B C D E F
DCPA/%w/w 50 30 60 60 60 60
Eudragit LlOO/pph 2 2 2 3 3 3
Dispex A40/pph 1 1 1 1 1 1
Inlet temperature/°C 120 200 200 200 180 160
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3.6.6.1 Results and Discussion
It was observed that compared to slurries with PEG 1000, slurries with Eudragit 
LI00 generally produced spray-dried products with better flow characteristics. All 
formulations (A-F) produced highly satisfactory spray-dried products. Products 
flowed smoothly from the main chamber, through the cyclone into the collection 
bottle. This flow pattern was different from the flow pattern of PEG containing 
products, which tended to stay in the cyclone.
Formulation A was a 50% w/w DCPA slurry spray-dried at inlet temperature of 
120 °C and the product was a free flowing powder. This experiment shows that 
slurries with Eudragit L100 can be successfully spray-dried at temperatures as low as 
120 °C, as the products obtained are still relatively dry. This was not the case for 
slurries with PEG 1000. Under the same spray-drying conditions, the moisture 
evaporation for slurries with Eudragit LI00 appears to be more complete than for 
slurries with PEG. This is probably due to the different properties of Eudragit L100 
and PEG.
SEM micrographs of the spray-dried product of Formulation A at three different 
magnifications are shown in Figure 3.13. These micrographs show hollow 
microspheres. The shell of the some of the hollow spheres erupted under the high 
internal pressure created during moisture evaporation and the shell collapsed as 
explained in section 1.5.1. Hence, some microspheres had dimples, holes or were 
doughnut-shaped. At x 10,000 magnification, it was clear that these microspheres 
were made up from DCPA particles of different sizes, a consequence of the ball- 
milling process (see Table 3.1 in section 3.5.6 for particle sizing results).
SEM micrographs of spray-dried products from Formulation B, C, D, E and F are 
shown in Figure 3.14. The difference between Formulation B and Formulation C is 
the solids content (30% and 60% w/w DCPA respectively). 60% w/w slurry 
produced bigger microspheres. This is observation is consistent with the results 
obtained from slurries using PEG 1000 as a binder (section 3.6.2).
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Formulation C and Formulation D have Eudragit L100 concentration of 2 pph and 
3 pph respectively. SEM results show that the slurry with a higher concentration of 
binder (Formulation D) produced bigger and rounder microspheres. These 
microspheres also appeared to have bigger hollow centres and thinner shells.
Formulation D, E and F have the same composition, but were spray-dried at different 
inlet temperatures (200 °C, 180 °C and 160 °C respectively). These formulations 
produced microspheres with thin shells and big holes on the surface. Products from 
Formulation D and E were found to be similar, while Formulation F (lowest inlet 





Figure 3.13 SEM micrographs of spray-dried products obtained from Formulation A 









Figure 3.14 SEM micrographs of spray-dried products obtained from Formulation B 
to Formulation F (constant magnification of x500).
3.6.7 Internal Morphology Studies
To investigate the internal morphology of microsphere samples under the SEM, the 
microspheres need to be sectioned. The microspheres are too fragile and too small to 
be hand manipulated; therefore, for the sectioning procedure to be carried out, the 
microspheres need a good support in the form of a resin matrix. There are 
hydrophobic (epoxy) and hydrophilic (acrylic) resins available for embedding 
samples.
In this study, an epoxy resin was used. Microsphere samples were first mixed with a 
liquid resin, and the resin was allowed to penetrate into the pores. When the resin 
was polymerised and hardened, it provided a good platform for the samples to be 
sectioned or polished. For details of the resin embedding technique and SEM 
examination procedure please refer to section 2.7.5.
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3.6.7.1 Results and Discussion
Samples of epoxy resin-embedded microspheres were found to have good contrast 
for SEM examination. SEM micrographs of sectioned microspheres obtained from 
Formulation F are shown in Figure 3.15. The results showed that hollow-centred 
microspheres had been produced. It was expected that these big hollow centres were 
created during the moisture evaporation when the droplets were sprayed into the 
main chamber, as explained in section 1.5.1. The suspended solids were drawn to the 
droplets’ surfaces and the liquid at the interior of the droplets diffuses to the surfaces 
to be evaporated. Hence, the centres of the droplets are empty and the solids form 
the shells.
IQOpm
Figure 3.14(a) SEM micrographs of sectioned microspheres obtained from 
Formulation F at x300 magnification
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Figure 3.15(b) SEM micrographs of sectioned microspheres obtained from 
Formulation F at x l400  magnification.
3 . 7  Spray-drying of Beta-Tricalcium Phosphate (p-TCP)
3.7.1 Characterisation of Powder As-Received
The spray-drying of beta tri-calcium phosphate (P-TCP), Ca3(P0 4 >2, was also studied. 
Visually, p-TCP powder has a more ‘fluffy’ appearance compared to DCPA powder. 
The p-TCP as-received was imaged under the SEM (Figure 3.16) and its particle-size 
distribution was analysed using a Mastersizer X (section 3.7.5). These results were 
then compared to the DCPA powder as-received.
3.7.1.1 Results and Discussion
The SEM micrographs of P-TCP as-received powder are shown in Figure 3.16. 
Compared to DCPA as-received [Figure 3.5 (a)], in terms of shape, p-TCP particles 
are more ‘flaky’ while DCPA particles are more ‘cubic’.
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(a) Magnification = x500
(b) Magnification = x5000
Figure 3.16 SEM micrographs of p-TCP powder as-received at magnification of 
a) x500, b) x5000
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The results of particle-size analysis are summarised in Table 3.3. Comparing the two 
powders, the results indicated that p-TCP powder has a smaller volume mean 
diameter (DCPA: 4.56 pm; p-TCP: 3.41 pm) and has a narrower particle-size 
distribution (80% confidence interval, DCPA: 0.74 pm - 19.4 pm; p-TCP: 1.01 pm - 
9.58 pm).
Table 3.3 Results of particle-size analysis of DCPA and p-TCP powder as-received.
Particle-size/pm, n = 3
Sample d(v, 0.1) d(v, 0.5) d(v, 0.9)
DCPA as-received 0.74 ±0.00 4.56 ±0.30 19.4 ±1.95
P-TCP as-received 1.01 ±0.01 3.41 ±0.03 9.58 ±0.35
Note: Measurements were made in the small-volume cell (SVC) and the samples 
were subjected to 5 min sonication before analysis.
3.7,2 Stage 1 Study for p-TCP
As described earlier (section 3.5.6.1), 30% w/w solids content DCPA in water was a 
liquid suspension. However, 30% w/w p-TCP in water was found to be a viscous 
paste, which could not be pumped into the spray-dryer. It is interesting to note that 
with an addition of 2 pph Dispex A40 to the p-TCP paste, the viscosity of the paste 
reduced markedly, and it became a pumpable liquid slurry. By visual observation, it 
was noticed that this slurry was a good suspension, since it was thick enough to 
suspend all the particles with no sedimentation, the pre-treatment of ball-milling 
carried out for DCPA was therefore unnecessary for p-TCP.
Four p-TCP formulations (Tl, T2, T3 and T4) were prepared and spray-dried. Their 
compositions and spray-drying conditions are listed in Table 3.4. Two binders were 
investigated: T l and T2 contained PEG 1000, while T3 and T4 contained Eudragit 
L100. T l has a higher pump speed (500 ml/h) compared to T2; and T3 was sprayed 
at a higher temperature (245 °C) compared to T4 (200 °C).
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Table 3.4 p-TCP slurry compositions and spray-drying conditions for Stage 1 Study.
Formulation
T1 T2 T3 T4
C/3c
p-TCP/%w/w 30 30 30 30
O*4—> Binder PEG 1000 2 2 - -
o
a
/pph Eudragit LI00 - - 2 2
o
U Dispex A40/pph 2 2 2 2
Inlet temperature/°C 200 200 245 200
C/3e Pump speed/dryer scale 15 10 10 10o
*3 (ml/h) (500) (350) (350) (350)
G
O
U Jet Size/mm 0.5 0.5 0.5 0.5
1,1 ■ ■ ■ i i i ----
Note: Air-flow and compressor air pressure were set to the maximum values, 62 m /h 
- 64 m3/h and 180 kPa respectively, in all experiments.
Slurries with PEG 1000 were prepared as follows:
1) PEG 1000 was weighed out and dissolved in deionised water in a vial.
2) Dispex A40 was weighed out and dissolved in deionised water in a vial.
3) P-TCP powder was weighed out in a beaker.
4) The solutions of binder and dispersant obtained in 1) and 2) were added into 
the beaker containing p-TCP.
5) Sufficient quantity of aqueous ammonia (2.7 M) to adjust the pH to 8.4-8.7 
was added by pipette. The increase of pH was monitored by pH paper.
6) Deionised water was added to make up to the final weight.
A typical formula is illustrated as below:
DCPA 60.0 g (30% w/w)
Eudragit LI00 1-2 g (2 pph)
Dispex A40 1-2 g (2 pph)
Aqueous ammonia (2.7M) ~ 2 ml (to adjust pH to 8.4-8.7)
Purified water to 200.0 g
To ensure complete dissolution of Eudragit L100, 1) of the above preparation 
procedure was modified for the preparation of slurries containing Eudragit L100.
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Eudragit L100 was first weighed out and dissolved in water with aqueous ammonia. 
The mixture was then sonicated until all solids dissolved. This precautionary step 
was carried out because Eudragit L100 does not dissolve well in acidic conditions33 
and p-TCP suspension is slightly acidic, pH ~ 5. All other steps in the procedure 
above were then followed.
The slurries were magnetically stirred throughout the spray-drying process. The 
surface morphology and the internal morphology of the spray-dried products were 
examined under the SEM (sample preparations and resin-embedded techniques are 
detailed in sections 2.7.4 and 2.7.5).
3.7.2.1 Results and Discussion
With the addition of dispersant, Dispex A40, p-TCP powder was found to readily 
form a good suspension by visual observation, therefore, the particle reduction 
process -  ball-milling was found to be not necessary. This may be because P-TCP 
particles are smaller and ‘flaky’ in shape. This finding was welcome because it 
reduces the ball-milling steps which may introduce one more possible variation to the 
final products, and is time consuming.
The spray-dried products of all four formulations obtained were free flowing 
powders. Their SEM micrographs are shown in Figure 3.17. As can be seen from 
the micrographs, the products consisted of microspheres with a range of sizes.
SEM results showed that there was no distinctive difference between the products of 
T1 and T2, i.e., the higher feeding rate (pump speed) of T1 (500 ml/h) has not made a 
marked difference. T4 (Eudragit LI00 as binder, inlet temperature = 200 °C) was 
found to contain some larger microspheres compared to all other formulations; this 
could be the result of change in viscosity due to the binder. Viscosity is one of the 
main factors that influence the droplet size.
It was found that the binder type also influenced the surface morphology of the 
microspheres produced (Figure 3.18). Eudragit L100 was found to produce 
microspheres with a smoother surface than PEG 1000.
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The SEM micrographs of sectioned microspheres from T3 and T4 (Figure 3.19) 
showed that T4 consisted of microspheres with hollow regions while T3, even at a 
higher magnification observation (as shown in Figure 3.19), consisted of more solid 
centred microspheres. The results indicate that at higher spraying temperature 
(245 °C) solid microspheres were produced, whilst at lower spraying temperature 
(200 °C) porous microspheres were produced.
In conclusion, during Stage 1 Study free-flowing spray-dried P-TCP microspheres 
were successfully produced. p-TCP was found to be easier to spray dry than DCPA 
because:
1) A homogeneous suspension of p-TCP powder can be readily prepared 
without the additional step of ball-milling.
2) P-TCP slurries produced spray-dried products which flowed distinctively 
better in the spray-dryer.
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Figure 3.17 Spray-dried products obtained from formulation (a) T l, (b) T2, (c) T3, and (d) T4. (Constant magnification)
(a) M icrospheres containing PEG 1000
(b) Microspheres containing Eudragit L I00.
Figure 3.18 SEM micrographs of p-TCP microspheres using (a) PEG 1000, 
(b) Eudragit L I00, as binder.
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(a) Inlet temperature = 245 °C, T3
100|jm
(b) Inlet temperature = 200 °C, T4 
Figure 3.19 SEM micrographs of sectioned microspheres obtained from spray-drying 
at inlet temperature of (a) 245 °C, T3, and (b) 200 °C, T4.
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3.7.3 Stage 2 Study for p-TCP
Stage 2 study aimed to refine the slurry compositions and spray-drying conditions to 
produce microspheres with the following desired characteristics: highly porous, 
diameter as large as possible and well-formed spherical shape. These characteristics 
are favourable because the project aims to produce drug carriers which have a high 
porosity to serve as reservoir, a large diameter for increasing the drug diffusional 
pathway, therefore delaying the drug release, and a uniform geometry for uniform 
drug release.
The range of slurry compositions and the spray-drying conditions chosen for Stage 2 
Study were based on the results obtained from Stage 1 Study and previous experience 
as presented below:
I) Inlet temperature
The inlet temperatures of 180 °C and 200 °C were chosen because:
a) Temperatures < 160 °C are unlikely to supply enough energy for moisture 
evaporation to produce free flowing products (section 3.6.1);
b) The higher temperature tested (245 °C) was found to produce relatively less 
porous microspheres (section 3.7.2);
c) The frequency of nozzle blockage was found to increase with increasing inlet 
temperature, for a given pump speed;
d) Pharmaceutical products should preferably to be spray-dried at the lowest 
possible temperature to reduce the risk of heat damage.
II) Solids content
To investigate the effect of solids concentration on the spray-dried products, p-TCP 
slurries with solids content of 10% w/w to 50% w/w, at an increment of 10%, were 
chosen. A high solids content is desirable in the spray-drying of ceramics, as 
discussed in section 3.1. Solids concentration as high as 50% w/w were tried to 
estimate the approximate maximum solids contents that is achievable.
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III) Dispersant
The Dispex A40 concentration of 2 pph was used because it was found to produce a 
well-dispersed suspension in Stage 1 Study (section 3.7.2). The spray-drying of 
slurry without Dispex A40 was also investigated. The effect of Dispex A40 as a 
dispersant for the systems was further studied by measuring the height of sediments 
as detailed in section 3.8.
IV) Binder
Eudragit L100 was chosen over PEG 1000 to be used as the binder. This is because 
in the Stage 1 Study (section 3.7.2), it was found that the spray-drying of Eudragit 
containing slurries produced microspheres which:
a) flowed better in the spray-dryer, as observed visually;
b) had the largest diameter (Figure 3.17);
c) had uniform spherical shape and smooth surface (Figure 3.18).
IV) Jet size
The mean drop size is roughly proportional to the square root of the liquid jet 
diameter89. A higher drop size will theoretically produce particles with larger 
diameter. A jet with internal diameter of 0.5 mm was used in Stage 1 Study. Aiming 
to produce microspheres with larger diameter, the use of jets with internal diameter 
of 1.0 mm and 1.5 mm was investigated. Bigger jet sizes also have the added 
advantage of having less nozzle blockages.
Fourteen formulations with compositions listed in Table 3.5 were prepared and 
spray-dried at the conditions given in the table. Note that the sequence of 
formulation listed in the table does not represent the chronology sequence of the 
experiments. Slurries were magnetically stirred throughout the spray-drying process. 
All spray-dried products were then examined under the SEM. The internal 
morphology of these products was studied by examining the sectioned open resin- 
embedded samples (technique see section 2.7.5) under the SEM.
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Table 3.5 P-TCP slurry compositions and spray-drying conditions for Stage 2 Study.
Formulation





P-TCP/%w/w 30 30 30 20 20 10 10 10 30 15 30 10 30 40
Eudragit LlOO/pph
Dispex A40/pph 0





Pump speed /dryer 
scale*
10 10 10 15 15 15 15 25 10 15 10 15 10 15
Jet size/mm 0.5 0.5 1.5 0.5 0.5 0.5 0.5 0.5 1.5 0.5 1.0 1.0 0.5 0.5
*Dryer scale: 10 = 350 ml/h, 20 = 600 ml/h, and 30 = 1000 ml/h according to the spray-dryer operational manual (LabPlant Ltd., UK). 
Air-flow and compressor air pressure were set to the maximum value, ~ (62 - 64) m /h and ~ (150 -180) kPa respectively, at all time.
3.7.3.1 Results and Discussion
I) Inlet Temperature
30% w/w P-TCP slurries were spray-dried at inlet temperature of 180 °C (T6). Slurries 
with the same composition have also been spray-dried at 200 °C (T4) and 245 °C (T3) 
in Stage 1 Study while other conditions remained constant. The products of these 
formulations were examined and compared under the SEM (Figure 3.20). A 
temperature of 245°C was found to produce microspheres of smaller diameter and 
cause frequent nozzle blockages. Also, whilst temperatures of 180 °C and 200 °C were 
found to produce highly porous microspheres, a temperature of 245 °C was found to 
produce solid centred microspheres (as discussed earlier in section 3.7.2.1. and shown 
in Figure 3.19)
II) Solids content
Slurries with solids content of 10% w/w - 40% w/w p-TCP were successfully spray- 
dried. Slurries with solids content > 40% could not be prepared because there was not 
enough water to wet all the solids. Therefore, only slurries with solids content up to 
40% w/w are listed in Table 3.5. T10, T9, T6 and T18 contained solids contents of 
10%, 20%, 30% and 40% w/w respectively, and their SEM micrographs are shown in 
Figure 3.21. Under the SEM, it appears that microspheres with larger diameter were 
obtained with increasing solids content.
HI) Dispersant concentration
Slurries of 20% w/w P-TCP were successfully prepared and spray-dried with, and 
without Dispex A40 (T8 and T9 respectively). The resultant spray-dried microspheres 
appear to be similar under the SEM (Figure 3.22). These results suggest that at lower 
solids content (< 30% w/w), the addition of Dispex A40 is not essential. However, 
slurries of 30% w/w solids content, are too viscous to be spray-dried and the use of 
Dispex is essential.
IV) Binder concentration
The only difference between T5 and T6 is the binder concentration, at 4 pph and 2 pph 
Eudragit L100 respectively. Under the SEM, in terms of surface morphology and
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dimensions of the microspheres obtained, no marked difference was observed between 
the spray-dried products of these formulations (Figure 3.23).
V) Jet Size
Slurries of 30% w/w p-TCP were spray-dried using jet sizes of 0.5 mm, 1.0 mm and 
1.5 mm (T6, T15, T7 respectively) while other conditions remained constant. Visual 
observation under the SEM found that there was no marked increase in spray-dried 
microsphere diameter with increasing jet size (Figure 3.24). Experiments also revealed 
that the 1.5 mm jet is not suitable as wet products accumulated in the main chamber; the
0.5 mm jet produced good spray but it got blocked easily; the 1.0 mm jet produced 
good spray and the best free flowing products without frequent nozzle blockages. 
Therefore it was concluded that 1.0 mm jet is the most suitable jet size for the 30% w/w 
P-TCP slurry.
Slurries of 10% w/w p-TCP were also spray-dried using 0.5 mm and 1.0 mm jet (T il 
and T16 respectively). The 0.5 mm jet was found to produce good spray but the 
1.0 mm jet produced wet products at 10% solids content. This indicates that different 
jet sizes are suitable for slurries with different solids content.
VI) Internal morphology of microspheres
By examining the sectioned open microspheres, it was found that all microspheres 
produced were porous. These sectioned open samples were also subject to 
backscattered electron imaging because backscattered electron images are useful for 
identifying and confirming pores within the microspheres. The regions containing 
calcium phosphate are presented as bright areas in the image while the pores and the 
resin are presented as dark areas. The images obtained have excellent contrast and give 
a good indication of the hollowness of the microspheres. A typical backscattered 





Figure 3.20 Spray-dried products from 30% w/w P-TCP slurries spray-dried at 
(a) 180°C, T6, (b) 200°C, T4, and (c) 245°C, T3.
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(a) 10% w/w (b) 20% w/w
(c) 30% w/w (d) 40% w/w
Figure 3.21 Spray-dried products obtained from slurries with (a) T10, (b) T9, (c) T6, (d) T18.
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(b) with 2 pph Dispex A40.
Figure 3.22 Spray-dried microspheres obtained from 20% w/w slurry, (a) T8 without 
Dispex A40, (b) T9 with 2 pph Dispex A40.
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(a) 4 pph binder (T5)
(b) 2 pph binder (T6).
Figure 3.23 SEM micrographs of spray-dried microspheres obtained from slurries with 





Figure 3.24 SEM micrographs of spray-dried products from jet of three different sizes 
(a) 0.5 mm (T6); (b) 1.0 mm (T15); (c) 1.5 mm (T7).
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Figure 3.25 Backscattered electron image of sectioned microspheres obtained from T9. 
3.7.4 Scale-Up Manufacturing
From Stage 1 and Stage 2 Studies, it was found that Formulation T15 produced the best 
spray-dried microspheres. Therefore, based on this formula, the production was scaled 
up to produce larger batches of microspheres (from ~ 200 g to 800 g slurries per batch) 
to be used in all other following stages of this project.
The composition, method and spray-drying conditions used in the scaling up of 
microspheres production are described below:
Slurry Composition (T15):
p-TCP 240.0 g (30% w/w)
Eudragit L I00 4.8 g (2 pph)
Dispex A40 4.8 g (2 pph)
Aqueous ammonia (2.7M) ~ 28 ml (to adjust pH to 8.4-8.7)
Purified water to 800.0 g
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Methods:
Eudragit L100 (4.8 g) was first weighed out in a flask. 200ml of deionised water and 
10 ml of aqueous ammonia (2.7 M) were then added to the flask. The mixture was 
sonicated for 6 min with occasional manual stirring until all solids dissolved and the 
solution was clear. Dispex A40 (4.8 g) was then weighed into a small vial and 
dissolved in about 5 ml of water before it was transferred to Eudragit L100 solution. (3- 
TCP (240 g) was then weighed into an 800 ml flask and the mixture of Eudragit L100 
and Dispex A40 prepared earlier was added to the flask. Water was added to make the 
weight of the mixture up to about ~775 g. ~ 28 ml of 2.7 M aqueous ammonia were 
then added to adjust the pH to 8.4-8.7. The pH changes were monitored by pH paper. 
Finally the slurry was made up to the final weight (800.0 g) with distilled water. The 
final mixture was sonicated for 8 min.
Spray-drying conditions (SDC) Set 3:
Jet size: 1.0 mm
Inlet temperature: 180 °C
Exhaust temperature: 108 - 115 °C
Pump rate: 350 ml/h
Compressor: 150 kPa
Air flow:
(dryer scale = 10) 
(maximum setting)
62 -64 m /h (dryer scale = 41-44, maximum setting)
The connection between main chamber and cyclone was lightly greased before each 
spraying process to provide a better seal. The SD-05 spray-dryer was allowed to warm 
up for 5 min followed by spraying of deionised water for 5 min before each turn. 
Throughout the spray-drying process, the slurry was magnetically stirred. Four batches 
of microspheres were produced.
3.7.4.1 Percentage Product Yield
To investigate the relationship between percentage product yield and inlet temperature, 
slurries of T15 were spray-dried at inlet temperatures of 200 °C and 220 °C, with other 
parameters unchanged. Four batches of product were produced at each temperature.
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To investigate the relationship between percentage product yield and solids content, 
slurries of 10%, 20% and 40% w/w solid content of p-TCP with constant Eudragit L100 
and Dispex A40 concentrations were also prepared and spray-dried using SDC Set 3. 
Two batches of product were obtained for each solids content.
3.T.4.2 Results and Discussion:
All products were free-flowing powders. The percentage product yield of spray-dried 
products from three inlet temperatures was calculated as follows:
% yield  = ---------------- Weigkt 0 f pr°duCt---------------- *100 Equation 3.1
weight of solids (TCP + eudragit) in slurry
The results of percentage product yield at various inlet temperatures are given in Table 
3.6. Less than 100% products were obtained in all cases. The product lost can be 
explained by particles lost in the exhaust air-flow, and those deposited on the walls of 
the main chamber and the cyclone. One-way analysis of variance at p = 0.05 level 
showed that there is no significant difference in the % product yield at the three inlet 
temperatures investigated [F(2,9) = 2.99, p= 0.101].
The results of percentage product yield for slurries of various solids content are given in 
Table 3.7. No statistical analysis was performed for the data because the number of 
repeat is small (n = 2). The results indicate that among solids content of 10% - 
40% w/w, 30% w/w slurry gives the highest yield. The percentage yield increases 
steadily from 10% to 20%, and to 30% w/w. This is probably because as the solids 
content increases more complete moisture evaporation is achieved. Therefore less 
products are lost due to deposition on the walls of the main chamber and the cyclone. 
The 40% w/w slurry was highly viscous and was difficult to achieve a smooth and 
uniform spray-drying. Interestingly, the results show that the production yield is 
markedly lower than the 20 % and 30% w/w slurries.
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Table 3.6 Percentage product yield at different inlet temperatures of 180°C, 200 °C and 
220 °C.
Solids content = 30% w/w p-TCP, n = 4
Inlet temperature/°C 180 200 220
Yield ±SD/% 63 ±4.3 70 ± 4.8 68 ± 2.2
Table 3.7 Percentage product yield for slurries at various solids content.
Inlet temperature =180 °C, n = 2
Solid content/% w/w 10 20 30 40
Yield/% 41.6 57.3 66.6 44.2
3.7.5 Particle-Size Analysis
The particle-size of spray-dried p-TCP microspheres was characterised by Mastersizer 
2000. The experimental method is described in section 2.3.2.
3.7.5.1 Results and Discussion
The results (Table 3.8) show that slurries with increasing solids content produce 
microspheres with increasing mean diameter, d(v, 0.5). Slurries of 10%, 20%, 30% and 
40% (w/w) produced microspheres with volume mean diameter of 10.0 pm, 10.5 pm,
19.1 pm and 25.5 pm, respectively.
During spray-drying, liquid was dispersed into droplets by pressurised gas. In general, 
the droplet size D can be expressed by an empirical equation53 as below:
D  oc P~nM qrjrcrsp* Equation 3.2
where P = atomisation pressure 
M = Liquid flow rate 
7j = Viscosity of slurry 
cr= Surface tension of slurry 
p  = Concentration of slurry
n, q, r, s and t = constants, values depend upon operating conditions53,95.
109
Assuming that the spray-dried microspheres size is proportional to the droplet size 
(other spray-drying conditions remaining constant), an increase in slurry concentration 
is predicted to increase the size of the microspheres.
Table 3.8 Particle-size analysis results for microspheres obtained by spray-drying p- 




d(v, 0.1)/pm d(v, 0.5)/pm d(v, 0.9)/pm
Run 1 Run 2 Run 3 Run 1 Run 2 Run 3 Mean Run 1 Run 2 Run 3
10 3.26 3.28 3.30 10.03 10.04 10.06 10.05 22.21 22.16 22.18
20 3.30 3.32 3.37 10.45 10.46 10.47 10.46 24.62 24.60 24.54
30 4.38 4.39 4.42 19.21 19.06 19.08 19.12 53.16 52.45 53.01
40 5.56 5.53 5.56 25.59 25.39 25.43 25.47 67.11 65.67 66.09
3.7.6 Sieving
The products of spray-dried calcium phosphate slurries are spherical soft agglomerates 
with a size distribution as shown in Table 3.8. Spray-dried powders are never of one 
size because the atomiser cannot form a totally homogeneous spray95. The droplets are 
also subjected to shape distortion depending on their drying characteristics and their 
travelling mode in the dryer. One of the methods to reduce the size distribution of 
spray-dried products is sieving.
Attempts were made to discard the fines of the spray-dried products, i.e., only retain the 
coarse microspheres for the sintering and the drug loading studies. Products obtained 
from T6 were sieved through stacks of 45 pm and 32 pm stainless steel sieves. A sieve 
shaker (Endecotts Octagon Digital Test Sieve Shaker, Endecotts Ltd., London, UK) was 
used and the sieving process was performed at amplitude of 5 for 15 min, followed by 
amplitude of 6 for 15 min. About 6 g - 8 g of powder was sieved per batch. The 
particle-size of the microspheres before and after sieving (the fraction retained by the 
32 pm sieve) was analysed using the Mastersizer 2000 and examined under the SEM.
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3.7.6.1 Results and Discussion
The results of particle-size analysis (Table 3.9) show that the sieved products have a 
slightly higher mean particle-size, d(v, 0.5), but the particle-size distribution range 
remains similar. SEM examination confirmed that there were still a lot of fines in the 
sieved powder.
Table 3.9 Particle-size analysis for P-TCP microspheres before and after sieving.
d(v, 0.1)/pm d(v, 0.5)/pm d(v, 0.9)/pm
Sieving Run 1 Run 2 Run 3 Run 1 Run 2 Run 3 Run 1 Run 2 Run 3
Before 4.38 4.39 4.42 19.21 19.06 19.08 53.16 52.45 53.01
After 4.84 4.86 4.88 23.25 23.24 23.19 55.86 56.04 55.80
The reasons that render the sieving process ineffective could be:
1. Too much sample was sieved at once.
2. The sieving time was too short.
3. Most microspheres are < 10 pm. For particles of these sizes, the electrostatic
charge can be more dominant than gravity. The electrostatic forces between 
particle-particle and/or particle-sieve are relatively strong.
4. The microspheres broke up during the sieving process.
5. A combination of the factors above.
Possible ways of improving the sieving process include:
1. Using less powder sample in each sieving session.
2. Perform sieving for a longer period of time.
3. Re-sieving and cleaning the sieving surfaces more frequently.
4. Changing the humidity of the sieving environment. Lowering the humidity 
may decrease the clinging of the powder to the sieve96.
5. Include the use a Sonic Sifter device, which can help to push the powder 
through the mesh.
Sieving of fine particles has been well studied97. Getting the right sieving conditions 
and equipment can be a complicated process. Furthermore, to obtain enough sieved 
samples to be used in sintering the drug loading studies could be a time consuming
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The physical properties of a well-formulated suspension for spray-drying are:
a) The suspension must remain homogeneous for at least the period between the 
moment it leaves the feed container, and the moment it reaches the atomiser.
b) If sediment is produced on standing, it must be easily resuspended by the use of 
moderate mixing action, e.g. stirring mechanism.
c) The viscosity of the suspension may be increased to reduce the rate of settling of 
the particles. However, the viscosity must not be so high that the product is not 
pumpable.
Recent studies have shown that the level of flocculation/dispersion of the precursor 
ceramic slurries, considerably affects the structure of the spray-dried particles. Walker 
et al.55 reported that denser alumina spray-dried particles were produced at higher 
deflocculant levels. Takahashi et al.9% showed that changing the pH of the silicon 
nitride slurries changed their flocculation state. Using well-dispersed slurries, dense 
and hard granules with irregular shape were produced, whilst using flocculated slurries, 
lower density granules with well-formed spherical shape were produced.
Flocculation studies were performed, with the aim of investigating the influence of 
Dispex A40 and of the pH changes on the suspension stability of DCPA and P-TCP 
slurries. Changes in pH were considered because the performance of Dispex A40, an 
anionic dispersant, is pH-dependent".
In pharmaceutical suspension formulation, highly flocculated suspensions are generally 
desirable. This is because flocculated systems form loose sediments which are easily 
redispersed when shaken (e.g. when a patient shakes a syrup bottle). In contrast to this, 
deflocculated systems are required in ceramic slurry preparations, since deflocculated 
powders settle down more slowly, and are therefore considered a more stable.
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The stability of ceramic suspensions can be explained by considering the DLVO theory 
of colloid stability100. DLVO theory has a quantitative approach towards the stability of 
colloidal systems. It assumes that the only interactions between two particles involved 
are electrical repulsion (VR) and wan der Waals attraction (VA), and that these 
parameters are additive. As a result, the total potential energy of interaction V t is given 














Figure 3.26 Schematic curve of total potential energy of interaction VT, versus distance 
of separation, H, for two particles. V j= VR + VA (taken from Aulton101).
As two particles approach each other, they initially encounter a weak attractive force, 
represented by the secondary minimum in the curve. As the two particles move closer 
to each other, the repulsive electrical force increases exponentially, and the particles 
strongly repel each other, by means of the electric charges on their surfaces. If the 
energy supply is enough, and the primary maximum repulsive force is overcome, the 
two particles collapse into each other.
In a suspension, particles > 1 pm tend to settle due to gravity. The electrical repulsive 
forces between the particles enable them to slip past one another to form a close packed
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arrangement at the bottom of the container, with the small particles filling the voids 
between the larger ones. Those particles lowermost in the sediment are gradually 
pressed together by the weight of the ones above. When the repulsive force 
(represented by primary maximum in Figure 3.26) between the two particles is 
overcome, the particles move into close contact with each other and physical bonding, 
leading to ‘cake’ formation, may then occur. Hence, more energy is required to 
redisperse the sediment.
In short, when V t gives a positive potential energy maximum at intermediate particle 
separation distances, the result is a deflocculated system and when the V t gives a 
negative value, the result is a flocculated system. Since Va is fixed for any given 
suspension, the shape of the total interaction curve is determined by V r. The stability 
of the system is therefore a function of those parameters that control V R - the particle 
surface charge and the double-layer thickness.
The surface charge on a particle can be developed through adsorption of charged 
chemical species (i.e., dispersants) or by adjustment of the solution pH. It is also 
possible to deflocculate ceramic powders by steric effect, where the spatial arrangement 
of large adsorbed molecules prevents close particle-particle encounters. Gum arabic, is 
believed to deflocculate particles by this steric mechanism102.
The surface charge of a particle also builds up an electric double-layer around itself100, 
as shown in Figure 3.27. Consider a solid charged surface in contact with an aqueous 
solution containing positive and negative ions. The surface charge influences the 
distribution of ions in the aqueous medium. Counter-ions (ions of the opposite charge) 
are attracted towards the surface, partially neutralising the charge and co-ions (ions of 
like charge) are repelled away from the surface. A second layer of co-ions will 
surround this first layer of counter-ions in a diffuse manner in the aqueous medium. 























Figure 3.27 The double layer (adapted from Shanefield100)
3.8.2 Dispex A40
Dispex A40 is a commercial polyelectrolyte that is commonly used in the ceramic 
industry to produce ceramic suspensions (see also section 3.5.8). Greenwood et a l."  
have characterised Dispex A40 and suggest that it is an ammonia-neutralised 
polyacrylic acid with a molecular weight, M w, of ~ 10 000 Da and a polydispersity of 
of 1.56. The structure of Dispex A40 is shown in Figure 3.28.
o ^ " o "  n h 4+
Figure 3.28 Molecular structure of Dispex A4099.
Polyacrylic acids contain ionisable carboxylic groups, so the degree of ionisation 
changes with pH and ionic strength. For Dispex A40, the negative charge density 
increases with increasing pH. The ionisation properties of polyacrylic acids have been 
studied, and previous work has shown that they are completely ionised at pH > 8103,99. 
Therefore at pH 8 - 9, it is considered that Dispex A40 is fully ionised.
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Greenwood and Bergstrom" suggest that a fully ionised Dispex A40 will attain a 
relatively rigid, extended conformation in solution, and usually adsorb flat on a surface 
with essentially no parts of the polyelectrolyte extending into the solution. This is 
based on their findings that the plateau value of the adsorption isotherm of Dispex A40 
on Ce-ZrO, which corresponds to the area per ionised acrylic acid monomer, was found 
to be ~ 70 A2 (0.22 mg Dispex A40 per m2 powder area). This value corresponds well 
to the estimations of the cross-sectional area of the acrylic acid monomer, therefore, 
indicating that Dispex adsorbs in a flat conformation on the powder surface.
The monolayer of ionised Dispex A40 molecules covering the ceramic particles make 
the particles highly negatively charged (high zeta potential). The double layer 
electrostatic effect mutually repels the particles, and prevents the particles from 
flocculating, therefore maintaining a stable colloid and a well dispersed suspension.
3.8.3 Tests for Effectiveness
The effectiveness of the dispersion can be determined by height of sediment and 
viscosity92 as explained below:
1) Height of Sediment
If a ceramic powder with a particle-size range of 1 pm - 5 pm is well dispersed in a 
liquid, i.e. a deflocculated system, and then left to settle, after a few hours the particles 
will form a compact (cake) at the bottom of the container. This is because the liquid 
lubricates the particles as they fall by gravity, allowing them to pack effectively , as 
explained before (section 3.8.1). The more effective the lubrication is, the better the 
falling particles arrange themselves to fill in pores close to their sizes, and therefore a 
better packing results.
In contrast, if a powder is poorly dispersed, i.e. a flocculated system, loose sediment 
with higher volume will be formed. In cases where the powder is highly flocculated 
and is present in high quantity, the floe can fill the whole container and there might be 
no visible settling at all . Therefore, the height of the sediment can be used as a 
quantitative measure of dispersion effectiveness104’105.
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2) Viscosity
Another measure of dispersion effectiveness is the viscosity of the slurry, where the 
lower the viscosity, the better the dispersion achieved. It is commonly found that the 
minimum viscosity is achieved when there is approximately a monolayer of dispersant 
adsorbed on the powder surface". This is often at about 1 g of dispersant in 100 g of 
ceramic powder . As would be expected, the exact amount of dispersant required to 
achieve minimum viscosity depends on many variables, including the density of the 
powder; its specific surface area; and the size of the dispersant’s molecule. Typical 
values found to provide minimum viscosities for 0.5 pm ceramic powders are ~ 0.8% - 
1.7% dispersant106,107.
3.8.4 Experimenting Method
The effect of Dispex A40 with and without pH adjustment, on DCPA and p-TCP 
slurries was studied. The pH of the ceramic powders before pH adjustment was found 
to be ~5 - 6 (determined by pH paper). Aqueous ammonia was used to adjust the pH.
Slurries of 30% w/w ceramic powder (DCPA or P-TCP) and Dispex A40 (1, 2, 3 or 5 
pph), with or without aqueous ammonia, were prepared as follows: 3 g of ceramic 
powder were weighed into a 15 ml conical tube (Falcon Blue Max™ Jr. Polypropylene 
Conical tube, 17 x 120 mm, Becton Dickinson Labware Europe, Meylan Cedex, 
France). The Dispex A40 (30 mg, 60 mg, 90 mg or 150 mg) was weighed into a vial, 
dissolved in 7 g of purified water, and this solution was then transferred to the conical 
tube. In some tubes, aqueous ammonia (using a pipette, ~ 6 drops for DCPA and 27 
drops for p-TCP) was then added to adjust the pH to ~ 8.4. The slurries were then 
vigorously manually shaken and a rough comparison of viscosity was carried out by 
tipping the tubes upside down to observe the flow of the slurries. The height of the 
sediments and the redispersability of the systems were examined after allowing the 
slurries to settle for 2 days. The redispersability was assessed by counting the number 
of times needed by turning the tubes upside down (manually) for the powder to be 
resuspended. These results are then transformed into the easiness of redispersability in a 
scale of 1 to 5. Scale 1 corresponds to the slurry is easily redispersed while scale 5 
corresponds to the slurry is difficult to be redispersed.
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3.8.5 Results and Discussion
The results obtained for DCPA and p-TCP slurries are shown in Table 3.10 and 
Table 3.11 respectively. It was observed that the ratio of sediment height to 
suspension height (S/So) for all sediments was reduced by the addition of Dispex A40. 
This indicates that Dispex is an effective dispersant.
In the case of the DCPA slurries tested, the addition of Dispex produced a reduction in 
S/So from 0.39 to 0.23 or 0.24. This indicates that better dispersed systems were 
created with the addition of dispersant. However, increases in the amount of the Dispex 
A40 added from 0 pph - 5 pph had no obvious effect on the height of sediment. The 
addition of ammonia also had no marked effect on the height of sediment.
In the case of the p-TCP powder, the effect of Dispex A40 on the S/So is dependent on 
the amount of Dispex A40 added. The S/So decreases from 0.97 to 0.84 when the 
Dispex A40 concentration increases from 0 pph to 3 pph; and the S/So then increases to 
0.99 when the Dispex A40 concentration increases to 5 pph. Also, the addition of 
ammonia has a marked effect on the S/So. When comparing systems with equal 
amounts of Dispex A40, the addition of aqueous ammonia further reduces the S/So 
values. For example, with 2 pph Dispex A40, the S/So values decreases from 0.91 to 
0.82 with the addition of aqueous ammonia. This indicates that Dispex works better in 
the alkaline pH region. It was observed that the viscosity of the slurries was markedly 
reduced by the addition of Dispex.
The two days sedimentation results indicate that 2 pph to 3 pph Dispex A40 with pH 
adjustment produce the best dispersed p-TCP slurry. P-TCP systems with 5 pph Dispex 
A40 were found to increase the S/So, which in the first instant may indicate the forming 
of agglomerates. However, the S/So values for p-TCP systems with 5 pph Dispex A40 
were found to decrease to 0.83 and 0.63 (values are not shown in table), for system 
without and system with ammonia respectively, after allowing them to settle for two 
months. This indicates that the extra charges contributed by the high concentration of 
dispersant prevent the collision of the particles and hold the particles in the solution for 
a longer period of time, thus delaying the settlement of particles.
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Table 3.10 The results of dispersant effectiveness tests for 30% w/w DCPA after settling for 2 days
Dispex A40 (pph) - 1 2 3 5 1 2 3 5
Ammonia (aq) - - - - - Yes Yes Yes Yes
Viscosity + ++ ++ ++ ++ ++ ++ ++ ++
*S/S0 0.39 0.24 0.23 0.23 0.23 0.24 0.23 0.23 0.23
The number of times turning the 
tube upside down to redisperse
3 22 34 30 32 31 30 37 39
Redispersability (1= easy,5= hard) 1 3 4 4 4 4 4 4 4
Table 3,11 The results of dispersant effectiveness tests for 30% w/w p-TCP after settling for 2 days
DispexA40 (pph) - 1 2 3 5 1 2 3 5
Ammonia (aq) - - - - - Yes Yes Yes Yes
Viscosity + + + + + + + + + ++ + + + + + +
*S/S0 0.97 0.97 0.91 0.84 0.99 0.87 0.82 0.77 0.98
The number of times turning the 
tube upside down to redisperse
paste, 
no sediment
3 3 3 61 3 3 3 36
Redispersability (1= easy,5= hard) - 2 1 1 5 1 1 1 4
*S/Sq = Sediment height/Suspension height
3.9 General Discussion
The slurry composition and the spray-drying conditions suitable for producing porous 
microspheres of DCPA and P-TCP was investigated. It was found that under the 
appropriate conditions, free flowing calcium phosphate microspheres can be produced 
in batches of -  500 mg (60-70 % yield for 800 mg slurry). The average microspheres 
produced were - 1 0  pm - 20 pm in diameter. These are loosely bound soft agglomerate 
of calcium phosphates.
This study shows that for producing spray-dried calcium phosphate microspheres, a 
binder, a dispersant, and high solids content are needed in the slurry.
A binder is necessary for the agglomeration of ceramic powder to form microspheres. 
Without a binder, there are not adhesive forces to bind the ceramic powder together, 
and microspheres are not formed. The choice of a binder was found to be crucial as it 
may make the difference between obtaining free-flowing products or wet and sticky 
gums. Eudragit L100 was found to be a good binder in this study.
To produce good spray-dried products, the powders must be homogenously dispersed. 
To produce stable and homogeneous calcium phosphate slurries, it was found that high 
solids content and dispersant are required. A high solids content is desirable because it 
increases the viscosity of the slurry, which assists in suspending the powder in the 
liquid. However, high solids content normally results in highly viscous ceramic pastes 
not feasible for spray-drying. A dispersant can be used to reduce the slurry viscosity. 
Dispex A40 was found to be a suitable dispersant for calcium phosphate slurries. 
Particle-size of the ceramic powder also affects the dispersity of the slurry as large 
particles encourage rapid sedimentation. Ball-milling was found to effectively reduce 
the particle-size of DCPA and also help in mixing in all the excipients. p-TCP was 
found to produce good slurries and no extra step of particle-size reduction was 
necessary.
120
DCPA slurries with solids content of 30% - 60% w/w and p-TCP slurries with solids 
content of 10% - 40% w/w were successfully spray-dried. Higher solids content was 
found to produce microspheres of bigger size.
The solids content, the binder concentration and the dispersant concentration were all 
found to affect the spray-dried products. Generally, the results show that smaller 
microspheres were produced with higher concentration of dispersant.
The influence of spray-drying conditions on the spray-dried products, including the 
temperature and the jet size, were also investigated. Inlet temperature of ~ 180°C - 
220°C was found to be optimum. At these temperatures, hollow centred microspheres 
were produced. Higher inlet temperature (245°C) was found to produce solid centred 
microspheres and the frequency of nozzle blockage increased. When the inlet 
temperature is too low, there is not enough energy for complete moisture evaporation 
and free-flowing products to be obtained.
Among the jet size of 0.5 mm, 1.0 mm and 1.5 mm, the jet size of 1.0 mm was found to 
produce the best quality microspheres in this study.
The surface morphology of the microspheres was examined under the SEM. The 
internal morphology of these microspheres was also studied by examining the sectioned 
open microspheres. Results showed that highly porous microspheres were obtained.
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4 Sintering of Calcium Phosphate 
Microspheres and Their Characterisation
4.1 Introduction
To modify the porosity and the pore-size of spray-dried calcium phosphates 
microspheres, the microspheres were subjected to sintering. Sintering is a standard 
ceramic processing technique. It is a thermal treatment where the ceramic is heated to a 
high enough temperature, near to its melting point, to bond the particles together by a 
diffusion controlled mechanism.
Individual researchers have studied the sintering effect of some calcium phosphate 
compositions, mainly hydroxy apatite. Zakaria studied the microstructural properties 
changes of porous hydroxyapatite sintered between 1100 °C - 1400 °C and found that 
the sintering atmosphere (argon or air), temperature and holding time all affect the 
microstructure (grain size, density, porosity) of the final sintered product. He observed 
the presence of traces of p-TCP when hydroxyapatite was sintered at temperatures 
900 °C and higher, and at > 1300 °C the traces of P-TCP disappeared, but a further 
decomposition to a-tricalcium phosphate (a-TCP) and tetracalcium phosphate, 
Ca4P20 9, was found. Tas108 characterised calcium phosphate compositions (Ca/P ratio 
= 1.70) heated at 600 °C - 1150 °C in air. It was found that the initial formation of 
hydroxyapatite happened at 800 °C and 1000 °C, and the powders heated at 1150 °C 
consisted of single-phase hydroxyapatite.
In this study, dilatometry was used to ascertain the thermal expansion and shrinkage of 
the DCPA and p-TCP, and their suitable sintering temperatures. Sintering of spray- 
dried DCPA and p-TCP microspheres was then carried out. The non-sintered and 
sintered spray-dried DCPA and P-TCP microspheres were characterised and compared. 
The microstructural changes of the materials as the sintering temperature increases were 
also studied.
* a-TCP is a polymorph of P-TCP.
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It is important to include a representative sample in the analysis in powder 
characterisation. Random sampling and statistical analysis were applied, wherever 
possible, to improve sampling accuracy in this study.
4.2 Dilatometry
To investigate the thermal expansion and shrinkage of DCPA and p-TCP samples, and 
to identify the temperature required for sintering, a dilatometer (Netzsch Thermal 
Analysis, Bavaria, Germany) was used. This apparatus consists of a horizontal tube 
furnace, a molybdenum coil heating element, a water cooling system, and an alumina 
rod. It can accurately measure the relative change in sample length during the heating 
and cooling process, involving temperatures of up to 1550 °C. The apparatus was 
connected to a computer where the displacement information of the samples was 
recorded.
A rod of DCPA compact and a rod of P-TCP compact, ~14 mm long x 10 mm wide 
each, were prepared as follows: Firstly, the powder was fed into a 13 mm hardened 
steel die and pre-pressed uniaxially with a punch, to a pressure of 1 MPa for 30 s, 
before it was released. Secondly, the pre-pressed samples were placed inside a 
colostomy tube and vacuum-sealed, before immersing into the oil of the pressure 
chamber of a cold isostatic pressing apparatus (ISO-LAB, Stansted Fluid Power Ltd., 
England). A pressure of 150 MPa for 60 s was applied. The pressurised oil transmitted 
the pressure uniformly to the samples. The sample diameter was later reduced 
manually using P320 grit SiC paper (Extec Corp., Enfield, CT, USA) to fit into the 
alumina holder of the dilatometer (~10 mm). In the dilatometer, the samples were 
heated up at a rate of 3 °C/min up to 1200 °C and then maintained for 1 h at 1200 °C 
before cooling down.
4.2.1 Results and Discussion
The linear shrinkage and the rate of shrinkage of DCPA and 0-TCP compacts are 
shown in Figure 4.1 and Figure 4.2 respectively. From Figure 4.1, it is shown that the
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pattern of expansion and shrinkage of the DCPA and P-TCP compacts from 100 °C to 
1200 °C are markedly different. By studying the thermal behaviour of these samples, 
information on the practical range of sintering temperatures can be obtained. The 
starting point of shrinkage corresponds to the starting of the sintering process, and the 
end of shrinkage corresponds to the completion of the sintering process, where 
densification cannot progress further.
For DCPA, an initial expansion was observed when the temperature increased from 
room temperature to ~ 240 °C. This expansion was considered to be the result of 
thermal expansion. A sharp shrinkage occurred ~ 995 °C and continued up to 
~ 1070 °C. It can also be clearly distinguished in Figure 4.2 that there was a sudden 
and sharp increase in the rate of shrinkage at ~ 995 °C. The maximum overall 
shrinkage was ~ 7%. From ~ 1110 °C upwards, sample expansion was observed. This 
is probably because the sintering process has been completed and the material expanded 
due to increase in temperature. This dilatometry result indicates that densification of 
the DCPA particles take place at ~ 995 ° - 1070 °C, and sintering is most efficient at 
1038 °C.
For P-TCP, initial thermal expansion was not obvious. The gradual shrinkage started at 
~ 600 °C and the rate of shrinkage reached a second maximum at ~ 970 °C. A further 
sharper increase in the rate shrinkage was observed from ~ 1050 °C onwards. The 
overall shrinkage at 1200 °C from the starting dimension was ~ 19%, which is about 3 
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Figure 4.2 Rate o f  shrinkage for DCPA and P-TCP compact vs. temperature.
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4.3 Sintering
In this study, a Carbolite electric chamber furnace (Type CWF 13/13, Carbolite, 
Sheffield, UK) was used for sintering the samples. The spray-dried microspheres were 
placed in a non-reactive zirconia crucible and sintered in a stagnant air atmosphere in 
two stages (Figure 4.3). In the first stage, the samples were heated at a rate of 100 °C/h 
from room temperature to 350 °C with a holding time of 1 h. Holding time refers to the 
period of time the sample is maintained at the same temperature. This was designed to 
allow the additives (binders and dispersant that were introduced during spray-drying 
slurry preparation) to ‘burn-out’ completely before the shrinkage takes place. This 
stage is also useful from a pharmaceutical viewpoint, because all organic additives, 
which are added in the slurry processing, but that are not desired in the final product, 
can be effectively removed to obtain a purer product. The second stage was to sinter 
the sample. The heating rate was increased to 300°C/h until it reached the final 
sintering temperature, from 900 °C -  1300 °C, with a holding time of 1 h. The sintered 









Figure 4.3 Heating stages during sintering
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4.3.1 Weight Loss During Sintering
The sample and the zirconia crucible were weighed before and after sintering. The 
weight loss of p-TCP microspheres during sintering was calculated as follows:
% weight loss - x!00%
v W j
B = Weight of sample and crucible before sintering 
A = Weight of sample and crucible after sintering 
W = Weight of sample before sintering
The percentage weight loss of spray-dried p-TCP microspheres during sintering is 
shown in Table 4.1. The results show that there is a generally weight loss of ~ 7%. The 
weight loss includes the loss of adsorbed/absorbed moisture and the burnout of organic 
additives, binder and dispersant.
Table 4.1 Percentage weight loss of spray-dried p-TCP microspheres during sintering.
Sintering temperature % Weight loss ± SD (n = 3)
900 °C 6.86 ±0.13
1000°C 6.96 ±0.23
1100 °C 7.17 ±0.34
1150 °C 6.96 ± 0.73
1200 °C 7.43 ±0.11
4.4  Powder Characterisation
The spray-dried P-TCP and DCPA microspheres, sintered at temperatures of 
900 °C - 1300 °C, were characterised by the following methods: visual observation; 
SEM; tap density and true density measurements; surface area analysis; mercury 
intrusion porosimetry; and X-ray diffraction (XRD) analysis.
Sintered samples, especially those sintered above 1100°C were loosely bound powder 
blocks. These powder blocks were loosened up manually by means of a spatula, or by 
lightly grounding in an agate mortar with pestle, when necessary for analysis.
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4.4.1 Visual Observations
The samples before and after sintering were observed visually. The shrinkage of 
powder beds from sintering crucible, and the easiness of breaking up the sintered 
sample blocks into fine powder were noted.
4.4.1.1 Results and Discussion
No colour changes after samples were sintered at all temperatures applied were noticed. 
Both p-TCP and DCPA microspheres were white before and after sintering.
It was observed that the powder beds shrank after sintering, and the degree of shrinkage 
increased with increasing sintering temperature. The initially loose powder became 
more and more compact powder blocks as temperature increased. At 1300 °C, the 
microspheres were effectively sintered ceramic blocks in the form of consolidated 
microspheres. It was found that the higher the sintering temperature, the more difficult 
it was to section the samples for internal morphology examination, due to the increased 
hardness of the samples.
4.4.2 Scanning Electron Microscopy (SEM)
SEM was used to examine the surface morphology and the internal morphology of 
microspheres sintered at various temperatures.
For surface morphology examination, all samples were pre-sputter coated with gold for 
10 min. Sample preparation details are described in section 2.7.4. For internal 
morphology examination, samples were first embedded in epoxy resin, followed by 
careful manual sectioning of the sample with glass knives before they were sputter 
coated. Full sample preparation details are described in section 2.7.5.
Apart from topographic imaging, some samples were also analysed by backscattered 
imaging (section 2.7.1.) and X-ray analysis (section 2.7.2). Samples for backscattered 
imaging were carbon coated for 3 min in a carbon coating unit (Pirani Penning, Model
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4, Edwards High Vacuum Ltd., Sussex, UK). Backscattered imaging can differentiate 
elements of high atomic number from elements of low atomic number. Carbon coating 
was used because carbon has a low atomic number of 6. Compared to gold (atomic 
number 79), carbon is less likely to interfere with the signal given out by calcium 
(atomic number 20). Therefore, areas with and without calcium phosphate can be 
distinguished and therefore the pores within the microspheres can be identified.
4.4.2.1 Results and Discussion
Surface morphology of DCPA microspheres, which are non-sintered, sintered at 900 °C 
and sintered at 1000 °C for 1 h, are shown in Figure 4.4. It can be seen that after 
sintering neighbouring particles fused together to form bigger grains. The 
particles/grain surface become smoother, and larger open pores were found.
The surface morphology of p-TCP microspheres, which are non-sintered and those 
sintered at selected temperatures between 900 °C and 1300 °C for 1 h, are shown in 
Figure 4.5. As the sintering temperature increases, marked grain growth of the P-TCP 
particles are observed. At 900 °C and 1000 °C, particle surface smoothing and the 
formation of grain boundaries started, followed by neck formation and formation of 
interconnected open pores. At higher temperature of 1100 °C, more energy is provided, 
enhancing material diffusion to occur, leading to a considerably increase in grain size. 
The diffusion process gradually removed smaller pores, leaving the larger pores that 
cannot be sintered out. Because these microspheres are highly porous, when the 
material moved and smaller pores disappeared, the larger interconnected pores became 
wider. Rounding of pores was observed at 1150 °C, followed by continuous shrinkage 
of open pores from 1200 °C to 1300 °C. Above 1150 °C, interconnected pores 
diminished gradually and the closed pores intersected grain boundaries. The open 
pores, which connect the external and internal structures of the microspheres, 
disappeared progressively as the temperature rose from 1150 °C to 1300 °C. At 
1300 °C the material was effectively a fully sintered ceramic.
The sectioned open p-TCP microspheres sintered at 900°C are shown in Figure 4.6. 
Figure 4.6a shows the internal morphology of 12 microspheres, and Figure 4.6b is a
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higher magnification micrograph of 1 of the 12 microspheres. It can be seen that 
hollow regions exist in the microspheres. These results show that these microspheres 
are highly porous. To further confirm the hollow nature of the microspheres observed, 
two additional techniques, X-ray analysis and backscattered imaging, as described 
below, were used to identify the porous regions of the microspheres. These results 
confirm the hollow nature of the microspheres.
1) X-Ray Analysis - Dot Map
In theory, X-ray analysis can differentiate areas with high concentration of calcium 
(microspheres matrix) from areas of low calcium (hollow regions). X-ray analysis using 
calcium as an indicator was performed and the results are presented in a dot map format 
(see section 2.7.2 for details) as shown in Figure 4.7. This figure shows the background 
noise, and compares the X-ray analysis map of the microsphere sample to its 
topographical image. The result illustrates that the matrix and the pores the 
microsphere were not distinctive in the X-ray dot map. This might be due to the spatial 
resolution of secondary electrons being much higher than that of X-rays. As a result, a 
feature large enough to be seen in the secondary electron image may not be large 
enough to contain the entire interactive volume from which X-rays emanate. Often, the 
electron beam penetrates the sample, causing X-rays to emanate from subsurface 
regions or surrounding regions having compositions different from that at the point of 
surface incidence109. X-rays can penetrate ~1 - 2 pm thickness into the sample, and 
pick up calcium signals underneath the resin. Hence, areas of calcium phosphate matrix 
and areas of pores cannot be clearly distinguished. The technique was not used further.
2) Backscattered Electron Imaging
Sectioned P-TCP microspheres sintered at 900 °C were examined under backscattered 
electron imaging (Figure 4.8). Regions containing calcium phosphate were presented 
as bright areas, and regions without calcium phosphate were presented as dark areas. 




(b) 900  °C
(c) 1000 °C
Figure 4.4 SEM micrographs of surface morphology of DCPA microspheres (a) non- 
sintered, (b) sintered at 900 °C, and (c) sintered at 1000 °C.
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(a) non-sintered (b) sintered at 900 °C
(c) sintered at 1000 °C (d) sintered at 1100 °C
(e) sintered at 1150 °C (0  sintered at 1200 °C
(g) sintered at 1300 °C
Figure 4.5 SEM micrographs of surface morphology of p-TCP microspheres before 
and after sintered at 900°C - 1300°C (constant magnification).
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Figure 4.6 SEM micrographs of sectioned open P-TCP microspheres sintered at 900 °C
(a) x800 magnification; (b) x!700 magnification.
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(a) Background noise
(b) Calcium x-ray dot map
(c) Topographic image
Figure 4.7 SEM micrographs comparing (a) background noise; (b) X-ray dot map; and 





Figure 4.8 Backscattered electron SEM micrographs showing interior structure of P- 




The tap density of a powder is obtained when a predetermined amount of powder in a 
container of known dimensions is vibrated or tapped under predefined conditions. The 
tap density depends on the orientation and arrangement of the individual particles, 
which control their packing, and the presence, shape and size of pores between and 
within particles.
Tap density was measured using a tap density tester as described in section 2.4.1. 
Carr's compressibility index was calculated from the bulk and tap densities using the 
equation below110.
 ̂tap density -  bulk density  ̂  
tap density
x 100 = % compressibility Equation 4.1
4.4.3.2 Results and Discussion
The measured bulk-density, tap density and the calculated Carr’s compressibility index 
for p-TCP microspheres, before and after sintering, are presented in Table 4.2. The 
results show that there is a general trend of gradual increase in both bulk and tap 
densities as the sintering temperature increases. No sudden decrease in tap volume was 
observed during the tapping cycles. This indicates that there was no significant break 
down of microspheres due to tapping. The Carr’s index is generally used to predict the 
powder flowability. All powder tests exhibited a Carr’s compressibility index > 35. 
This indicates that these powders have very poor flow properties111, which is in 
agreement with their poor flowability observed during the experiments.
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Table 4.2 Bulk-density (n=3), tap density (n=3) and the Carr’s compressibility index 
for spray-dried p-TCP microspheres before and after sintering.
Bulk-density ± 
SD (g/cm3)





















Non-sintered 0.259 ±0.011 0.436 ± 0.006 40
Sintered at 900 °C 0.310 ±0.015 0.537 ±0.013 42
Sintered at 1000 °C 0.356 ± 0.007 0.656 ±0.012 46
Sintered at 1100 °C 0.490 ± 0.005 0.844 ± 0.004 42
Sintered at 1150 °C 0.532 ± 0.012 0.917 ±0.018 42
Sintered at 1200 °C 0.656 ±0.011 1.124 ±0.011 42
Sintered at 1300 °C 0.671 ±0.069 1.066 ±0.010 37
4.4.3.3 True Density
True density measurements of P-TCP microspheres sintered at selected temperatures 
between 900 °C -1300 °C were determined using a helium pycnometer (AccuPyc 1330, 
V2.01, Micromeritics Instruments Co., Georgia, USA) as described in section 2.4.2. 
The basic principle of gas pycnometry lies within the ideal gas law: PV = nRT. For a 
given amount of gas, the pressure changes are directly related to the volume changes 
when temperature remains constant. In AccuPyc 1330, a known amount of helium gas 
at constant temperature flows from a calibrated reference volume into the sample tube. 
The volume of the sample occupied is then calculated from the pressure changes112. It 
is assumed that there is independent evidence that the gas is not absorbed, and the solid 
does not contain closed pores.
4.4.3.3.1 Results and Discussion
The pycnometry density measurements obtained are shown in Table 4.3. Analysis of 
variance using Minitab (V12.2) indicated that there are significant density differences
(F = 1389.11, P < 0.001) between the mean values of the samples tested. Fisher’s
137
pairwise comparisons at P < 0.05, showed that the main differences lie between the 
non-sintered (group 1 & 2) and the sintered samples (group 3-8) [see Appendix I (a)]. 
Group 1, 2 and 3 are significantly different from each other and with other groups; 
among groups 4 - 8  there are in general no significant differences indicating that the 
true density of a material does not change during sintering in most cases. The observed 
true density change during sintering may be due to one or a combination of the 
following factors:
a) The physical changes, e.g., fusing of particles, result in occlusion of internal 
pores. This violates the assumptions that the solids do not contain enclosed 
pores. The measuring gas, helium, cannot reach those pores, hence, reduced 
density values were observed.
b) Phase changes resulting in a different crystal structure with a different true 
density being obtained.
c) The number of samples, n = 3, is not representative.
Table 4.3 Pycnometer true density values (n=3) for the spray-dried P-TCP 
microspheres before sintering and after sintering at various temperatures.
Group no. P-TCP samples True Density ± SD (g/cm3)
1 Powder as-received 2.7746 ± 0.0026
2 Spray-dried, before sintering 2.8489 ±0.0051
3 Sintered at 900 °C 3.0136 ±0.0061
4 Sintered at 1000 °C 3.0402 ± 0.0068
5 Sintered at 1100 °C 3.0404 ± 0.0075
6 Sintered at 1150 °C 3.0276 ±0.0030
7 Sintered at 1200 °C 3.0407 ± 0.0022
8 Sintered at 1300 °C 3.0376 ±0.0016
4.4.4 Surface Area and Pore Structure Analysis by Gas 
Adsorption
Surface area analysis provides information about void spaces on the surfaces of 
individual particles or their aggregates. It is important in the characterisation of solid
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pharmaceutical materials because factors such as chemical activity, adsorption,
dissolution, and bioavailability of the drug may heavily depend on the nature and area
1 1-7
of the surface available on the solid . Generally, a powder with a larger surface area 
will be more reactive, have enhanced solubility, sinter at lower temperatures, have more 
adsorptive capacity and exhibit greater catalytic activity114. The flowability, which may 
greatly influence the handling properties of a powder, is also related to its surface area 
and the particle-size111. The BET method, developed by Brunauer, Emmett and 
Teller115 is the most widely used method for surface area measurements based on gas 
adsorption.
The physical adsorption of gases by solids increases with decreasing temperature and 
with increasing pressure. This process is exothermic. The BET method is based on the 
monolayer adsorption of an inert gas, generally nitrogen, on the solid surface at reduced 
temperature. The way in which a material adsorbs a gas is referred to as an adsorption 
isotherm. The shape of the isotherm reflects specific conditions for adsorption, such as 
pore-size and heat of adsorption114.
In this study, the surface area of sintered P-TCP microspheres was investigated by gas 
adsorption using two types of apparatus:
1) 5-point BET N 2  adsorption surface analyser, Gemini 2360 (Micromeritics 
Instruments Co., Georgia, USA).
2) Accelerated Surface Area and Porosimetry Analyser (ASAP 2010 V2.00 
Micromeritics Instruments Co., Georgia, USA).
4.4.4.1 5-point BET N2 Adsorption Analyser
The surface area of accurately weighed microsphere samples (0.5 g - 6.3 g) was 
determined using the 5-point BET N2 adsorption analyser. Experimental methods are 
detailed in section 2.5.1. Two different batches of P-TCP powder were spray-dried and 
subsequently sintered at selected temperatures from 900 °C to 1200 °C. These samples 
were subjected to analysis and two data sets were obtained.
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4.4.4.1.1 Results and Discussion
The surface area analysis results o f two batches o f p-TCP microspheres are shown 
graphically in Figure 4.9, and the detailed values are shown in Table 4.4 and Table 4.5.
□ Batch 1
■ Batch 2
As- Spray dried 900 °C 1000 °C 1100°C 1150°C 1200 °C
received
Set
Figure 4.9 Specific surface area o f  p-TCP powder as received, spray-dried, and spray- 
dried samples which were sintered at temperatures from 900 °C to 1200 °C (n = 5).
According to Micromeritics, the Gemini 2360 apparatus is capable o f  measuring 
specific surface areas as low as 0.01 m2/g, and total surface areas from 0.1 m2 to 
300 m2. The microsphere surface area measurements are well within this working 
range. The measured values were found to be between 70 m2/g - 0.5 m2/g and the total 
surface area measured were adjusted to be within 2 m -3 5  m by using a higher sample 
mass for samples with lower surface area.
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Table 4.4 Surface area measurements of batch 1 p-TCP powder as received; spray-
dried; and spray-dried plus subsequently sintered at various temperatures as indicated.
Batch 1 (3- 
TCP Samples
Run Adsorption Parameters Specific Surface Area (m2/g)
C Intercept Correlation
Coefficient
Mean ± SD (n=5)
Powder as- 
received
1 183 0.0004 1.0000 61.7118
62.54901 1.3350
2 182 0.0004 1.0000 61.3497
3 194 0.0004 1.0000 62.6917
4 183 0.0004 1.0000 64.7561




1 78 0.0008 0.9999 69.5886
50.71801 18.0584
2 86 0.0015 1.0000 33.3311
3 83 0.0008 0.9999 63.7455
4 95 0.0015 0.9999 29.8423
5 81 0.0009 0.9999 57.0824
Sintered at 
900 °C
1 170 0.0031 0.9999 8.1274
8.262910.1047
2 174 0.0030 1.0000 8.2974
3 180 0.0029 1.0000 8.3670
4 158 0.0033 1.0000 8.3435
5 160 0.0033 0.9999 8.1792
Sintered at 
1000 °C
1 137 0.0073 1.0000 4.2877
4.287410.0328
2 135 0.0074 1.0000 4.3230
3 125 0.0081 1.0000 4.2514
4 133 0.0072 1.0000 4.2770
5 134 0.0060 0.9999 4.2978
Sintered at 
1100°C
1 116 0.0210 0.9999 1.7894
1.826410.0274
2 149 0.0160 0.9999 1.8199
3 140 0.0166 0.9999 1.8590
4 157 0.0150 0.9999 1.8471
5 86 0.0271 1.0000 1.8165
Sintered at 
1150 °C
1 171 0.0221 1.0000 1.1519
1.1808 1 0.0366
2 176 0.0213 1.0000 1.1598
3 167 0.0226 1.0000 1.1537
4 143 0.0247 0.9999 1.2333
5 138 0.0262 0.9999 1.2051
Sintered at 
1200 °C
1 188 0.0310 1.0000 0.7436
0.7429 1 0.0162
2 186 0.0305 1.0000 0.7636
3 164 0.0354 1.0000 0.7512
4 180 0.0322 0.9999 0.7354
5 157 0.0384 1.0000 0.7207
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Table 4.5 Surface area measurements of batch 2 p-TCP powder as received; spray-




Run Adsorption Parameters Specific Surface Area (m /g)
C Intercept Correlation
Coefficient
Mean ± SD (n=5)
Powder as- 
received
1 201 0.0004 0.9999 54.8920
54.7413 ±0.7335
2 203 0.0004 1.0000 55.2678
3 200 0.0004 1.0000 55.3279
4 180 0.0005 1.0000 53.5138




1 93 0.0014 0.9999 33.1846
37.8946 ± 4.0990
2 98 0.0010 0.9999 43.5702
3 87 0.0014 0.9999 36.4048
4 93 0.0011 1.0000 40.4430
5 83 0.0014 0.9999 35.8703
Sintered at 
900 °C
1 97 0.0078 0.9999 5.7328
5.9691 ±0.1452
2 113 0.0065 1.0000 5.9347
3 123 0.0059 0.9999 6.0246
4 136 0.0053 1.0000 6.0532
5 169 0.0043 0.9999 6.1000
Sintered at 
1000 °C
1 140 0.0109 0.9999 2.8550
2.9160 ±0.0518
2 144 0.0105 0.9999 2.8638
3 144 0.0102 0.9999 2.9572
4 167 0.0088 0.9999 2.9525
5 146 0.0102 0.9999 2.9514
Sintered at 
1100°C
1 84 0.0450 0.9999 1.1545
1.1697 ±0.0188
2 83 0.0454 0.9998 1.1603
3 113 0.0325 0.9998 1.1791
4 85 0.0429 0.9998 1.1984
5 110 0.0340 0.9997 1.1560
Sintered at 
1150 °C
1 122 0.0504 1.0000 0.7058
0.7310 ±0.0170
2 171 0.0341 1.0000 0.7423
3 170 0.0347 1.0000 0.7388
4 174 0.0335 1.0000 0.7466
5 179 0.0337 0.9999 0.7217
Sintered at 
1200 °C
1 87 0.0938 0.9999 0.5318
0.5381± 0.0042
2 104 0.0773 0.9999 0.5408
3 151 0.0530 1.0000 0.5427
4 114 0.0710 0.9999 0.5368
5 132 0.0614 0.9999 0.5383
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To ensure the validity of the experimental data, a few parameters were checked during 
data analysis. A correlation coefficient in the range of 0.999 to 1 is acceptable in most 
cases114. The constant C in Table 4.4 and Table 4.5 is a measure of the affinity of the 
adsorbate, in this case the nitrogen gas, to the material. For surface area 
determinations, the ideal adsorbate should exhibit C values sufficiently low to preclude 
localised adsorption of the adsorbate to specific adsorption sites, and sufficiently high 
that the adsorbate lateral mobility on the adsorbent surface will not disrupt any 
tendency for an organised structure to develop. For the majority of adsorbents the C 
value for nitrogen lies in the range 50 - 300116.
The results show that the specific surface area of P-TCP microspheres is greatly 
reduced by sintering. This can be explained by the dissolution and the incorporation of 
smaller particles into bigger grains after sintering, as observed under the SEM (section 
4.4.2.1). The high standard deviation obtained for spray-dried but non-sintered 
microspheres are due to the presence of other materials, i.e., the binder, Eudragit L100 
and the dispersant, Dispex A40.
In batch 1, the specific surface area decreased sharply from 62.5 m2/g for non-sintered 
microspheres to 8.3 m2/g for microspheres sintered at 900 °C, and further decreased to 
0.74 m2/g for microspheres sintered at 1200 °C. Batch 2 results showed a similar trend.
To investigate the effect of sintering on the samples, two-way analysis of variance 
(ANOVA) comparing powders as-received and powders sintered at 900 °C was carried 
out. The result [Appendix 1(b)] indicated that there is a significant interaction between 
batch and the effect of sintering [F(l,16) = 65.37, p < 0.001]. There are also significant 
differences between batches [F(l,16)= 218.98, p < 0.001] alone, and the effect of 
sintering [F(l,16) = 23000, p < 0.001] alone.
To investigate the effect of sintering temperature, data obtained from samples sintered 
at temperatures between 900 °C and 1200 °C were analysed. Two-way ANOVA 
revealed a significant interaction between batch and temperature [F (4,40) = 465.81, p < 
0.001]. There are also significant differences between batches alone [F(l,40) = 
3221.45, p < 0.001], and sintering temperature alone [F(4,40) = 19000, p < 0.001]
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[Appendix 1(c)]. Post hoc Bonferroni-Dunn (All Means) comparisons revealed that all 
specific surface area values of the sintered samples were significantly different from 
each other (p < 0.001) in all cases, except the comparison of
a) Batch 1 sample sintered at 1150 °C and Batch 2 sample sintered at 1100 °C;
b) Batch 1 sample sintered at 1200 °C and Batch 2 sample sintered at 1150 °C.
Thus, it is concluded that the sintering temperature (900 °C - 1200 °C) has a significant 
effect on the specific surface area of p-TCP microspheres. In other words, sintering 
temperature has a significant effect on how far particles coalesce. Therefore, precise 
temperature control is crucial in the sintering process.
Two different powder batches were found to have different specific surface area after 
sintering. Batch 1 powder as-received has a higher specific surface area than batch 2 
as-received powder. It was observed that under the same sintering conditions, batch 1 
powder consistently gave higher specific surface area value than batch 2 powder.
4.4.4.2 Accelerated Surface Area and Porosimetry (ASAP) Analyser
The ASAP analyser utilises the principle of physical adsorption to obtain information 
about the surface area and porosity of a solid material. The ASAP 2010 analyser is 
capable of measuring materials with specific surface area from less than 0.01 m2/g to 
3000 m2/g and determines pore diameter in the range of 0.35 nm - 300 nm. That is, this 
apparatus is capable of analysing nano-pores but not larger ones. Non-sintered 
microspheres, and microspheres sintered at 1000 °C and at 1100 °C from batch 1 spray- 
dried powder were characterised by ASAP analyser (method see section 2.5.2).
4.4.4.2.1 Results and Discussion
The adsorption and desorption isotherms obtained are shown in Figure 4.10. These are 
Type 2 isotherms, typical of either non-porous adsorbents or adsorbents having 
relatively large pores. For Type 2 isotherm, the isotherm rises comparatively rapidly at 
low relative pressures, rises only moderately at intermediate relative pressure, and then 
rises quite rapidly as the relative pressure approaches unity114. The initial rise in the 
curve is due to a single layer of adsorbing molecules, N 2 , interacting with the most
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energetic regions of the powder, followed by the less energetic regions. As these sites 
are occupied, the rising curve weakens. By midpoint of the curve, additional layers of 
N 2  molecules are forming as further N 2  molecules become attached to N 2  molecules 
already on site. The sudden rise at the end corresponds to bulk condensation of N 2  gas 
to a liquid. The desorption isotherms for microspheres sintered at 1000 °C and 1100 °C 
are nearly retraces of their absorption isotherms; these are typical isotherms for 
materials completely without nano-pores. The adsorption curve for non-sintered 
microspheres rises more rapidly in the intermediate zone and shows a hysteresis loop. 
This is typical behaviour of materials with mesoporous and macroporous, i.e. materials 
with pores diameter >1 .5  nm and > 100 nm, respectively. Such pores are likely to be 
of various sizes and shapes and they may also be interconnected.
The knee point in an isotherm indicates the monolayer coverage of N 2  and the surface 
area information can be extracted from the lower region of the curve. The adsorption 
isotherms were interpreted using the BET equation below113:
Where Va = volume of gas adsorbed at pressure P  
P = partial pressure of nitrogen 
Vm = volume of nitrogen adsorbed in the monolayer 
Po = saturation pressure of nitrogen gas
C = BET constant, exponentially related to the heat adsorption of the nitrogen
The surface area was determined as a product of the number of molecules in a 
completed monolayer and the effective cross-sectional area of nitrogen. The relevant 
equation is given in Equation 4.3:
P  1 C - l f  p )
Equation 4.2+
V J P o -P ) Vmc  Vmc { p j
Equation 4.3
Where St = total surface area
No = Avogadro’s number, 6.022 x 1023
Acs = cross sectional area of nitrogen (0.1620 nm2)
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(c) Microspheres sintered at 1100°C
Figure 4.10 The adsorption and desorption isotherms o f (a) non-sintered microspheres;
(b) microspheres sintered at 1000°C; and (c) microspheres sintered at 1100°C.
The surface areas obtained are shown in Table 4.6. A high or a negative C value, 
showed for samples sintered at 1000 °C and 1100 °C, is indicative o f  the presence o f  
micropores. In these cases, modification o f  the BET model may be needed for the 
analysis. However, in this study, the specific surface areas obtained using ASAP 2010 
agree with the results obtained using Gemini 2360, therefore, no further calculations 
were performed.
147
Table 4.6 Results of BET surface area obtained using ASAP 2010 analyser.




Non-sintered 1 190.1 0.0003 0.9993 68.5217± 0.9635
Non-sintered 2 267.2 0.0002 0.9981 68.3928 ± 0.6293
Sintered at 1000 °C 1 -1513.7 -0.0007 0.9997 4.4199 ±0.0220
Sintered at 1100 °C 1 7641.6 0.0003 0.9999 1.9823 ± 0.0077
4.4.5 Mercury Intrusion Porosimetry
The pore structure of a drug carrier can affect the adsorption, disintegration, dissolution 
and diffusion drug materials113. Therefore, porosity and pore-size distribution have 
been extensively studied in pharmaceutical powders, granules, tablets and excipients117. 
Mercury porosimetry is a well established technique for the characterisation of porous 
materials118,119,12°. Apart from pharmaceutical materials, it has been used to 
characterise hydrogels121 and ceramics 98,122.
Porosity is a measure of the void spaces within a material. It can be calculated using 
data obtained by several techniques, including density, gas adsorption, water 
displacement and mercury porosimetry. Among these methods, mercury porosimetry 
and gas adsorption can also provide information about the actual pore structure of a 
material, including pore radii and volume.
Lowell et al.123 developed a classification system of pore-sizes as follows:
• Pores with radii > 1000 A are termed ‘macropores’;
•  Pores with radii from 15 A - 1000 A are termed ‘traditional’ or ‘mesopores’;
•  Pores with radii < 15 A are termed ‘micropores’.
While gas adsorption it only useful in measuring pores micropores ( < 15  A), mercury
porosimetry is capable of measuring a very wide range of pore-sizes, including 
macropores and mesopores118,113.
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Mercury porosimetry is based on the understanding that mercury behaves as a non­
wetting liquid towards most substances and will not penetrate such a solid unless 
pressure is applied. For a non-wetting liquid and assuming cylindrical pores, the 
intrusion pressure at which the mercury enters a pore can be equated with the pore-size 
information required using the Washburn equation (Equation 4.4)124:
Where D = pore diameter 
P= applied pressure 
y  = surface tension
9= contact angle between mercury and sample
The volume of mercury, V, penetrating the pores is measured directly as a function of 
the applied pressure. Therefore, P-V  information provides a unique characterisation of 
pore structure. The amount of mercury intruded in the sample is related to the pore 
volume of the system.
A disadvantage of this method is that it is assumed all pores are cylindrical in shape. In 
real life, pores are rarely cylindrical and are usually of a different shape, such as 
spherical or irregular. In addition, because the pressure required for mercury to enter a 
pore depends on the entry diameter of the pore, mercury porosimetry cannot 
differentiate between pore A and pore B as shown in Figure 4.11.
Figure 4.11 Schematic of two pore types, A and B, which cannot be differentiated by 
mercury porosimetry





P-TCP microspheres sintered at 900 °C - 1200 °C, were analysed by mercury 
porosimetry. The experimental method is detailed in section 2.6. Each sample was 
analysed in triplicate. Non-sintered samples were not characterised because it was 
perceived that the loosely agglomerated spray-dried powder probably could not 
withstand the high-pressure applied in mercury porosimetry.
4.4.5.1 Results and Discussion
The data obtained from mercury porosimetry can be presented in several graphic forms. 
Figure 4.12 shows the mercury intrusion/extrusion curves as a function of pore diameter 
for p-TCP microspheres sintered at various temperatures. As the pressure increases, 
mercury is forced into the pores and an intrusion curve is produced. When the pressure 
is decreased, mercury leaves the pores, resulting in a decrease in volume, and an 
extrusion curve is produced. The extrusion curves do not retrace the intrusion curve 
due to hysteresis. The extent of the hysteresis observed in Figure 4.12 indicates that 
some mercury was permanently trapped in the samples pores. This indicates that most 
pores are either interconnected or have narrow-neck openings.
Figure 4.13 shows the pore-size distribution of the microspheres sintered at various 
temperatures. The areas under the curves indicate pore volume. Data accumulated at 
very low pressures corresponding to pore diameter > 2.5 pm are not considered because 
these data account for the volume entering the interparticle spaces between the 
microspheres. SEM examination showed that pores within microspheres are unlikely to 
exceed 2.5 pm in diameter. The porosimetry results show that as the sintering 
temperature increases, the total pore volume of sample decreases. Microspheres 
sintered at 900 °C were found to have the biggest pore volume, and they contained a 
great number of small pores of 0.1 pm - 1 pm in diameter. These small pores 
diminished quickly as the sintering temperature increased.
The percentage porosity for the sample is extracted from the data using the Equation 4.5 
and Equation 4.6.
_ ^ sample mass _  , _
Envelope Density =     Equation 4.5
^Penetrom eter ^M ercury  ^Interparticle
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Vpenetrometer= penetrometer volume 
VMercury = cumulative mercury volume 
Vinterparticle= interparticle volume
% Porosity = 1 -
envelop density 
true density
x 100% Equation 4.6
The interparticle volume is the sum o f all the incremental mercury volume which 
corresponds to pores with diameter > 2 . 5  pm. True densities used are the density 
measured by the pycnometer (refer to section 4.4.3.3).
The calculated results (Table 4.7) show that there is a decrease in % porosity as the 
sintering temperature increases, for the same sintering duration o f  1 h.














Figure 4.12 Mercury intrusion/extrusion curves as a function o f  pore diameter for p- 
TCP microspheres sintered at selected temperatures from 900 °C to 1200 °C.
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Figure 4.13 Pore diameter vs. incremental intrusion volume for p-TCP microspheres 
sintered at selected temperatures.
Table 4.7 % porosity o f  P-TCP microspheres sintered at various temperatures.
Sintering temperature % Porosity ± SD (n =3)
900 °C 7 5 .0± 0 .5
1000 °C 62.3 ± 7.2
1100 °C 4 7 .4 1 1 .8
1150 °C 3 7 .9 1 9 .4
1200 °C 3 5 .9 1 1 2 .2
4.4.6 X-ray Diffraction (XRD) Analysis
X-ray diffraction is a very useful technique in the study o f  ceramic materials and it can 
be used to:
(a) Characterise the crystalline phases present;
(b) Identify the presence o f  specific compounds;
(c) Provide information regarding the degree of crystallization and the orientation 
texture.
In this study, an X-ray diffractometer was used to characterise the phases present in the 
samples of DCPA as-received, p-TCP as-received, and their spray-dried microspheres 
sintered at various temperatures. In order to maintain the sample height constant, 
samples were pressed onto an aluminium sample holder for the analysis. Experimental 
methods are described in section 2.10.
4.4.6.1 Results and Discussion
The XRD spectra of the p-TCP powder as-received and those sintered at various 
temperatures from 900 °C - 1300 °C are shown in Figure 4.14. The sharpening of the 
characteristic peaks indicates that the crystallinity of the powder increases after 
sintering. The results also revealed the presence of hydroxyapatite, one of the most 
stable forms of calcium phosphate, in samples sintered at 1100 °C and 1300 °C. A 
detailed comparison of the XRD spectra for sintered P-TCP to hydroxyapatite standard 
and P-TCP standard is shown in Figure 4.15. The XRD spectra of P-TCP before and 
after sintering are shown in Figure 4.15.
The XRD spectra of DCPA before and after sintering are compared in Figure 4.17. 
DCPA is not stable at high temperatures35. The shift in peaks’ positions suggests that 
DCPA transformed into other forms of calcium phosphate. In this study it was not 
possible to relate the peaks obtained with the International Centre for Diffraction Data, 
the database available. However, it is expected that the samples may contain calcium 
pyrophosphate, Ca2 P2 C>7 , tetracalcium phosphate, Ca^PO^O, and p-TCP, as these are 
the more stable forms of calcium phosphate at high temperatures ’ .
Analysis of all sintered samples of DCPA and p-TCP in this study suggests the absence 
of a-TCP. a-TCP might have been present if a much longer sintering holding time or a 
higher temperature were used as reported by Zakaria , who found that a-TCP was 
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Figure 4.14 The X-ray diffraction pattern o f  p-TCP powder before and after sintering 
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Figure 4.15 XRD spectra o f p-TCP before and after sintering, and hydroxyapatite.
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Figure 4.16 XRD spectra o f P-TCP before and after sintering.
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Figure 4.17 XRD spectra o f  DCPA before and after sintering.
4.5 General Discussion
Using controlled sintering conditions, calcium phosphate microspheres with controlled 
pore-size, controlled porosity, and controlled surface area were produced in this study.
It was found that DCPA and p-TCP showed different sintering patterns. DCPA is not 
stable at temperatures above 900 °C. The XRD results suggested transformation o f  
DCPA into other forms o f  calcium phosphates after sintering. DCPA was observed to 
undergo sintering between 995 °C and 1070 °C.
P-TCP is a more stable form o f calcium phosphate at high temperatures. Its sintering 
process was observed to start at ~ 600 °C, and from here, the rate o f sintering gradually 
increased as temperature increased. Traces o f hydroxyapatite were found in samples 
sintered at > 1100°C for 1 h.
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A weight loss of ~ 7% was observed during sintering of P-TCP microspheres. This 
weight loss is due to the loss of moisture and the burnout of organic additives, including 
binder and dispersant.
SEM examination of microspheres sintered at various temperatures showed the 
progressive stages of sintering. The process started by material diffusion that leads to 
particle surface smoothing and formation of grain boundaries, followed by neck 
formation and interconnected open pores formation. As the sintering temperature 
increases, marked grain growth was observed. The diffusion process gradually 
removed small pores, leaving larger pores that cannot be sintered out. As the sintering 
progresses, rounding of pores and continuous shrinkage of open pores was observed. 
At 1300 °C, p-TCP was effectively a fully sintered ceramic.
Under the SEM, sintered microspheres of both DCPA and p-TCP were found to be 
highly porous. Many of them also have a large hollow region near the centre of the 
microspheres. The porosity was found to decrease as the sintering temperature 
increases. The mercury porosimetry results suggest that the range of porosity for these 
microspheres is from 75% (microspheres sintered at 900 °C) to 36% (microspheres 
sintered at 1200 °C).
Combining the results of ASAP and mercury porosimetry suggested that these 
microspheres have pores of 0.1 pm - 5 pm in diameter and these pores diminished 
gradually during sintering. The materials hardly have any small pores in the nanometer 
range.
Sintered bioceramics of p-TCP were found to be physically strong and have a high 
density of ~ 3 g/cm3. This dense and robust nature of the microspheres makes them a 
suitable candidate to be used as drug carrier in needle-free injection.
The surface area of the microsphere ceramic materials is possible by controlling the 
sintering time and the sintering temperature. Sintering temperature is the more 
important factor as it also affects the morphology of the voids/pores. The small pores 
sinter up and disappear. In the ceramics industry, the size of the larger voids and their
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volume fraction can be controlled by pressing the green powder. In the case of spray- 
drying slurries, the porosity is expected to be influenced by the solids content.
The surface area of the microspheres was found to decrease significantly after sintering, 
and the surface area decreased further as the sintering temperature increased. Non- 
sintered sample was found to have a surface area of ~ 60 m2/g, while the fully sintered 
sample (sintered at 1200 °C) had a surface area of only ~ 0.7 m2/g. This study 
demonstrates that the surface area of the microsphere systems can be effectively 
controlled by controlling the sintering temperature.
Surface area characteristics of the microspheres are important for developing the 
microspheres into drug carrier systems because these characteristics may
1) determine the amount of drug which can be adsorbed onto the carrier;
2) influence the drug release profile of the drug;
3) provide information about the porosity of the microspheres, which in turn 
indicates the volume of the drug which can be carried.
Spray-dried p-TCP microspheres have a mean diameter of ~19 pm (according to 
Mastersizer 2000) and a density of ~ 3.0 g/ml. If the microspheres were spherical and 
nonporous, the expected specific surface area would be 0.10 m2/g. However, the 
specific surface area obtained for microspheres sintered at 900 °C was found to be ~ 80 
times higher than this value. This result confirms the porous structure of the 
microspheres and also suggests that these pores are mainly interconnected.
In conclusion, sintering was found to be an effective way of modifying and controlling 
the porosity, pore-size and surface area of the spray-dried calcium phosphate 
microspheres. The ability to control these parameters may allow the development of 
carrier systems which release drugs at various rates, i.e. flexible ‘designer’ drug carrier 
systems.
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5 Drug Loading and In Vitro Release 
Studies
5.1 Introduction
Drugs have been incorporated into microparticles via several methods. The main 
methods used involve direct mixing of drugs in the carrier materials before the 
formation of the microspheres. These include:
• Spray-drying - Drugs were added into spray-drying slurries, and therefore 
incorporated into the carrier materials (usually organic polymers) during the 
microparticle formation process of spray-drying15,125.
• Emulsion solvent extraction/evaporation - Drugs were added into polymer 
emulsions, and drug-containing microspheres were obtained as a result of 
solvent evaporation/extraction process12.
•  Coacervation - Oppositely charged polyions in aqueous media may 
spontaneously coacervate to form two liquid phases; a dense coacervate phase, 
which is relatively concentrated in the polyions, and a dilute equilibrium
1 9Aphase . Coacervation has been used to encapsulate drugs by placing the drugs 
in a polymer solution and then changing the pH or the temperature, resulting in 
a layer of polymer coating formed around the drug particles10,127. A hardening 
step usually follows the formation of coacervates to obtain hard 
microparticles10,126.
This chapter describes the investigation of the use of spray-dried P-TCP microspheres, 
in both non-sintered and sintered forms, as drug carriers. The schematic diagram of the 
drug loading methods used are shown in Figure 5.1:
a) Non-sintered microspheres -  A model drug was added directly into the p-TCP 
slurry, the mixture was then spray-dried.
b) Sintered microspheres -  A vacuum method was employed to incorporate model 
drugs into sintered microspheres.
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Model drugs were not incorporated into microspheres before the microspheres were 
sintered because the sintering process involved high temperatures (~1000 °C), which 
thermally destroys the drugs.
A B
Non-sintered system Sintered system
Calcium phosphate Calcium phosphate
+ binder + binder
+ dispersant + dispersant
+ model drug






Drug loading by 
vacuum method






Figure 5.1 Drug-loading methods for (A) non-sintered, and (B) sintered systems.
Three model drugs - benzamide, propranolol hydrochloride (propranolol.HCl) and 
paracetamol - were used in this study. The drugs were chosen mainly for their 
solubility properties, and availability.
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5.2 Background
5.2.1 Drug Loading by Spray-drying
Many researchers have studied the spray-drying of drugs with drug carrier materials, 
usually an organic polymer, as a way to obtain drug-containing microcarriers. In 1995, 
Giunchedi et a l}5 published a review on spray-drying as a preparation method of 
microparticulate drug delivery systems. Other recent examples include Billon et
Q i T . I ^ O
al. ' that studied the spray-drying of paracetamol with microcrystalline cellulose and 
sodium carboxymethylcellulose; Baras et al.129 studied the spray-drying of bovine 
serum albumin with polylactide; He et al.no studied the spray-drying of ^-antagonists 
with chitosan. Depending on the type of polymers used, controlled release (e.g. Billion 
et a l}2* and Baras et a l}29) and instant release (He et al.130) of drugs were reported.
The structure of the microparticles obtained in spray-drying depends on whether the 
drug is dispersed or dissolved in the feedstock prior to spray-drying. When drugs are 
dispersed in a polymer solution, the microcapsules obtained consist of drug crystals 
surrounded by a polymer coating; when the drug is dissolved in the spray-drying 
solution, the product obtained is composed of a matrix with drug distributed 
throughout131,132.
The crystallinity of the drug in the products obtained depends on whether the drug is 
dissolved or dispersed before spray-drying. During spray-drying, dispersed drugs 
maintain their crystalline state, while dissolved drugs may become amorphous133,134. 
This is relevant because the amorphous form of a drug usually dissolves more rapidly 
than crystalline forms135. Therefore the drug dissolution profiles of the spray-dried 
products obtained may be affected by whether the drug is dissolved or dispersed before 
spray-drying.
5.2.2 Drug Loading by Vacuum Method
When a porous matrix is placed in a solution, the solution might not penetrate into the 
pores because these might be occupied by trapped air. If a vacuum is applied, the 
imposed pressure on the liquid is reduced, and the trapped air will surface and be 
removed. Liquid penetration into the pores can be achieved.
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1Itokazu et al. investigated the loading of isepamicin sulfate, an antibiotic, into porous 
hydroxyapatite blocks by a vacuum method. These were 2 cm3 cubic blocks with pore- 
size 2 pm - 2000 pm. The blocks were immersed in the isepamicin solution and 
decompressed under varying vacuum pressures. The amount of isepamicin that 
penetrated the block was shown to depend on the vacuum pressure, and the time the 
vacuum was applied.
The vacuum loading method described by Itokazu et al. was adapted in this study to 
load benzamide into sintered (3-TCP microspheres. To achieve higher drug loading, 
successive loading, and loading at elevated temperature were also studied.
To further increase the drug loading, the cultivation of drug crystals inside the pores of 
the microspheres was also investigated.
After loading the model drugs into the microspheres, the in vitro release characteristics 
of the drug were investigated by dissolution studies. The composition of drugs before 
and after loading onto microspheres were characterised by nuclear magnetic resonance 
(NMR) spectroscopy, mass spectroscopy (MS), and X-ray diffraction (XRD) studies.
5.3 Loading by Spray-drying
5.3.1 Model Drug -  Benzamide
The first model drug used was benzamide. Its physicochemical properties are listed in 
Appendix n. Benzamide was chosen for this study because:
(a) It is sparingly soluble, therefore it provides a typical model of a low dose water- 
soluble system;
(b) It can be monitored by spectrophotometry, Xmax = 225 nm in phosphate buffer;
(c) It is a simple molecule, and it does not degrade easily;
(d) It is readily available.
162
5.3.2 Benzamide Loading by Direct Spray-drying
Benzamide was added to the p-TCP spray-drying slurry as a solute or as a suspension.
1 ̂ 7The solubility of benzamide is 1 g in 74 ml of water . A 100 ml of 30% w/w solids 
content slurry contains ~ 70 g of water. Therefore the maximum amount of benzamide 
that can be dissolved in the slurry is 0.95 g or 3.2 pph (parts per hundred of solids). If 
more then that amount of benzamide is added, not all drug will be dissolved and a drug 
suspension will be formed. Benzamide is more soluble in alcohol (1 g in 6 ml137). 
Therefore, to produce slurries with higher benzamide concentrations, 40% ethanol in 
water was used as solvent instead of water alone.
To prepare benzamide as a solution to incorporate in the slurry, benzamide powder was 
first dissolved in the solvent by sonication. This solution was then added to the p-TCP 
slurry. To prepare benzamide as a dispersion in the slurry, benzamide powder was first 
dry ball-milled for 10 h to reduce its particle-size (the particle-size was not measured) 
and then added directly into the p-TCP slurry. The P-TCP slurry contained Eudragit 
L100, Dispex A40 and aqueous ammonia, and was prepared as before (see section 
3.7.4). Slurries as listed in Table 5.1 were spray-dried under conditions SDC Set 3 (see 
section 3.7.4).
Table 5.1 Spray-drying slurries containing benzamide.
Formulation
Ingredients B zl Bz2 Bz3
* P-TCP slurry 
solids content
30% 30% 30%
Benzamide (pph) 2.5 15 15
Solvent water water 40% ethanol
Benzamide status dissolved dispersed dissolved
*P-TCP slurry was prepared as in section 3.7.4.
Slurry B zl contained 2.5 pph of dissolved benzamide in water. Slurry Bz2 contained 15 
pph of dispersed benzamide in water. Slurry Bz3 contained 15 pph of dissolved 
benzamide in ethanol. The spray-dried products were examined under the SEM. The 
benzamide release profiles from these microspheres were studied by dissolution tests
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using phosphate buffer, pH = 6.8 as dissolution medium. The dissolution conditions 
and experimental details are described in section 5.4 further on.
5.3.2.1 Results and Discussion
Under the SEM, the benzamide-loaded microspheres were found to be similar to the 
benzamide-free microspheres. No drug crystals were observed on the surface of the 
microspheres.
Dissolution results showed that for microspheres produced from all three slurries, Bzl ,  
Bz2 and Bz3, benzamide was released rapidly. More than 90% of the benzamide- 
loaded was released in the first 30 min. The dispersed benzamide system (Bz3) showed 
a slightly slower release than the dissolved system (Bz2). However, since benzamide 
was released rapidly in both systems, a clear difference could not be established.
According to the mechanism of droplet drying in during spray-drying, it is reasonable 
to expect that dissolved benzamide might deposit mainly on the outside of the 
microspheres. As a dissolved solute in a spray-drying slurry, benzamide diffuses 
together with the solvent to the surface to evaporate. After the solvent evaporates, 
benzamide might then crystallise, and form a layer on the outside of the dry particle. 
This might explain the instant release of benzamide from the drug-loaded microspheres 
of B zl and Bz3 observed during dissolution tests.
The dispersed benzamide particles in the spray-drying slurry are expected to disperse 
within the calcium phosphate matrix in the spray-dried product, if the particle-size of 
the benzamide particles are similar to, or smaller than the particle-size of the calcium 
phosphate. However, if the particle-size of the benzamide particles is much larger than 
the calcium phosphate particles, the benzamide cannot be incorporated into the 
microspheres, and fast dissolution profile are expected. Big benzamide particles may 
be the main contributing factor for the instant release of benzamide from the spray- 
dried products of Bz2.
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5.3.3 NaCMC and Eudragit
To delay the release of benzamide from p-TCP microspheres, the addition of sodium 
carboxymethylcellulose (NaCMC), and the use of higher concentrations of the binder 
Eudragit L100, were investigated.
NaCMC is a commonly used pharmaceutical coating polymer, and it has been used as a
O Z  1 -3Q  1 O Q
spray-drying excipient by several researchers ’ ’ .
Eudragits have been used for developing controlled release dosage forms. For example, 
Eudragit L100 has been shown to sustain the release of erythromycin140. Many other 
examples can be found in the review Acrylic polymers by Dittgen et al.21.
Slurries with compositions listed in Table 5.2 were prepared and spray-dried. Slurry 
Bz4 and Bz5 contained 10% and 20% w/v of NaCMC respectively. Slurry Bz6 
contained in total 10 pph Eudragit LI00 (8 pph now added + 2 pph already present in 
the initial slurry). It was found that the order of mixing was crucial for good and 
uniform slurry production. NaCMC had to be pre-hydrated by soaking in water for 4 to 
5 h before it was mixed with other ingredients.
The benzamide release from the spray-dried products of these slurries was investigated 
by dissolution tests (see section 5.4).
5.3.3.1 Results and Discussion
Dissolution results (Figure 5.2) for microspheres produced from all 3 slurries (Bz4 -  
Bz6) showed that the release of benzamide started immediately, and more than 80% of 
the benzamide was released in the first 30 min. These results indicate that neither the 
extra Eudragit L100 nor NaCMC at the concentrations used have a marked effect on the 
benzamide release profiles.
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Table 5.2 Spray-drying slurries containing benzamide.
Formulation
Ingredients Bz4 Bz5 Bz6
* p-TCP slurry solids 
content/% w/w
30 30 30
Eudragit L 100/pph - - 8
Benzamide/pph 10 10 10
NaCMC/pph 10 20 -
Solvent 40 % ethanol 40 % ethanol 40 % ethanol
in water in water in water
* p-TCP slurry was prepared as in section 3.7.4.
100
80
60 +  20% NaCMC (Bz5)
+ 10% NaCMC (Bz4) 
Spray dried benzamide 
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Time/min
Figure 5.2 Dissolution results for spray-dried products o f  slurry Bz4, Bz5 and Bz6, 
compared to spray-dried benzamide (see section 5.4.5 for spray-dried benzamide). 
Standard deviations are not shown for clarity.
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5.3.4 Sieving
Spray-dried microspheres had a size distribution ~ 3 jam - 50 jam (section 3.7.5.1). It is 
reasonable to expect that the drug release patterns from microspheres of different sizes 
are different. Attempts were made to separate the bigger and the smaller benzamide- 
loaded spray-dried microspheres by sieving. Spray-dried microspheres of slurry Bz2 
and Bz5 were sieved using a 32 jam metal sieve. Particles retained by the sieve were 
subjected to dissolution studies as described section 5.4.
5.3.4.1 Results and Discussion
The dissolution results of the sieved and of the non-sieved products showed that almost 
all benzamide was released quickly in the first 30 min. The release was too fast for any 
differences between the benzamide release of the sieved and non-sieved products to be 
identified.
5.3.5 Dissolution in Acidic Media
To mimic the acidic condition in the stomach, dissolution tests using 0.1 M HC1 as 
medium were also performed. The spray-dried products of slurry Bz2 and Bz6 were 
subjected to dissolution tests in acidic medium. All other dissolution conditions 
remained the same as described in section 5.4.
5.3.5.1 Results and Discussion
Dissolution results showed that spray-dried microspheres of slurry Bz2, including the 
p-TCP matrix itself, dissolved almost completely in about 15 min after dissolution. 
These observations confirm that P-TCP dissolved well in strong acidic conditions.
Eudragit L100 is not soluble in pH < 633. Therefore, it is expected that microspheres 
containing high concentration of Eudragit L100 will resist acid dissolution. This is 
confirmed by the experimental results, which showed that capsules containing products 
from slurry Bz6 did not get wetted fully. Part of the collapsed capsules stayed 
unchanged in the dissolution medium for the whole period of the test (2 h). This 
observation was consistent for all 6 capsules tested. This indicates that an acid-resistant
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polymer coating could be used to protect the microspheres from acid dissolution in the 
stomach.
5.4 Dissolution Conditions for Drug-loaded Microspheres
Dissolution studies were performed according to the British Pharmacopoeia 1998, 
Dissolution Test Apparatus II (paddle method). Experimental details are described in 
section 2.11.
5.4.1 Sampling
Sampling was carried out manually every 15 min using a 5 ml syringe withdrawing 
5 ml samples from a point halfway between the surface of the dissolution medium and 
the top of the rotating blade. To the volume maintain constant, an equal volume (5 ml) 
of dissolution medium (at 37 °C ± 0.5 °C) was replaced in each dissolution vessel 
following each sample withdrawal. The samples were then filtered with a 1 pm FITE 
membrane filter (Acrodisc® CR 25 mm syringe filter, Pall Gelman Laboratory, 
Portsmouth, UK), and analysed by UV spectrophotometry (Unicam 8625, 
ThermoSpectronic, Cambridge, UK). The filters were pre-tested to check if they absorb 
benzamide, by filtering solutions of known benzamide concentrations and measuring 
the benzamide absorbance before and after filtering. The results showed that the filters 
do not absorb benzamide. The quantity of drug released at each time point was 
calculated, allowing for the amount removed by sampling and the progressive dilution 
of the dissolution medium (see Appendix IE for model calculation).
5.4.2 Dissolution Media Preparation
The main dissolution medium used was BP phosphate buffer, pH 6.8. It was freshly 
prepared using KH2PO4 powder, NaOH pellets and deionised water (6.81 g KH2PO4 + 
0.95 g NaOH per litre of water). 0.1 M HC1 was occasionally used as dissolution 
medium, and it was also freshly prepared by diluting concentrated HC1. All media were 
degassed by bubbling with helium gas for 1 h before use.
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5.4.3 UV Spectrometry Assay and Calibrating Method
The concentration of benzamide was monitored at its Xmax using a Unicam 
spectrophotometer (Unicam Helios a, Cambridge, UK). Its were first determined 
by scanning its UV absorption in dissolution media, both phosphate buffer and acid, in 
the range of 200 nm - 320 nm. The X ^  of benzamide was found to be 225 nm in the 
phosphate buffer and 227 nm in the acid.
A stock solution of benzamide (0.02%) was prepared by dissolving 50 mg of 
benzamide in ~ 200 ml of phosphate buffer, followed by sonication (Fb200b, Decon 
Labs Ltd., Hove, UK) for 20 min until all particles dissolved, and then adding more 
phosphate buffer to made up to 250 ml volume . Aliquots of the stock solution were 
diluted to produce a series of solutions having target concentrations of 0.0004%, 
0.0008%, 0.0012%, and 0.0016% w/v of benzamide. The absorbance of these solutions 
at 225 nm was determined with the Helios spectrophotometer against a pure phosphate 
buffer blank. The procedure was performed in triplicate, using a new stock solution 
each time.
The calibration data for UV absorbance of benzamide in 0.1 M HC1 at 227 nm was 
obtained using the same method as described above.
5.4.4 Calibration Data (Benzamide)
The calibration data of benzamide in phosphate buffer, pH = 6.8, and in 0.1 M HC1 are 
shown in Table 5.3 and Table 5.4, respectively. Calibration plots are given in 
Appendix IV. The calibration plots for benzamide in phosphate buffer and in acid were 
both found to be linear in the concentration range 0.0000% - 0.0016% w/v. Calibration 
plots covered a concentration range 0% - 120% of the maximum concentration 
achievable after full dissolution. The extra 20% coverage was to ensure that the 
measured results were still valid even when the measured concentration was higher than 
the expected value. As shown in Table 5.3 and Table 5.4, the calibration data obtained 
are in good agreement.
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Table 5.3 Calibration data of benzamide in BP phosphate buffer, pH=6.8
Calibration Data
Run 1 2 3 Mean
Intercept 0.0022 0.0021 0.0002 0.0015
Slope 752.00 749.25 763.50 754.92
Regression (r2) 0.9999 1.0000 1.0000
SD of the regression 0.0043 0.0029 0.0012
Table 5.4 Calibration data of benzamide in 0.1M HC1
Calibration Data
Run 1 2 3 Mean
Intercept 0.0014 0.0016 0.0014 0.0015
Slope 750.50 749.50 751.00 750.33
Regression (r2) 1.0000 1.0000 1.0000
SD of the regression 0.0027 0.0020 0.0019
5.4.5 Controls and Comparisons
As discussed earlier (see section 5.2.1), spray-drying may affect the crystallinity of 
drugs, which in turn may affect the dissolution rate of drugs. The benzamide as- 
received and the spray-dried benzamide may have different dissolution rates. This was 
investigated by comparing the dissolution profile of benzamide release from drug- 
loaded spray-dried microspheres and benzamide release from spray-dried benzamide. 
This spray-dried benzamide was prepared by spray-drying 4.5% w/w of benzamide 
solution in ethanol. In all dissolution tests, a control was also run simultaneously. A 
control was a capsule that contained drug free microspheres with the same weight 
content as test capsules.
5.4.6 Determination of Drug Stability
For the dissolution tests to be valid, it is essential that the drugs remain stable. The UV 
absorbance of freshly prepared benzamide solutions in phosphate buffer (pH = 6.8) and
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0.1 M HC1, and the same solutions kept at 37.0 ± 0.5 °C for 24 h were measured at 
225 nm and 227 nm. The results showed that benzamide was stable over the 
dissolution period.
5.4.7 Assessment of Excipients Interference
Soluble and insoluble excipients can potentially interfere with the UV absorbance of 
drugs. p-TCP (non-sintered and sintered), Eudragit LI00 and Dispex A40 in phosphate 
buffer were individually scanned in the range of X = 200 nm to 320 nm using the 
Unicam spectrophotometer. The results showed that these excipients, in the 
concentrations used, do not interfere with the UV absorbance of the three model drugs.
5.4.8 Dosage Form
Drug-loaded P-TCP microspheres are essentially powders. To perform paddle 
dissolution tests on a powder, the powder has to be placed in a ‘container’ so that it can 
be put at the bottom of a dissolution vessel. Initially, benzamide-loaded microspheres 
were placed in size 0 hard gelatin capsules. It was found that the capsules have some 
absorbance at 225 nm, hence, interfering with the UV absorbance of benzamide.
The use of capsules made from other materials, starch and Hydroxypropyl 
Methylcellulose (HPMC), was then investigated. The starch capsules were found to 
dissolve readily in the phosphate buffer, and to interfere with benzamide absorbance at 
225 nm. HPMC capsules were found not to interfere with absorbance at 225 nm, but it 
was found that HPMC capsules containing P-TCP microspheres did not dissolve 
adequately in either phosphate buffer at pH 6.8 or pH 5.8. In the dissolution tests, the 
HPMC formed a stable gel coating the microspheres. This gel was still present after 
24 h for all 12 capsules tested. The agglomerate of gel plus microspheres was collected 
in a petri dish and examined by visual inspection. With the aid of a spatula, it was 
verified that the contents of the capsules were dry to the touch, indicating that there had 
been no contact between the microspheres and the buffer. It was then concluded that 
HPMC capsules were not suitable for the dissolution tests of the p-TCP matrix in a 
phosphate buffer.
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Other forms of materials, e.g. heatsealable filter (Grade 117/3, Papeteries De Cascadec, 
Scaer, France) and precision woven nylon mesh (50 pm mesh , Lockertex, Warrington, 
UK) were considered to replace capsules but none of these were found to be capable of 
confining the fine P-TCP microspheres powder. Therefore, gelatin capsules were 
continued to be used in dissolution studies. A control consisting of drug free P-TCP 
microspheres in a gelatin capsule was performed in all dissolution experiments, and the 
experimental results obtained were then corrected accordingly by deducting the UV 
absorbance contributed by the gelatin capsules.
5.4.9 Microsphere Stability in Dissolution Medium
To investigate the stability of the microspheres in phosphate buffer dissolution medium, 
drug-loaded microspheres were subjected to dissolution conditions by soaking them in 
phosphate buffer at 37°C for 24 h. They were then filtered and dried in the oven at 
50 °C overnight. The microspheres were sputter coated and examined under the SEM. 
The SEM results showed that the microspheres retained their structure after subjection 
to 24 h of dissolution test conditions. This shows that the microsphere carriers 
themselves are stable in phosphate buffer for that length of time.
5.5 Loading by Vacuum Method -  Preliminary Studies
5.5.1 Loading of Benzamide
To incorporate the model drug, benzamide, into sintered microspheres, a vacuum 
loading method was investigated. p-TCP microspheres sintered at 1100 °C were used 
for the initial studies.
20 ml of 3.75% w/v benzamide in ethanol solution was prepared in a 100 ml beaker, 
and 5 g of sintered microspheres were added. The mixture was then placed in a vacuum 
oven (Gallenkamp, Loughborough, UK) at 87.5 kPa, at 50 °C overnight to allow for 
solvent evaporation. The experiment was repeated with 0.75 %w/v of benzamide in 
water solution. The aqueous benzamide solution has a lower benzamide concentration 
because benzamide is less soluble in water than in alcohol.
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The drug content of the microspheres was determined by spectrophotometry (method 
see section 2.12). Briefly, drug-loaded samples were placed in 0.1 M HC1 and the 
mixture was sonicated until all microspheres dissolved. The UV absorbance of drug in 
the final acid solution was determined spectrophotometrically and the results were 
compared to a calibration plot. The calibration plots for benzamide are shown in 
Appendix IV. It was possible to calculate the drug loading efficiency because both 
non-sintered and sintered P-TCP materials were found to dissolve readily in 0.1 M HC1, 
and their dissolution did not interfere with the chosen identification peak of benzamide 
in the UV spectrum.
The release of benzamide from these microspheres was studied by dissolution tests as 
before (method see section 5.4).
5.5.1.1 Results and Discussion
After the complete evaporation of the solvent, the dried samples were found to have a 
layer of benzamide crystals on the top surface. The crystal layer was removed by 
means of a spatula and discarded.
The results of drug loading measurements are shown in Table 5.5. Loading solution 
with a higher drug concentration (3.75% w/v) was found to give a higher percentage 
drug loading.
Table 5.5 Drug loading (%) of sintered microspheres by a vacuum loading method.
Loading solution Drug Loading/%, n = 3
3.75 %w/v benzamide in ethanol 4.86 ±0.62
0.75 %w/v benzamide in water 3.00 ± 0.63
Dissolution results (Figure 5.3) show an instant release of benzamide, and ~ 80% of 
benzamide was released in the first 15 min. The drug release profiles obtained for both 
loading solutions were found to be similar, indicating that the drug loading solution 
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Figure 5.3 Dissolution results o f  vacuum loaded p-TCP sintered at 1100 °C.
The release o f  benzamide from the microspheres was instant. The possible reasons for 
this were considered as follows:
(1) A layer o f  benzamide was deposited on the microspheres’ surfaces, hindering the 
loading o f benzamide into the microspheres;
(2) The pores in the micro sphere matrices were too big for delayed release to be 
achieved, as liquid can freely flow in and out o f the pores;
(3) There was a physical incompatibility between p-TCP and benzamide, that 
interfered with the attachment o f  benzamide onto the microspheres matrix.
To improve the vacuum loading method, and to investigate the instant release o f  drug 
from the microspheres, the next stage o f  the experiments was designed as follows.
(1) To understand if  the instant release o f  benzamide was due to the drug being only 
loaded on the outer surface o f  the microspheres, a stronger vacuum pressure 
should be applied. This would be to ensure the removal o f  trapped air inside the 
microspheres, and the penetration o f  drug loading solution to the centre o f the 
microspheres. A washing experiment would also be carried out after the drug 
loading stage to aid removal o f  benzamide residues on the outer surface o f  the 
microspheres.
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(2) Sonication would be used as an alternative for removing trapped air inside the 
microspheres.
(3) To determine the release profile of benzamide from microspheres from a narrow 
size range, the process of separating by sieving bigger microspheres from fines 
would be studied.
(4) To investigate the effect of pore-size and surface area on drug release, 
microspheres sintered at various temperatures would be used.
(5) To study the physical state of benzamide inside the microspheres, and to eliminate 
the possibility of incompatibilities between benzamide and p-TCP, thermal 
analysis would be performed.
(6) To investigate if the drug release pattern was drug specific, the release of other 
model drugs from the microspheres would be studied.
5.5.2 Use of a Stronger Vacuum
It was perceived that it might be advantageous to use a stronger vacuum to ensure the 
complete removal of trapped air, to facilitate the penetration of loading solution into the 
microspheres. This was achieved using an Edwards-Pearce Freeze Dryer (EPD3, BOC 
Edwards, Sussex, UK), with a vacuum chamber that can produce low pressures down to 
~ 133 Pa (1 0 1 torr). The vacuum pressure can be manually controlled. Microspheres 
sintered at 1150 °C were used in this studied. 1.5 g of microspheres sample was soaked 
in 5 ml of 15% w/v benzamide in ethanol in a 20 ml vial. The vial was placed in the 
vacuum chamber of the freeze dryer and the vacuum pressure was carefully increased to 
such a level that air bubbles were released from the microspheres, without the liquid 
boiling. The vacuum was released when no more bubbles were observed (~ 5 min). 
The vial was then placed in a vacuum oven at 87.5 kPa at 50 °C overnight for the 
solvent to evaporate. Triplicate samples were run.
5.5.2.1 Results and Discussion
During vacuuming it was found that the temperature dropped dramatically due to heat 
loss associated with rapid solvent evaporation, and a small amount of benzamide 
crystallisation was observed on the surface of the solvent. The solubility of benzamide 
decreases as the temperature decreases (Figure 5.4). The combination of a decrease in
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solvent volume and a decrease in temperature brought the drug solution to 
supersaturation, and therefore recrystallisation was initiated. Crystallisation is not 
desirable at this stage because it was perceived that rapid crystal growth would result in 
crystals mainly formed outside the microspheres.
During solvent evaporation in the vacuum oven, the concentration of benzamide in the 
solution increased further, and more benzamide crystals were formed, especially on the 
upper surface of the samples. After complete solvent evaporation, a layer of benzamide 
crystals was found on the top layer of all the samples, identical to what was observed 
earlier (section 5.5.1.1). The crystal layers were removed by means of a spatula and 
discarded. The samples were then subjected to a dissolution test. The dissolution 
results are shown Figure 5.5. 80% of benzamide was released in the first 50 min. The 
higher standard deviations observed during the first 15 min of drug release are probably 
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Figure 5.5 Dissolution results of vacuum loading using a freeze dryer.
5.5.3 Surface Drug Removal by Washing
The instant release profile of benzamide in dissolution tests may be because there was a 
substantial layer of benzamide on the microspheres surfaces. Methods to remove the 
drugs on the outer surface of microspheres were investigated. Leo et a l.u 2 removed 
surface drug from polylactic acid microspheres by washing with water, and found the 
method to be effective. A washing method for the removal of surface drug from p-TCP 
microspheres was studied.
Since benzamide is more soluble in ethanol than in water, a washing method using 
ethanol was developed. A batch of P-TCP microspheres sintered at 1100 °C was 
vacuum loaded with benzamide as before (section 5.5.2). 4 x 0.2 g of benzamide- 
loaded microspheres were then weighed in four 20 ml vials. 10 ml of ethanol was 
added to each vial. The vials were then immediately tipped upside down twice 
manually and left to stand for different lengths of time. The first set of vials [method
(a)] was filtered immediately, and an extra 2 ml of ethanol was used in transferring the 
leftover solids from the vials to the filter. Other vials were left to stand for 1, 3, or 5 
min [method (b), (c) and (d)]. The contents of each vial were then filtered through a 3.0
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pm filter (Nuclepore®, Kent, UK) into a 250 ml conical flask connected to a tap water 
vacuum system. During filtering, an extra 10 ml of ethanol was used for transferring 
leftover solids in the vials to the filter. The filtrates were collected in an aluminium 
dish (43 cm, Agar Scientific, Stansted, UK) and dried in an oven (Model OV-440, 
Gallenkamp, Loughborough, UK) at 50 °C overnight. The whole experiment was 
repeated using a second batch of benzamide-loaded sample.
The amount of benzamide remaining before and after washing was determined by 
dissolving 0.20 g of microspheres, accurately weighed, in 50 ml of 0.1 M HC1 and the 
drug concentration in the acid determined spectrophotometrically (see section 2.12).
5.5.3.1 Results and Discussion
The benzamide contents before and after washing are shown in Table 5.6. It was found 
that almost all benzamide was removed from the microspheres during washing. The 
results obtained for the brief washing of 10 s with 2 ml ethanol (a), are comparable to 
the results obtained for the longest washing of 5 min with 10 ml ethanol (d). Therefore 
the washing method (a) was adopted for all experiments as a quick, effective method in 
removing most of the benzamide from the microspheres’ surface.
Table 5.6 Washing experiment results.
Benzamide content/%
Sample 1 Sample 2










(a) 10 s in 10 ml ethanol
+ 2 ml ethanol for transferring
0.09 0.08
(b) 1 min in 10 ml ethanol
+ 10 ml ethanol for transferring
0.04 0.06
(c) 3 min inlO ml ethanol
+ 1 0  ml ethanol for transferring
0.06 0.04
(d) 5 min in 10 ml ethanol




The process of evaporating solvent in the oven after vacuum loading was used because:
(1) It was a step for recovering the microspheres from the liquid;
(2) It was thought that evaporation would be advantageous as the drug concentration 
would increase and more drug would be deposited in the microspheres.
However, as discussed in sections 5.5.1.1 and 5.5.2.1, solvent evaporation results in 
formation of a layer of benzamide on the surface of the sample. This is undesirable. 
This step was therefore abandoned, and replaced with a filtration step.
A vacuum loading experiment was carried out using a freeze dryer as in section 5.5.2. 
The solids were then filtered immediately through a 3.0 pm filter (Nuclepore®, Kent, 
UK) into a 250 ml conical flask connected to a tap water vacuum system. The filtered 
solids were then dried in an oven overnight at 50 °C. To remove benzamide on the 
outer surface of the microspheres, a washing experiment [see section 5.5.3, washing 
method (a)] was also carried out. The drug contents of the microspheres before and 
after the washing experiment were determined (method see section 2.12). The 
experiment was repeated using microspheres sintered at 900°C, 1000 °C, 1150°C, and 
1200 °C. Five replicates were produced for each sample.
5.5.4.1 Results and Discussion
Using filtration, no built up of drug crystals layers on the surface of the microspheres 
samples was observed. The drug content of the dried microspheres is shown in Table 
5.7. It was found that the amount of drug-loaded onto the microspheres decreases with 
increases of the sintering temperature of the microspheres. After the washing 
experiment, almost all benzamide was removed from the microspheres, with 
microspheres sintered at 900 °C retaining the most drug.
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Table 5.7 Benzamide content of microspheres, before and after washing.
% Benzamide loading, n=5
Microspheres sintered at Before washing/% After washing/%
900 °C (n = 3) 6.66 ±0.77 0.09 ±0.02
1100 °C (n = 5) 2.90 ±0.61 0.03 ± 0.00
1150 °C (n = 5) 0.81 ±0.35 0.03 ± 0.00
1200 °C (n = 2) 0.80 ±0.13 0.02 ± 0.00
5.5.5 Sonication
It was perceived that sonication might be an alternative way of releasing trapped air in 
microspheres, and assisting the penetration of drug loading solution.
To investigate the feasibility of this method, firstly, the effect of sonication on 
microspheres itself was studied. p-TCP microspheres sintered at 1000 °C and 1100 °C 
were placed in water and subjected to 10 min sonication (Jenway Fb300b, Hove, UK). 
These microspheres, before and after sonication, were studied under the SEM.
Samples of microspheres sintered at 1100 °C were soaked in 15% w/v benzamide in 
ethanol and then sonicated for 30 s. The product was then filtered (3.0 pm filter, 
Nuclepore®, Kent, UK) and dried in the oven at 50 °C overnight. The benzamide 
release profile from these microspheres was then studied using dissolution tests.
5.5.5.1 Results and Discussion
Under the SEM, the sonicated microspheres appeared intact, indicating that the sintered 
microspheres were strong enough to maintain their structure under the sonication 
process. The dissolution results showed that all the benzamide was released instantly, 




It was perceived that microspheres with various pore-sizes might release drug in 
different rates. To study the drug release profile from microspheres of a narrow size 
range, attempts were made to separate the larger sintered microspheres from the fines 
by sieving. Microsphere samples sintered at 1100 °C were sieved with a 32 pm metal 
sieve. The sieved and retained products were then observed under the SEM.
5.5.6.1 Results and Discussion
It was found that sieving sintered microspheres was harder than sieving non-sintered 
samples (see section 3.7.6 for sieving of non-sintered microspheres). This is because 
the sintered microspheres aggregated more extensively. SEM examination showed that 
the sieving process was not effective in separating the bigger microspheres from the 
fines. Therefore, the method was discontinued.
5.5.7 Pre-Vacuuming
The loading methods described so far (section 5.5.1 and section 5.5.2) extracted the 
trapped air within the microspheres after they had been submerged in drug solution. It 
was perceived that if a vacuum is applied before the drug solution is introduced, trapped 
air could be better eliminated.
To enable a pre-vacuum action, the set up illustrated in Figure 5.6 was assembled. A 
sample of microspheres sintered at 1150 °C was placed in a quick-fit round bottom 
flask. A vacuum pump was run for few minutes to create a vacuum in the flask before 
the benzamide solution (15 %w/v in ethanol) was introduced by means of a syringe 
over a rubber stopper. Vacuum pumping was continued for 10 min after the addition of 
the benzamide solution. The sample was left overnight, and then filtered (3 pm 
Nucleopore® filter). The drug loading efficiency was determined (method see section 
2.12) and dissolution studies (method see section 5.4) were also performed.
181
injection of drug 
solution




Figure 5.6 Schematic diagram of glass set up which allows pre-vacuuming.
5.5.7.1 Results and Discussion
A diamond shape benzamide crystal was found at the bottom of the round flask. The 
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The dissolution results showed that ~ 80% benzamide was released in the first 15 min.
In all the experiment conducted so far, drug contents < 7 %  before washing were 
obtained, and instant drug release in dissolution tests was observed. Almost all drugs 
were removed during washing, indicating that liquid penetrates into the microspheres 
freely.
5.5.8 Increased Temperature
To increase drug loading, it was then considered to conduct the drug loading 
experiments at higher temperatures. This is because a higher concentration of drug 
loading solution can be prepared at higher temperature, and higher drug loading 
solution has been shown to produce higher drug loading in microspheres (section 
5.5.1.1). Furthermore, if the temperature of the loading equipment could be controlled,
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by cooling the system after drug loading controlled drug crystallisation inside the pores 
might be encouraged.
The solubility of benzamide increases as the temperature increases, and the increase is 
exponential above ~ 40 °C (Figure 5.7, see also Figure 5.4 for zooming in of graph for 
solubility below 60°C). Therefore, by increasing the experimental temperature above 
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Figure 5.7 Solubility of Benzamide in water (adapted from M ullin '41).
A set-up was assembled to allow vacuum loading experiments to be performed at 
controlled temperatures. The set-up is shown in Figure 5.8, and schematically 
represented in Figure 5.9.
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Figure 5.9 Schematic diagram of the set-up assembled for vacuum loading experiments.
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The set-up consists of two chambers, A and B, which are connected via tubing with a 
valve (valve 1). Chamber A is the drug solution chamber; chamber B is the loading 
chamber where microspheres are placed. Chamber B is also connected to a vacuum 
pump (40 1/min) with a valve (valve 2). A pressure gauge is coupled to chamber B to 
monitor the loading vacuum pressure inside the chamber.
The desirable features of this set-up are:
(1) The chambers are water jacketed to allow temperature control;
(2) It has a large loading chamber (~ 200 ml volume), therefore a larger amount of 
sample can be loaded at any one time;
(3) It allows pre-vacuuming, i.e., a vacuum can be applied to the sample before 
introducing the drug solution;
(2) Transparent glassware means that all the experiment process can be directly 
observed visually.
5.5.8.1 Loading Procedure at Increased Temperature
Before a loading experiment, the glass equipment was warmed up by circulating water 
at 50 °C around both chambers for ~ 15 min. The tubing connecting chamber A to 
valve 1 was then pre-filled with drug solution to ensure that there was no trapped air in 
the tubing. This was achieved as follows.
•  Firstly, a drug solution was placed in chamber A;
• Secondly, low-pressure was created in chamber B by running the vacuum pump 
while valve 1 is closed and valve 2 is opened;
• Thirdly, valve 2 was closed, and valve 1 was carefully opened to allow the drug 
solution from chamber A to reach valve 1.
The temperature of circulating water in the water jackets (± 0.1 °C) was controlled by a 
refrigerated circulator (DC5-K20, Thermo Haake, Karlsruhe, Germany).
A drug loading experiment using benzamide was performed at 50 °C. The temperature 
was chosen because the solubility of benzamide increase dramatically above ~ 40 °C. A 
drug solution of 35% w/v of benzamide in ethanol was placed in chamber A. 1.25 g of 
microspheres sintered at 1150 °C was placed in chamber B. While the vacuum pump 
was running, valve 2 was opened for ~ 5 min to create a low-pressure in the chamber
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and then closed, whilst valve 1 was opened briefly for sufficient quantity of benzamide 
solution to enter chamber B to immerse all the microspheres. Valve 2 was then re­
opened for 10 min until no bubbles could be observed rising from the sample. During 
this period, chamber B was gently tapped by hand to loosen trapped air. Two filtering 
procedures were carried out as follows:
(a) Filtering Procedure I
Half the sample was filtered with a sintered glass filter (porosity 4, BDH 
Laboratory Supplies, Poole, UK) into a 250 ml conical flask connected to a tap 
water vacuum system. The filtrate collected on the glass filter was scraped into an 
aluminium dish (43 cm, Agar Scientific, Stansted, UK) using an aluminium spatula 
and dried in an oven (Model OV-440, Gallenkamp, Loughborough, UK) at 50 °C 
overnight.
(b) Filtering Procedure II
The other half of the sample was poured into ~ 20 ml of water at room temperature 
and then immediately filtered and dried as described in Filtering Procedure I.
The experiment was performed in duplicate. Washing experiments [section 5.5.3 
method (a)] and preliminary dissolution tests were also performed.
5.5.8.1.1 Results and Discussion
The % benzamide loading before and after the washing stage is shown in Table 5.8.
Table 5.8 % benzamide loading of microspheres using Filtering Procedure I and II, 
before and after the washing stage.
Sample 1150 °C, 
n = 2
Mean Drug content 
before washing/%
Mean drug content after 
washing/%
Filtering Procedure I 7.20 0.05
Filtering Procedure II 0.16 0.04
At 50 °C, a benzamide solution of high concentration (35% w/v) can be prepared, and a 
7.2% drug loading (Filtering Procedure I) was obtained. This was the highest
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benzamide loading achieved until then. Dissolution tests showed that the release of 
benzamide from these microspheres was instant, with > 90% drug release in the first 
15 min.
It was observed that tiny benzamide crystals were formed, both on the surface of the 
microspheres and on the filter using Filtering Procedure I. It was suggested that 
recrystallisation happened immediately when temperature dropped during filtering. To 
avoid crystallisation happening during filtering, Filtering Procedure II was used. 
Results showed that after immersion in water, the percentage loading was dramatically 
reduced, from 7.20% to 0.16%.
5.5.9 DSC Analysis
DSC analysis is frequently used to investigate interactions between a drug entity and 
excipients during the preformulation stage. To investigate possible interactions 
between benzamide and sintered p-TCP surfaces and to study the physical state of 
benzamide inside the sintered calcium phosphate microspheres, DSC analysis was 
performed. The experimental methods are described in section 2.9. Benzamide as- 
received; sintered p-TCP microspheres (at 1100°C); physical mixture of benzamide and 
sintered p-TCP microspheres (20:80); and benzamide-loaded sintered microspheres 
were analysed. Each sample was analysed in triplicate.
5.5.9.1 Results and Discussion
The DSC thermograms obtained are shown in Figure 5.10. Under the experimental 
conditions, no DSC peaks were observed for the p-TCP sintered microspheres material. 
An endothermic sharp peak at the melting point of benzamide at -128 °C was observed 
for benzamide as-received, physical mixture of benzamide and p-TCP sintered 
microspheres, and benzamide-loaded sintered P-TCP microspheres. This suggests that 
benzamide remained in a crystalline form in the physical mixture of 
benzamide-microspheres, and after it was loaded into microspheres. The results show 
that there are no physical and no chemical interactions between benzamide and the 
sintered P-TCP material. It was concluded that p-TCP is a compatible carrier for 
benzamide.
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Figure 5.10 DSC thermograms obtained of (a) p-TCP microspheres sintered at 1100°C;
(b) benzamide as-received; (c) physical mixture of benzamide and sintered P-TCP 
microspheres (20:80); and (d) benzamide-loaded P-TCP microspheres.
5.6 Loading of Propranolol
5.6.1 Model Drug - Propranolol.HCI
The incorporation of a second model drug, (RS)-propranolol hydrochloride (HCI), into 
the microspheres was studied. Propranolol.HCl was chosen because:
1. Propranolol.HCl is more soluble in water than benzamide (~ 4 times more 
soluble), therefore a higher concentration of drug solution can be prepared for 
loading experiments at room temperature;
2. Propranolol.HCl has a Xmax at 289 nm in phosphate buffer. Therefore it does not 
interfere with gelatin absorption as gelatin absorbs at X < 228 nm in the UV 
spectrum.
Propranolol.HCl is a synthetic non-selective beta-adrenergic receptor blocking agent. It 
is clinically used in the management of hypertension, angina pectoris, cardiac 
arrhythmias and myocardiac infarction. The physicochemical properties of 
propranolol.HCl are listed in Appendix II.
5.6.2 Vacuum Loading
Propranolol.HCl was vacuum loaded into microspheres using the set-up described in 
section 5.5.8 (see Figure 5.8). A loading solution of 5% w/v propranolol.HCl. in water 
was placed in chamber A. About 5 g of microspheres to be loaded were placed in 
chamber B. The loading procedure was similar to the loading procedure of benzamide 
in section 5.5.8.1 but was performed at room temperature. While valve 1 was closed
and valve 2 was opened, chamber B was evacuated for 5 min and the pressure gauge
indicated that the vacuum pressure inside the chamber was - 95 kPa. Subsequently, 
valve 2 was closed and valve 1 was opened briefly to allow sufficient propranolol.HCl 
solution from chamber A to enter chamber B to immerse all the microspheres. Valve 2 
was then re-opened for 10 min until no further bubbles could be observed rising from 
the sample. During this period, chamber B was then gently tapped manually, to release 
air trapped between the microspheres. The loaded microspheres were then poured into 
a glass jar and left overnight for the system to reach equilibrium.
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The propranolol.HCl-loaded microspheres were then filtered using a sintered glass filter 
into a 250 ml conical flask connected to a tap water vacuum system. The filtrate 
collected on the glass filter was scraped into an aluminium dish and dried in an oven at 
50 °C overnight.
The loading experiments were performed using samples of microspheres sintered at 
900 °C, 1000 °C, 1100 °C, 1150 °C and 1200 °C. Experiments were performed in 
triplicates using three different batches of spray-dried microspheres.
Attempts were made to load drug into non-sintered microspheres in the same way. 
However, it was found that non-sintered samples were too frail to stand the pre-vacuum 
suction.
The percentage propranolol.HC1 loading of the microspheres was determined (method 
see section 2.12). Three replicates were performed for each sample.
5.6.2.1 Results and Discussion
The results obtained (Table 5.9) show that the percentage drug loading decreases as the 
temperature at which the microspheres were sintered increases. This finding is 
consistent for all three batches of microspheres studied. With microspheres sintered at 
900 °C the highest drug loading at ~ 5.6% was obtained, while with microspheres 
sintered at 1200 °C the lowest drug loading at ~ 1.4% was obtained. All percentage 
loadings are calculated in weight. If the percentage loadings were calculated in volume, 
these values would become ~ 3 times higher because sintered p-TCP has a high density 
of ~ 3 g/cm3. It was found that these percentage loading results correlate with the 
specific surface area of the microspheres (see section 4.4.4.1 for surface area results). 
Comparisons between the percentage loadings and the surface area of the microspheres 
are shown in Table 5.10. A plot of specific surface area versus % drug loading is 
shown in Figure 5.11. The calculated regression coefficient, r2, has a value of 0.8943, 
indicating a very strong correlation between surface area and percentage drug loading. 
These results suggest that propranolol.HC1 was adsorbed on the matrix surfaces, 
including internal surfaces, of the microspheres. The results also confirm that the 
vacuum loading method has successfully introduced the drug solution into the internal
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area of the porous microspheres. On close examination, the data point for samples 
sintered at 900 °C appears to be a rogue value in the graph. When this point is not 
considered, the calculated r2 value reaches a near unity of 0.9997 (Figure 5.12). 
According to this regression line, the percentage drug loading for microspheres sintered 
at 900 °C achieved a lower value than expected. The reason for this is unknown.
Table 5.9 Results of loading percentage of propranolol.HCl into microspheres sintered 
at different temperatures.
Percentage loading ± SD/ % (w/w)
Samples sintered at Batch 1, n = 3 Batch 2, n = 3 Batch 3, n = 3
900 °C 6.69±1.63 5.3710 .74 4.98 10 .39
1000 °C 4.60 ± 0.75 5.1710 .22 4 .5110 .17
1100 °C 1.9910.22 2 .3510.03 2.65 10 .23
1150 °C 1.3610.06 2.1710 .06 1 .7310.02
1200 °C 1.3910.30 1.4310.05 1.4410.05
Table 5.10 Comparisons between the percentage loading of propranolol.HCl and 
surface area of sintered microspheres.
Samples sintered at Propranolol.HCl loading 1  
SD/%, n = 9
Surface Area 1  SD/m2 g'1, 
n = 5
900 °C 5 .6711 .20 5 .9710 .15
1000 °C 4.7610 .51 2 .9110 .05
1100 °C 2.3210 .33 1 .1710.02
1150 °C 1.7510.35 0.73 10 .02
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Figure 5.12 Regression line of microspheres’ surface area vs. % propranolol.HCl 
loading, excluding the point contributed by microspheres sintered at 900 °C.
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5.6.3 Modified Vacuum Loading Methods
Aiming to increase the percentage drug loading, three modified drug loading methods 
were investigated:
Method 1 -  Successive loading 
Method 2 -  Increased temperature 
Method 3 -  Crystal growth
5.6.3.1 Method 1 - Successive Loading
It was proposed that by exposing previously drug-loaded microspheres to drug solution 
for a second time, a second layer of drug might be deposited in the microspheres and 
therefore a higher total percentage drug loading could be achieved. The 
propranolol.HCl-loaded microspheres (Batch 3 in section 5.6.2) were subjected to a 
second cycle of loading experiments. The loading method and conditions used were the 
same as those in section 5.6.2. Experiments were performed in duplicate for each 
sample. Percentage drug loading for these samples was then determined (method see 
section 2.12).
5.6.3.1.1 Results and Discussion
The percentage propranolol.HCl loading of the successively loaded microspheres is 
shown in Table 5.11. The results show that there is no consistent drug loading 
increment after a successive drug loading experiment. The reason for this might be that 
the propranolol.HCl loading solution used was not a saturated solution**. During the 
second loading process, the drug-loaded in the first time might have re-dissolved into 
the loading solution to establish equilibrium. This would explain why the total amount 
of drug loading did not increase after the second loading.
The solubility of propranolol.HCl at normal laboratory temperature (~ 22 °C) was found to be 
11.4 %w/v . Therefore, a 5% w/v drug loading solution was far from saturation.
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Table 5.11 Percentage propranolol.HCl loading of successive loading experiments.
Samples 
sintered at
% Drug loading ± SD
After 1st loading, n=3 After 2nd loading, n=3
Batch 1 Successive Batch A Successive Batch B
900 °C 4.98 ±0.39 4.06 ±1.01 4.28 ± 0.04
1000 °C 4.51 ±0.17 3.23 ±0.13 3.48 ± 0.02
1100 °C 2.65 ± 0.23 3.28 ± 0.27 2.70 ± 0.04
1150 °C 1.73 ±0.02 1.59 ±0.02 2.44 ± 0.09
1200 °C 1.44 ±0.05 1.81 ±0.14 1.96 ±0.16
5.6.3.2 Method 2 -  Increased Temperature
It has been shown in section 5.5.8 that by increasing the loading temperature, a higher 
concentration of benzamide loading solutions could be prepared, resulting in higher 
benzamide loading into the microspheres. To obtain higher drug loading for 
propranolol.HCl, the same concept was applied.
5.6.3.2.1 Production of a High Concentration Propranolol.HCl Solution
A high concentration propranolol.HCl solution was prepared by dissolving 170 mg 
propranolol.HCl in 500 ml deionised water at 60 °C, using a magnetic stirrer. The 
temperature of the system was then cooled down to 45 °C. No re-crystallisation was 
observed during the cooling process by visual observation. The solution was then 
filtered through a 0.02 pm filter (Nalgene MF75 with polyethersulphone filter, Nalge 
Nunc International Co., Rochester, NY, USA), with the aid of a hair dryer blowing hot 
air to prevent re-crystallisation due to temperature drops. The filtered solution was then 
placed in a water jacketed sealed flask and maintained at 45 °C.
The accurate concentration of the propranolol.HCl solution prepared was determined as 
follows. An accurately weighed amount of the propranolol.HCl solution (15 g) was left 
in a dark cupboard at room temperature for 5 days, until all the water evaporated, and 
then placed in an oven at 50 °C for 2 days. The weight of the propranolol.HCl crystals
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collected was then determined. The concentration of the propranolol.HCl solution was 
found to be 26.65% w/w.
5.6.3.2.2 Vacuum Loading
Using the prepared high concentration propranolol.HCl solution as loading solution, 
drug loading experiments were performed as before (section 5.6.2) but at 45 °C. 
Microsphere samples sintered at 900 °C and 1150 °C were used. The percentage drug 
loading was then determined (method see section 2.12).
5.6.3.2.3 Results and Discussion
The results of percentage drug loading obtained are shown in Table 5.12. Compared to 
loading at room temperature (section 5.6.2, drug loadings of 5.67% and 1.75% were 
obtained for microspheres sintered at 900 °C and 1150 °C, respectively), much higher 
drug loadings were obtained (drug loadings of 26.7% and 12.0% were obtained for 
microspheres sintered at 900 °C and 1150 °C, respectively). These experimental results 
are in accordance with previous findings (section 5.5.8.1.1, using benzamide) that a 
more concentrated drug loading solution produced a higher drug loading microspheres, 
and microspheres sintered at a higher temperature achieved a lower drug loading.
Table 5.12 Percentage drug loading obtained using high concentration propranolol.HCl 
solution.
Samples sintered at Propranolol.HCl loading (% w/w)
900 °C 26.7
1150 °C 12.0
5.6.3.3 Method 3 -  Crystal Growth
As discussed earlier (section 5.6.2.1), the total surface area of the microspheres, 
including internal surface of the porous matrix, was found to correlate with the amount 
of drug-loaded into the microspheres. This shows that by using the vacuum loading 
method, drugs are deposited or adsorbed on the matrix of the microspheres.
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It was then perceived that if the pores of the microspheres could be filled with drugs 
crystals, the percentage drug loading could be increased dramatically. Furthermore, 
such a system itself could also serve as a basis of a controlled release system - the 
porous area of the microspheres being the drug reservoirs. Drug near the opening of the 
pores would be released first, and drug deeper in the pores would be released later.
Attempts were made to grow drug crystals within the pores of the microspheres. 
Concepts of crystallisation, crystal growth, and the experiments carried out to grow 
propranolol.HCl crystals inside the microspheres are detailed in section 5.9.
5.6.4 Dissolution Studies
The drug release profiles of propranolol.HCl from propranolol.HCl-loaded 
microspheres using vacuum loading (section 5.6.2), and modified vacuum loading 
(Method 1, 2 and 3 in section 5.6.3) methods were studied by dissolution test. The 
conditions used were the same as those used for benzamide-loaded microspheres 
(section 5.4). Sampling was carried out using an automatic set-up. At programmed 
intervals, the solution was pumped automatically through 5 pm filters (Pharma Test, 
Hamburg, Germany) using a peristaltic pump (C8-midi, Watson-Marlow AliteaAB, 
Stockholm, Sweden) under the control of a valve machine (Ven-At, Pharma Test, 
Hamburg, Germany) that allows for dissolution medium to flow into a flow through cell 
in a spectrophotometer (Unicam 8625, Cambridge, UK). The absorbance of the 
medium was then measured at 289 nm. The flow rate of the pump was calibrated every 
week. The drug release data were calculated automatically by WinDiss 4.106 software 
(Pharma Test, Hamburg, Germany) based on a previously constructed referenced 
calibration curve (see section 5.6.4.1).
Each dissolution unit consisted of 500 mg of drug-loaded microspheres placed in a size 
0 gelatin capsule, unless otherwise stated. The dissolution medium was phosphate 
buffer. In each dissolution run, 5 capsules of the drug-loaded samples and a control (a 
capsule contained drug free microspheres) were run.
The release profiles of propranolol.HCl from microspheres were compared to 
dissolution profiles of propranolol.HCl crystals which had been treated as follows.
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Propranolol.HCl as-received was first dissolved in water. The drug crystals were then 
recovered by evaporating the water off in an oven at 50 °C. The dried crystals were 
crushed with a mortar and pestle. A control runs of these treated propranolol.HCl 
crystals was used as a control instead of propranolol.HCl powder as-received. This is 
because it was perceived that their crystallographic nature would be closer to the 
propranolol.HCl deposited in the microspheres, since the drug undergoes dissolution 
and re-crystallisation during the loading experiments. The dissolution studies of 6 
capsules each containing 30 mg of the treated propranolol.HCl crystals, were 
performed.
5.6.4.1 Calibration Method
The A-maxOf propranolol.HCl in phosphate buffer, pH = 6.8, and in 0.1 M HC1 was found 
to be 289 nm and 290 nm respectively, when its absorbance was scanned from 200 nm 
to 320 nm (Unicam Helios a  spectrophotometer, Cambridge, UK). These A,max were 
then used to monitor the concentration of propranolol.HCl in the respective media.
A stock solution of propranolol.HCl (0.05%) was prepared by dissolving 50 mg of 
propranolol.HCl, accurately weighed, into ~ 80 ml of BP phosphate buffer, pH = 6.8, 
and then the solution was made up to 100 ml final volume. Aliquots of the stock 
solution were diluted to produce a series of solutions having target concentrations of 
0.001%, 0.002%, 0.003%, 0.004%, and 0.005% w/v of propranolol.HCl. The 
absorbance of these solutions was determined at 289 nm. The procedure was 
performed in triplicate, using a new stock solution each time. The calibration data of 
propranolol.HCl in 0.1 M HC1 were also obtained using the same method measuring at 
X = 290 nm.
5.6.4.2 Calibration Data (Propranolol.HCl)
The calibration data of propranolol.HCl in phosphate buffer, pH = 6.8, and in 0.1 M 
HC1 are shown in Table 5.13 and Table 5.14, respectively. Calibration plots are given 
in Appendix IV. The calibration plots in phosphate buffer and in acid were both found 
to be linear in the concentration range of 0.000% - 0.005% w/v.
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Table 5.13. Calibration data of propranolol.HCl in BP phosphate buffer, pH=6.8.
Calibration Set
1 2 3 Mean
Intercept 0.0027 0.0022 0.0147 0.0065
Slope 192.00 192.29 190.20 191.50
Regression (r2) 1.0000 1.0000 0.9976
SD of the regression 0.0023 0.0025 0.0192
Table 5.14 Calibration data of propranolol.HCl in 0.1 M HC1.
Calibration Set
1 2 3 Mean
Intercept 0.0018 0.0032 0.0043 0.0031
Slope 192.14 191.97 190.09 191.40
Regression (r2) 1.0000 1.0000 1.0000
SD of the regression 0.0015 0.0025 0.0031
5.6.4.3 Determination of Drug Stability
The UV absorbance of freshly prepared propranolol.HCl in a phosphate buffer, before 
and after they were kept at 37 °C ± 0.5 °C for 10 h were measured. The results show 
that propranolol.HCl is stable over the dissolution period.
5.6.4.4 Dissolution Results
The dissolution results of vacuum loading at room temperature (section 5.6.2) of the 
three batches of microspheres sintered at various temperatures are shown in Figure 
5.13, Figure 5.14 and Figure 5.15. The results show that the propranolol.HCl release 
from microspheres is slightly slower than the dissolution of pure propranolol.HCl. 
However, most of the drug was generally released quickly. ~ 50% of the drug was 
released in the first 20 min, and almost all drug was released in 150 min. There are no 
marked differences between the release profiles of the propranolol.HCl from 
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Figure 5.15 Dissolution results for Batch 3 microspheres sintered at various 
temperatures as indicated in the graph.
The dissolution results o f  microspheres loaded using Method 1 (successive loading, 
section 5.6.3.1) are shown in Figure 5.16. It was found that the release patterns o f the 
propranolol.HCl were similar to that o f first time loading. No marked differences were 
found between these results and those concerning the release patterns o f  microspheres 
sintered at different temperatures.
Loading Method 2 (increased temperature) produced high loaded microspheres (section 
5.6.3.2.3). Therefore, in dissolution studies, the amount o f  sample in each capsule was 
reduced so that the final concentration in the dissolution vessel stayed within the 
calibration plots. Each dissolution unit was a 100 mg o f microsphere sample in a size 3 
gelatin capsule. Dissolution results (Figure 5.17) show that the drug release patterns are 
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Figure 5.17 Dissolution results for microspheres loaded using Method 2.
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5.6.4.5 Dissolution in Acidic Media
Dissolution of propranolol.HCl-loaded microspheres in acidic medium (0.1 M HC1) at 
37 ± 0.5°C was also studied. The results showed that all microspheres dissolved in the 
medium after 20 min. This finding is comparable with finding of the fast dissolution of 
spray-dried non-sintered p-TCP in section 5.3.5. The results confirm that to be used for 
oral controlled release delivery the microspheres need to be enteric coated.
5.6.5 Low-Temperature Scanning Electron Microscopy (LTSEM)
To study propranolol.HCl and propranolol.HCl-loaded samples under the microscope, 
low-temperature SEM (LTSEM) was used. LTSEM was used because propranolol.HCl 
crystals were found to change shape quickly under the electron beam in a conventional 
SEM. This destruction may be the result of moisture sublimation from the drug crystals 
due to low-pressure (<10 ' 3  Pa), and also due to the heat generated by the electron beam. 
Hydrated samples are normally unstable for conventional SEM analysis.
The advantages of analysing samples at low temperatures (-100 °C to -175 °C) 
include82'83:
(a) Delicate samples can be analysed in their fully-hydrated state. Samples retain 
most of their associated water and display less artefacts (shrinkage or structural 
collapse) due to dehydration;
(b) Surface water in the specimen is stabilised, hence minimising the unwanted 
charging effects caused by disruption of the conducting coating.
The LTSEM sample preparation used in this study is detailed in section 2.8.1. This is a 
modified sample preparation procedure from Potter et al. 83. The cryofixation step (to 
immerse sample in liquid nitrogen) used by Potter et al. was omitted because it was 
found to be unnecessary in this study.
Propranolol.HCl-loaded microspheres were studied using LTSEM combined with 
Energy Disperse X-Ray Analysis (EDX). EDX can be used because propranolol.HCl 
contains a high atomic number element, chlorine, which can be detected by the 
analysis. EDX elemental spot analysis was performed to confirm the identity of those 
structures which were identify as propranolol.HCl by visual observation under the
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microscope. Both the surface morphology and internal morphology of the 
propranolol.HCl-loaded microspheres were studied. Sample preparations are detailed 
in section 2.7.4 and 2.7.5.
5.6.5.1 Results and Discussion
For microspheres that were propranolol.HCl-loaded by vacuum loading at room 
temperature (section 5.6.2), no structural differences were observed before and after 
drug loading under the LTSEM. No drug crystals could be identified. This is probably 
because the drug might be present as a thin layer on the surface of the microsphere 
matrix as suggested earlier (section 5.6.2.1).
For microspheres which were loaded by vacuum loading at 45 °C (section 5.6.3.2), 
well-defined propranolol.HCl crystals were observed on the surface of the 
microspheres, as shown in Figure 5.18. Close examination showed that some crystals 
were embedded in the pores of the microspheres (Figure 5.19). The crystals were 
confirmed to be propranolol.HCl by EDX; the analysis detected a high signal for Cl. It 
is suggested that drug crystals on the outer surface of the microspheres might have been 
formed during the filtration process. When the bulk of the drug solution was drained 
away, there would still be a layer of solution that covered the microspheres due to 
capillary force. Solvent evaporation would have started due to the low content of water 
in the atmosphere, therefore the concentration of drug on the microspheres’ surfaces 
would have increased, and drug crystals were formed on the surfaces.
It was observed that some microspheres were totally covered in drug crystals (Figure 
5.20). It is thought that these were the microspheres located at the base of the filter 
during the filtration process. These microspheres were likely to have collected drug 
solution seeping down from microspheres above. If the drug solution around them was 
not drained away sufficiently quickly, the drug crystallised rapidly due to temperature 
dropped, and the microspheres became coated with a layer of drug crystals. The 
presence of drug crystals on the surface also explains the fast release of 
propranolol.HCl for these high drug loading microspheres in the dissolution test.
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Figure 5.19 A zoom in SEM micrograph of Figure 5.18, showing how propranolol.HCl 
crystals attached to the microsphere surface. Some crystals were found inside pores.
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Figure 5.20 SEM micrograph of a microsphere fully covered by propranolol.HCl 
crystals.
These microspheres were embedded in resin and then sliced open (preparation method 
see section 2.7.5) for examination of the internal morphology. It was found that in the 
presence of resin, it was difficult to differentiate drug crystals from the microspheres’ 
matrix. Therefore, no conclusion about the existence of drug crystals inside the 
microspheres can be drawn from SEM examination.
5.7 Loading of Paracetamol
5.7.1 Model Drug - Paracetamol
The loading of a third model drug, paracetamol, into P-TCP sintered microspheres was 
studied to ascertain that loading patterns reported are reproducible and are not drug 
specific. Apart from being economical, the main reasons that paracetamol was chosen 
was:
1. It is an active drug that is sparingly soluble in water and has a marked solubility 
difference in water and alcohol (it is 13 times more soluble in ethanol than in 
water). It was thought that the high alcohol solubility would allow a high 
concentration alcohol based drug loading solution to be prepared, and a low water
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solubility mean a slow drug release profile in dissolution test. This would enable 
the release kinetics in the dissolution test to be studied more accurately.
2. It has good chromophore that can be monitored spectrophotometrically at X > 
240 nm, therefore its absorbance will not interfere with gelatin absorbance.
The physicochemical properties o f paracetamol are given in Appendix II.
5.7.2 Wavelength Determination for UV Assays
The A,max o f  paracetamol was found to be 241 nm in both phosphate buffer, pH = 6.8, 
and in 0.1 M HC1, when its solutions were scanned in the range o f  200 nm - 320 nm 
with a spectrophotometer. However, this value was not used for UV assays in this 
study because interference o f gelatin absorption at this wavelength was found. The 
absorbance o f gelatin capsules in buffer, paracetamol in buffer, and gelatin capsule plus 
paracetamol in buffer, are shown in Figure 5.21. A similar absorbance pattern was also 
obtained using 0.1 M HC1 as media. The graph shows that at 249 nm gelatin absorbs 
little whilst paracetamol has a high absorbance. Therefore, 249 nm was used in all the 
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Figure 5.21 UV absorbance o f paracetamol, gelatin capsule, and paracetamol plus 
gelatin capsule in phosphate buffer, pH = 6.8.
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5.7.3 Calibration Method
A stock solution of paracetamol (0.025%) was prepared by dissolving 50 mg of the 
drug, accurately weighed, into 200 ml of BP phosphate buffer, pH = 6 .8 . Aliquots of 
the stock solution were diluted to produce a series of solutions having target 
concentrations of 0.0003%, 0.0005%, 0.0008%, 0.0010% and 0.0015% w/v of 
paracetamol. The absorbance of these solutions was determined at 289 nm. The 
procedure was performed in triplicate, using a new stock solution each time. The 
calibration data of paracetamol in 0.1 M HC1 was also obtained using a similar method.
5.7.3.1 Calibration Data (Paracetamol)
The calibration data of paracetamol in phosphate buffer, pH = 6 .8 , and in 0.1 M HC1 are 
shown in Table 5.15 and Table 5.16 respectively. Calibration plots are given in 
Appendix IV. The calibration plots of paracetamol in phosphate buffer and in 0.1M 
HC1 were found to be linear in the range 0 - 0.0015% and 0 - 0.0020% w/v respectively.
Table 5.15 Calibration data of paracetamol in BP phosphate buffer, pH=6 .8 .
Calibration Set
1 2 3 Mean
Intercept 0.0006 0.0006 0.0005 0.0006
Slope 595.64 588.79 590.74 591.72
Regression (r2) 0.9999 0.9997 0.9998
SD of the regression 0.0028 0.0060 0.0047
Table 5.16 Calibration data of paracetamol in 0.1 M HC1.
Calibration Set
1 2 3 Mean
Intercept 0.0032 0 . 0 0 1 2 0 . 0 0 1 0 0.0018
Slope 567.40 590.20 588.80 582.13
Regression (r2) 0.9999 1 . 0 0 0 0 1 . 0 0 0 0
SD of the regression 0.0046 0.0024 0.0023
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5.7.4 Determination of Drug Stability
Paracetamol in phosphate buffer (pH = 6 .8 ) was freshly prepared and kept at 37 ±
0.5 °C for 24 h. The UV absorbance of the solution before and after the incubation was 
measured at 249 nm. The results show no marked difference between the absorbance, 
indicating that paracetamol is stable over the dissolution period.
5.7.5 Loading Experiments
Paracetamol is more soluble in alcohol than in water (see Appendix II). Therefore 
ethanol was chosen as solvent to allow the making of a high concentration paracetamol 
solution for loading experiments. The loading solution was 12.5 %w/v paracetamol in 
ethanol. The vacuum loading experiments were performed at room temperature using 
the set-up and the procedure described in section 5.6.2. The microsphere samples used 
were those sintered at 900 °C and at 1150 °C. Each sample was loaded in triplicate.
5.7.6 Loading Efficiency Test and Washing Experiments
The drug loading efficiency was determined as before (section 2.12, X = 249 nm). To 
remove the drug adhering on the outer surface of the microspheres, a washing 
experiments was performed. Washing method (a) in section 5.5.3 was used, but water 
instead of ethanol was used as a solvent. This is because paracetamol is a lot more 
soluble in ethanol than in water. Complete extraction of paracetamol from the 
microspheres was not required.
5.7.6.1 Results and Discussion
The results of the percentage loading and washing experiments are shown in Table 
5.17. More paracetamol was loaded onto microspheres with a higher surface area, i.e., 
microspheres sintered at a lower temperature. This observation is consistent for all 
three model drugs tested. The ratio of drug-loaded for microspheres sintered at 900 °C 
and microspheres sintered at 1150 °C for propranolol.HCl and for paracetamol, were 
found to be similar (5.67/1.75 = 3.24 and 17.28/5.39 = 3.21 respectively). This further 
confirms that:
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( 1 ) the amount of drug-loaded using the vacuum loading method is related to the 
surface area of the microspheres;
(2 ) the drug was loaded as a layer on the matrix of the microspheres.
Table 5.17 Paracetamol content of microspheres, before and after washing.
% Paracetamol loading, n=3
Microspheres sintered at Before washing/% After washing/%
900 °C 17.28 ± 2.00 3.96 ± 0.88
1150 °C 5.39 ±0.52 0.74 ± 0.04
5.7.7 Dissolution Studies
The release profile of paracetamol from the microspheres was studied (method see 
section 5.6.4). The drug release was compared to the dissolution of paracetamol 
crystals that had been dissolved in ethanol followed by drying in the oven at 50 °C. 
The reason for this has been explained in section 5.6.4.
5.7.7.1 Results and Discussion
The dissolution results (Figure 5.22) show that the release profile of paracetamol is 
similar to the release profile of propranolol.HCl and benzamide:
(1) There are no marked differences of release among microspheres sintered at 
different temperature;
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Figure 5.22 Dissolution results o f  paracetamol release.
5.8 Drug Composition Studies Before and After Loading 
Experiments
p-TCP has a surface that is acidic in nature. In order to ensure that model drugs did not 
degrade when they came into contact with this acidic surface, possible changes to the 
drugs after loading into the sintered p-TCP surfaces were investigated. Furthermore, 
for all the loading calculations and dissolution results to be valid, the model drugs 
before and after loading experiments should remain the same.
All three model drugs were also subjected to analysis, as-received and after loading into 
p-TCP microspheres sintered at 900 °C. The analytical tests carried out were nuclear 
magnetic resonance (NMR) spectroscopy, mass spectroscopy (MS), and X-ray 
diffraction (XRD) studies.
5.8.1 Nuclear Magnetic Resonance (NMR) Spectroscopy
NMR spectroscopy is a most valuable analytical technique used to determine the 
structure o f an organic molecule. It is based on energy transitions o f  spinning nuclei in
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an applied magnetic field. It is used to identify the carbon-hydrogen structural 
framework in molecules.
As-received drug (benzamide, propranolol.HCl and paracetamol) were compared to
1 1 ̂drugs loaded into the P-TCP microspheres with H-NMR and C-NMR spectrometry.
!H-NMR spectroscopy is used to determine the number of different types of 
environment experienced by hydrogen atoms in a molecule, and where these hydrogen 
atoms are located along a carbon skeleton. The structure of a chemical is determined 
by analysing four characteristics of the spectrum:
1. The number of signals,
2. The position of a signal -  chemical shift,
3. The area under the signal -  integral,
4. The splitting of a signal into several lines -  coupling and multiplicity.
1 3 C-NMR spectroscopy is used to determine the number of different types of 
environment experienced by carbon atoms in the molecules. It gives information about 
the electronic environment of the different types of carbon and the number of 
‘neighbours’ a carbon atom has.
DMSO, (CD3 )2 SO, was chosen as the solvent used for analysis because all three sample 
drugs dissolve well in it. Samples containing drugs as-received were prepared by 
dissolving ~ 30 mg of model drugs in DMSO. Drugs in microsphere samples were
prepared by mixing microspheres that contained ~ 30 mg of drugs in DMSO. The
mixtures were allowed to settle and the supernatants were used in the NMR studies. 
Samples were analysed by the University of Bath NMR Service, Department of 





5.8.1.1 Results and Discussion
The following NMR spectra were obtained:
Benzamide as-received
5h(400 MHz ; DMSO) 8.0 (1H, bs, NH), 7.90-7.42 (5H, m, Ar), 7.40 (1H, bs, NH). 
5C(100 MHz, DMSO) 167.7 (0 = 0 ), 134.1, 131.0, 128.0, 127.3 (Ar).
Benzamide in microspheres
6h(400 MHz; DMSO) 8.0 (1H, bs, NH), 7.85-7.42 (5H, m, Ar), 7.33 (1H, bs, NH). 
5C(100 MHz, DMSO) 167.6 (0 = 0 ), 134.0, 131.0, 128.0, 127.3 (Ar).
Propranolol.HCl as-received
5h(400 MHz; DMSO) 8.24-6.92 (7H, m, Ar), 6.07 (1H, bs, OH exchangeable with 
D20 ), 4.37-4.31 (1H, sextet, CHOH), 4.14-4.12 (2H, d, OCH2), 3.45 (1H, bs, NH 
exchangeable by D20 ), 3.39-3.31 (1H, heptet, N C //C H 3), 3.24-3.07 (2H, m, CH2N), 
1.27-1.24 (6H, t, 2xCH3).
5C(100 MHz, DMSO) 153.5, 133.8, 127.2, 126.3, 125.9, 125.0, 124.7, 121.6, 120.0,
105.1 (Ar), 69.9, 65.2 (2 x C -0 ), 49.8, 47.0 (2xC-N ), 18.6, 18.3 (2xCH3).
Propranolol.HCl in microspheres
5h(400 MHz ; DMSO) 8.24-6.94 (7H, m, Ar), 6.05 (1H, bs, OH exchangeable with 
D20 ), 4.31-4.28 (1H, sextet, C//OH), 4.14-4.12 (2H, d, OCH2), 3.45 (1H, bs, NH 
exchangeable by D20 ) , 3.40-3.32 (1H, heptet, N C //C H 3), 3.24-3.07 (2H, m, CH2N), 
1.26-1.23 (6H, t, 2xCH3).
6C(100 MHz, DMSO) 153.5, 133.8, 127.3, 126.4, 126.0, 125.1, 124.7, 121.6, 120.1,
105.1 (Ar), 69.9, 65.3 (2 x C -0 ), 49.9,46.9 (2xC-N ), 18.8, 18.3 (2xCH3).
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Paracetamol as-received
5h(400 MHz; DMSO) 10.18 (1H, CONH exchangeable with D 2 0 ), 9.68 (1H, s, OH 
exchangeable by D 2 0 ), 7.88-7.84 (4H, m, Ar), 2.50 (3H, s, CH3).
5C(100 MHz, DMSO) 167.4 (C=0), 153.0, 130.9, 120.8, 114.9 (Ar), 23.8(CH3).
Paracetamol in microspheres
$h (400 MHz; DMSO) 9.66 (1H, s, CONH exchangeable with D 2 0 ), 9.17 (1H, s, OH 
exchangeable by D 2 0 ), 7.34-6.64 (4H, m, Ar), 1.97 (3H, s, CH3).
5C(100 MHz, DMSO) 167.4 (C=0), 152.9, 130.9, 120.7, 114.9 (Ar), 23.8 (CH3).
In the ]H-NMR spectra for benzamide, the exchange between CONH and D20  was not 
obvious as the proton exchange can be slow in amides. Also, two separate peaks were 
shown for the two H atoms in the CONH2  functional group. This is because the oxygen 
atom affects their local magnetic environment to different extents. Propranolol has one 
chiral centre, racemic propranolol.HCl was used in this study.
Comparisons of ^-N M R  and 1 3 C-NMR spectra, between the same drugs before and 
after they had been loaded into the microspheres, consistently show similar spectra. 
This suggests that the molecular structure of these compounds is similar. It was 
concluded that the loading experiment and the adsorption of drugs into P-TCP 
microspheres did not alter the drugs chemically. Nevertheless, one should bear in mind 
that this technique may not be sensitive enough to detect very small amounts of 
decomposition of the sample, should it have occurred.
5.8.2 Mass Spectroscopy (MS)
In MS, a vaporised substance is bombarded with atoms (or a high energy electron beam 
for electron impact) to produce detectable ions as a function of their mass-to-charge 
ratio (m/z). Ions having lower mass will be deflected more while high momentum ions 
will be deflected less by the applied magnetic field. By varying the strength of this 
field, a range of m/z particles can be bent to follow the path of the analyser, and is 
detected and recorded.
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Samples of model drugs as-received and drugs after loading into microspheres were 
analysed by the Mass Spectrometry Service, University of Bath, using a VG AutoSpec 
(Fisons Instruments, Manchester, UK). Positive and negative ion modes were used.
5.8.2.1 Results and Discussion
The output of the mass spectrometer shows a plot of relative intensity vs. mass-to- 
charge ratio (m/z). The results are:
Benzamide, C7 H7 NO, MW = 121 Da
As-received: m/z (FAB+ve) 122 (100%, [M +H f)
m/z (FAB -ve) 120 (100%, [M-H]')
In microspheres: m/z (FAB -ve) 120 (50%, [M-H]')
Propranolol.HCl is a salt and the HC1 salt is lost in MS. The working mass is that of the 
free base, C 1 6 H2 1 NO2 , MW = 259 Da.
As-received: m/z (FAB+ve) 260 (100%, [M+H]+)
In microspheres: m/z (FAB+ve) 260 (100%, [M+H]+)
Paracetamol, C8 H9 NO2 , MW = 151 Da
As received: m/z (FAB+ve) 152 (100%, [M+H]+)
In microspheres: m/z (FAB+ve) 152 (100%, [M+H]+)
When a molecule picks up a proton, it carries a unit positive charge, the value m/z is
equivalent to the molecular weight of the molecule plus 1, [M+H]+. When a molecule
loses a proton, the value m/z is equivalent to the molecular weight of the molecule
minus 1, [M-H]'. Small peaks (not shown here) are also observed one and two units
1 ̂above the calculated molecular weight due to the natural isotopic abundance of C and 
2 H. These results show that all three model drugs remained the same after being loaded 
into the microspheres.
214
5.8.3 X-Ray Diffraction (XRD) Studies
X-ray diffraction is useful in the study of solid materials. In contrast to spectrochemical 
methods, it identifies the crystallography of the compounds rather than just the 
elements. It can also differentiate between polymorphs, isomers and different hydrate 
forms. This is because each of these forms has a different crystallographic structure 
which gives rise to a different X-ray diffraction pattern. Model drag samples before 
and after loading into P-TCP microspheres sintered at 900 °C were analysed by XRD.
5.8.3.1 Results and Discussion
Comparisons of XRD analysis for benzamide, propranolol.HCl, and paracetamol as- 
received, and after loading into microspheres are shown in Figure 5.23, Figure 5.24 and 
Figure 5.25, respectively. XRD peaks of drugs that correspond to drugs loaded into 
microspheres have a lower intensity because the percentages of drugs were low 
compared to the P-TCP matrix. Nevertheless, the results showed that the XRD peaks of 
drug-loaded microspheres were a combination of pure drug and sintered p-TCP 
microspheres. No new peaks were identified. It is concluded that all three model drugs 
maintain their crystallographic structures after being loaded into the microspheres.
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Figure 5.23 XRD results for benzamide and benzamide-loaded microspheres.
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Figure 5.24 XRD for propranolol.HC1 and propranolol.HC1-loaded microspheres.
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At a given temperature, there is a maximum amount of solute that can dissolve in a 
given amount of solvent to form a solution. When this maximum amount is reached, 
the solution is said to be saturated. The amount of solute required to make a saturated 
solution at a given condition is called solubility. Solubility provides the concentration 
at which the solid solute and the liquid solution are in equilibrium. A supersaturated 
solution is a solution in which the solute concentration exceeds the equilibrium solute 
concentration at a given temperature (saturation). Supersaturated solutions are not in 
equilibrium; in order to relieve the supersaturation and move towards equilibrium, the 
solution crystallises, and separation occurs.
Atoms in crystals are arranged in a periodic repeating pattern that extends in three 
dimensions. Crystallisation is a separation and purification technique commonly 
employed in the pharmaceutical industry. It may be defined as a phase change in which 
a crystalline is obtained from a solution. It can be thought as a two-step process:
1) Nucleation -  phase separation, or formation of new crystals.
2) Crystal growth -  growth of present crystals into larger ones.
A supersaturated solution is essential for crystallisation to occur. There are four main 
methods to generate a supersaturated solution143:
1) Temperature change;
2) Evaporation of solvent;
3) Chemical reaction;
4) Changing the solvent composition.
Most solutes exhibit increasing solubility with increasing temperature. In reference to a 
hypothetical solubility diagram shown in Figure 5.26, a solution at Z is a stable system; 
the solute is dissolved in the solvent. If the solution is then cooled down to A, the 
solute and the solvent are in equilibrium, i.e., the solution is now saturated. If the 
solution is further cooled down to B, the solution is now supersaturated and it becomes 
a metastable system. Metastable means that even though the solubility of the solute has
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exceeded its solubility, crystals do not form readily. The metastability of a solution 
decreases as the supersaturation increases. If we further cool the solution down to C, 
the solution crystallises rapidly and no longer stable.
Supersaturated solutions exhibit a metastable zone and a labile zone. Nucleation is not 
spontaneous in the metastable zone. This is because at these concentrations the 
molecules start to associate and form aggregates, but these aggregates are unstable and 
will dissolve. The region where nucleation occurs spontaneously is called the labile 
zone. In this zone, the formed aggregates grow spontaneously and new crystals are 
created.
If a seed crystal is placed in a supersaturated solution, solute molecules in the solution 
will adsorb onto the crystal surface and therefore the size of the crystal grows. Crystals 
are thought to grow in a layer-by-layer sequential fashion144. The rate of crystal growth 
is proportional to the degree of supersaturation, and the degree of supersaturation can 
be controlled by precise temperature management. The difference between 
supersaturation and saturation (e.g., the difference between point B and point F in 
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Figure 5.26. Solubility and supersolubility curves (adapted from Price145)
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Supersaturation can be expressed in terms of degree. This refers to the difference 
between the temperature of the solution and the saturated temperature of the solution at 
the existing concentration. For example, when the temperature of a saturated solution 
at temperature A is lowered to temperature B, a solution with a degree of 
supersaturation = (A - B) is formed.
It is the relationship between the extent of nucleation to the extent of crystal growth that 
controls the product crystal size and size distribution.
The aim of this study was to fill the pores of the microspheres with drug crystals. The 
experiment was performed in two stages: 1) nucleation; and 2) crystal growth. In 
stage 1 , a vacuum loading experiment was performed to implant drug crystal seeds in 
the microspheres. In stage 2, the drug-seeded microspheres were placed in a 
supersaturated solution to allow the crystals to grow in the pores of the microspheres. 
The supersaturated solution was prepared by lowering the temperature of a saturated 
solution. Propranolol.HC1 was used as a model drug.
5.9.2 Experimental Methods
Small amounts of impurities can have dramatic effects on nucleation and crystal 
morphology144. To avoid any contamination, all glassware used in this work was 
thoroughly cleaned (by soaking in Decon 90 solution overnight), and only deionised 
water was used in the experiments and for washing up.
Stage 1 - Nucleation
Microspheres sintered at 900 °C and 1150 °C were vacuum loaded at 45 °C as 
described in section 5.6.3.2.
Stage 2 - Crystal Growth
A saturated propranolol.HCl solution was prepared by dissolving an excess (~ 32 g) of 
propranolol.HCl in 50 ml of deionised water at 35 °C. The solution was stirred 
overnight to allow the system to reach equilibrium. The solution was then filtered
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(Nalgene MF75 with 0.02 pm polyethersulphone filter, Nalge Nunc International Co., 
Rochester, NY, USA) and kept at 35 °C until used.
A set-up as shown in Figure 5.27 was used for the experiment. Test tubes were placed 
in a water bath maintained at 35 ± 0.1 °C (refrigerated circulator DC5-K20, Thermo 
Haake, Karlsruhe, Germany). ~ 0.6 g of microspheres was placed in each test tube, and 
the test tubes were then sealed with rubber stoppers. Through a needle, a rotary 
vacuum pump was used to produce a low pressure in the test tubes. 2 ml of the 
prepared saturated solution was injected into each test tube with a needle while the 
vacuum pump was still running. Both needles were then removed, and the temperature 
of the water bath was immediately dropped (8T) by either 5 °C, or 15 °C. The test 
tubes were then incubated for either 6 h or 24 h. The variables tested in the 
experiments are shown in Table 5.18. After the incubation period, the powders were 
filtered (porosity 4 sintered filter, BDH Laboratory Supplies, Poole, UK) and dried in 
an oven at 50 °C.
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Figure 5.27 Set-up used for crystal growth experiments.
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1 900 15 6
2 900 15 24
3 1150 15 6
4 1150 15 24
5 900 5 6
6 900 5 24
7 1150 5 6
8 1150 5 24
The microspheres were then examined using LTSEM. Some microspheres were 
mounted in epoxy resin and sliced open for study of the internal structure. These 
samples were then gold coated for 6  x 0.5 min in the sputter coater and observed using 
conventional SEM.
Attempts were also made to open microspheres to examine drug crystals inside the 
microspheres without the interference of resin. Microspheres were first sieved with 
50 pm nylon cloth, and then a few of the larger microspheres were carefully hand 
picked with a thin wire under the optical microscope. Tempfix resin (Neubauer, 
Munster, Germany. Supplied by Agar Scientific, Stansted UK) was melted at 120 °C 
onto an aluminium surface then cooled to room temperature to harden it. The 
aluminium substrate and resin were then heated to 40 °C at which temperature the resin 
becomes 'sticky' and microspheres were sprinkled on to the resin surface. Tempfix 
resin is a thermoplastic adhesive containing no solvents and is stable in a high vacuum. 
It has a smooth featureless surface when viewed in the SEM which becomes adhesive at 
40 °C allowing small particles to be mounted in it without being submerged. A metal 
weight was placed on top of the samples and briefly impacted with a hammer to break 
open the microspheres. Loose portions of microspheres were removed with a jet of 
compressed air. The samples were then prepared for LTSEM as before (see section 
2.8.1).
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5.9.3 Results and Discussion
During LTSEM examination, it was found that ice crystals were formed on the 
sample’s surface due to the sub-zero temperatures used. Ice crystals can be 
differentiated from propranolol.HCl crystals by EDX elemental spot analysis looking 
for chlorine (Cl). The signals were collected over a period of 100 seconds. A definite 
and strong chlorine peak confirmed the identity of drug crystals.
The SEM micrographs of crystal growth experiments are shown in Figure 5.28 and 
Figure 5.29. These micrographs show that larger temperature drops (5T) allowed 
cultivation of larger size crystals. At 8 T = 15 °C, large crystals of propranolol.HCl 
were formed. Some of these crystals are bigger than the microspheres themselves. The 
results also show that the amount of crystal growth is related to length of the incubation 
time. 6  h incubation produced smaller size crystals than 24 h incubation.
The results show that 8 T = 15 °C was too large a temperature drop for the amount of 
crystal growth desired. The crystals produced were too big to fit in the pores of the 
microspheres. 5T = 5 °C is more suitable as smaller crystals were produced. To study 
how crystals were attached on the p-TCP matrix, samples were examined under higher 
magnifications and the results are shown in Figure 5.30 and Figure 5.31. Figure 5.30 
shows how propranolol.HCl crystals attached on the microspheres sintered at 900 °C. 
The matrix of these microspheres is made from very small grains, and propranolol.HCl 
crystals inserted themselves between these grains. Figure 5.31 shows how 
propranolol.HCl crystals attached on the microspheres sintered at 1150 °C. These 
microspheres consisted of bigger grains, and propranolol.HCl crystals ‘fused’ 
themselves with these grains. It can be seen that some crystals were grown inside out 
from the pores of the microspheres.
To examine the growth of drug crystals inside the microspheres, microspheres were 
resin-embedded and sliced open. While examining these samples, it was found that the 
recognition of drug crystals was difficult in the presence of resin. To locate the drug 
crystals, the dissected microspheres were analysed by EDX analysis looking for Cl. 
The results (Figure 5.32) show that Cl was found in all areas of the microspheres, but 
higher peaks of chlorine compared to peaks of Ca were recorded nearer to the edge of
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the microspheres. This may indicate that more drug crystals were found in the 
peripheral areas of the microsphere. It was considered that EDX analysis might not be 
an accurate method of quantifying or locating drug crystals because incident electrons 
can penetrate into a deeper layer (up to 2 pm) of the microsphere, and the EDX detector 
can pick up the Cl signals from adjacent areas. However, with the consistent trend that 
a more intense Cl signal was detected near the periphery of the microspheres, it was 
concluded that more propranolol.HCl was found in the peripheral areas.
To avoid the interference of resin, it was attempted to crack open of the microspheres 
by force. However, the results show that microspheres were not cracked open as 
expected, but became flattened under the applied force. A flattened microsphere is 
shown in Figure 5.33. Some drug crystals on the surface of the microsphere can still be 
clearly identified.
These initial experiments indicate that crystallisation can be used to load drug into the 
microspheres. It is envisaged that by careful manipulation of the degree of 
supersaturation, incubation time, and the filtering process, p-TCP microspheres filled 
with drug crystals in their pores can be produced.
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(a)
5T = 15 °C 
time = 24 h
(b)
5T = 15 °C 
time = 6 h
(c)
5T = 5 °C 
time = 24 h
(d)
5T = 5 °C 
time = 6 h
Figure 5.28 Results of crystal growth experiments using microspheres sintered at 
1150 °C, under conditions as indicated.
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(a)
5T = 15 °C 
time = 24 h
(b)
5T = 15 °C 
time = 6 h
(c)
5T = 5 °C 
time = 24 h
(d)
5T = 5 °C 
time = 6 h
Figure 5.29 Results of crystal growth experiments using microspheres sintered at 




Figure 5.30 Two SEM micrographs showing propranolol.HCl crystals on the surface of 
a microsphere sintered at 900 °C (5T = 5 °C, time = 24 h)
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(b)Conditions: 8 = 1 5  °C, time = 6 h.
(b) Conditions: 8 = 5 °C, time = 24 h






Figure 5.32 The results of EDX analysis of areas of a dissected microspheres.
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Figure 5.33 A flattened microsphere.
5.10 General Discussion
In this study, methods for loading model drugs into P-TCP microspheres, both non­
sintered and sintered, were investigated. For non-sintered systems, benzamide was 
added directly to the p-TCP spray-drying slurry as a solute or as a suspension. The 
drug was then spray-dried together with the p-TCP. The benzamide-loaded and 
benzamide-free microspheres were found to be similar under the SEM. No drug 
crystals were observed. In vitro dissolution results show instant release of benzamide 
from the microspheres.
Based on the mechanism of how droplets dry in the spray-drying process, it is 
reasonable to expect that dissolved benzamide will stay mainly deposited on the outside 
of the microspheres and therefore quick release of benzamide resulted. Fine dispersed 
benzamide particles are expected to disperse evenly within the P-TCP matrix. 
However, the particle-size of the benzamide particles used may be too large for 
incorporation into the microspheres.
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The loading of model drugs into sintered microspheres was achieved by a vacuum 
method, followed by a filtration technique. It was found that using a higher 
concentration of drug loading solution, a higher percentage drug loading into the 
microspheres was achieved. This is consistent for all three model drugs tested. 
Therefore it is concluded that if a high drug loading is intended, a higher concentration 
of drug loading solution should be used. The methods to obtained high concentration 
drug solution include using an alternative solvent or using an increased temperature.
Drugs covering the outer surface of the microspheres were effectively removed by a 
brief washing method. However, the washing might have also extracted some of the 
drugs that were inside the microspheres.
It was found that the percentage drug loading is closely related to the surface area of the 
microspheres. Microspheres sintered at higher temperature had a lower total surface 
area and were found to achieve lower drug loading. For microspheres which were 
sintered at 900 °C, 1000 °C, 1100 °C and 1150°C, a correlation of r2  = 0.9997 was 
obtained for their specific surface area and percentage drug loading. These results 
suggest that drugs were adsorbed as a thin layer on the matrix surfaces, including 
internal surfaces, of the porous microspheres. No drug crystals could be observed 
under the SEM.
When a concentrated drug solution (prepared at an increased temperature) was used in 
loading, drug crystals were observed on the surface of the microspheres in the SEM. It 
is proposed that these surface crystals were mainly formed during the filtration process 
due to sudden temperature drops and rapid solvent evaporation.
Dissolution results for all drug-loaded microspheres show that drugs were released 
quickly with ~ 50% being released in the first 20 min in most cases. There were no 
marked differences between the drug release profiles from microspheres sintered at 
different temperatures. It is proposed that the reason for this observation is because the 
pores in these microspheres are too big to constrain the water entrance into the 
microspheres; water enters and leaves the microspheres freely. It is therefore concluded 
that these systems would be ideal for fast release drug delivery systems. It is also
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envisaged that delayed release could be achieved by coating the microspheres with a 
rate controlling polymer.
Analytical techniques including DSC, NMR, MS, and XRD suggested that the model 
drugs maintain their physical properties, chemical properties, and crystallographic 
structure after loaded into the microspheres.
To achieve very high drug loading, the cultivation of drug crystals inside the 
microspheres were studied. It was found that the size and the amount of the 
propranolol.HCl crystals produced are dependent on the degree of supersaturation and 
the incubation time. Some propranolol.HCl crystals were found inserted between the 
grains of the microspheres. It was also observed that some crystals were grown inside 
out from the pores of the microspheres. Based on these results, it is believed that with 
further work microspheres filled with drug crystals in all their pores, with no or limited 
crystals on their outer surface could be harvested. The future work could include 
growing drug crystals slowly by careful control of the degree of supersaturation, 
incubation time, and using an improved filtration technique. Filtration was found to be 
a crucial step in harvesting drug-loaded microspheres since concentrated solutions 
crystallise readily during filtration.
Both non-sintered and sintered p-TCP microspheres were found to dissolve readily in 
acidic media. They were found to dissolve completely in ~ 15 to 20 min using 0.1 M 
HC1 under the standard BP dissolution test conditions. These observations reveal that if 
the microspheres are to be used orally and the drug is not targeted to the stomach, they 
have to be enteric coated to protect them from the stomach acid. This study also found 
that by adding 10 pph of an acid-resistance polymer, Eudragit L100, to the slurry, acid- 
resistant microspheres were produced.
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6 Conclusions and Further Work
Organic microspheres for drug delivery have been extensively studied; however, the 
use of inorganic microspheres for such applications has barely been explored.
This project was therefore organised and undertaken to develop inorganic microspheres 
and to investigate the use of these microspheres for drug delivery. The materials 
chosen as the ceramic carrier were pharmaceutical grade calcium phosphates on the 
basis that they are mechanically strong, chemically stable and biocompatible.
In this study, inorganic bioceramic microspheres consisting of two types of calcium 
phosphates, DCPA and P-TCP, were produced by spray-drying. These were highly 
porous microspheres. The production was achieved by spraying a high solids content 
aqueous-based ceramic slurry, which also contained a binder (Eudragit L100) and a 
dispersant (Dispex A40), at ~ 200 °C. A binder was found to be necessary because it 
acted as the ‘glue’ that acted to bind the ceramic powder together to form microspheres. 
In this work, Eudragit L100 was found to be a suitable binder. The high solids content 
produced a high viscosity slurry that assists in forming a stable suspension of the 
particles in the liquid. A dispersant was required to reduce the viscosity of the slurry 
and to produce a stable and homogeneous ceramic slurry.
The freshly spray-dried microspheres consisted of loosely bound, highly porous soft 
agglomerates with an average particle-size of ~ 1 0  pm - 2 0  pm and a high surface area 
of ~ 45 m2 /g. The high porosity and high surface area of the microspheres are desirable 
characteristics for the system to be used as drug carriers because it means the carriers 
have a big capacity for drugs, i.e., there is available both a large-volume for drug 
containment, and a large surface area for drug adsorption.
It was observed that the characteristics of the sprayed products, including surface 
morphology, porosity, moisture content, and particle-size could be modified by 
changing the slurry compositions (solids content; binder type and binder concentration; 
dispersant concentration; ceramic powder type; and powder particle-size) and spray- 
drying operation conditions (temperature; jet size). This has important implications in
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that it means that a wide variety of calcium phosphate microspheres drug carriers with 
various characteristics could be produced.
In the ceramics industry, both traditional and advanced, the size of the voids and their 
volume fraction in a finished piece are controlled by the pressing regime on the green 
body. In the case of spray-dried products, the voids and porosity can be controlled by 
the solids content of the slurry used in the spray-drying and the control systems on the 
spray drier. In this study, it was found that the spraying temperature also affects the 
‘hollowness’ of the microspheres produced. At 180 °C - 220 °C, hollow centred 
microspheres were obtained; while at 245 °C, solid centred microspheres were 
obtained. This is probably because the rate of water evaporation is very fast at high 
temperature and the outer layer of a microsphere formed a crust immediately. This 
crust restricts the microsphere from expanding in size. The centre of the microsphere 
never reaches the boiling temperature of the water. Water at the centre of the 
microsphere diffuses to the surface through capillary action for evaporation. The heat 
flow in the system would also be expected to have a significant influence on the 
product.
A model drug, benzamide, was loaded into the microspheres by co-spray-drying 
benzamide with the ceramic powder. The dissolution test results show that the 
benzamide was released quickly from the systems. The reasons proposed for this 
observation are:
1) Dissolved benzamide travels with the solvent to the microspheres surface during 
solvent evaporation in the spray-drying process. The drug therefore finally deposits 
near the outer surface of the microspheres.
2) The microspheres are themselves highly porous and have pores that allow water to 
enter and leave freely.
It is therefore suggested that the basic microsphere system can be suitable for instant 
release applications.
The P-TCP microspheres were sintered over a temperature range of 900 °C to 1300 °C. 
It was found that after sintering, the microspheres became mechanically strong and 
hard. This study also found that the sintering treatment significantly alters the grain
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size, porosity, density, mechanical strength, surface area, and pore-size of the 
microspheres. These changes are the consequences of material diffusion at high 
temperatures. The particles fused together to reduce the surface area, which in turn 
reduced the energy state of the system. In the process, a desirable structure and 
morphology was developed.
The porosity, pore-size, and surface area are important characteristics of a drug carrier 
because:
1) They determine the quantity of drug that can be adsorbed onto the carrier;
2) They determine the volume of drug that can be contained in the carrier;
3) They influence the drug release profile because the drug being adsorbed on the
carrier surface and the drug being contained in the carrier may be released at a
different rate;
4) Different pore-sizes may release drugs at different rates.
In this study, principally, the effect of sintering temperature was investigated, simply 
because temperature is considered to be the most important factor in sintering as it 
affects the morphology of the voids/pores. However, it is also well established that the 
length of time and the atmosphere within which the sintering is carried out also affects 
the extent and the results of sintering. With further work, these variables could be used 
to extend the range of controls for optimising the properties of the microspheres.
It is envisaged that by controlling the spray-drying processes and the sintering 
conditions, a porous microsphere drug delivery systems with a wide range of controlled 
characteristics and manufacturing flexibility can be produced. In other words, with 
further work, these microspheres could eventually be developed into ‘designer’ carrier 
systems for different applications.
Sintering changes the physical form of the microspheres but it does not modify their 
biocompatibility. It is believed that as a bone implant, calcium phosphate bioceramic 
microspheres, either sintered or non-sintered, would be a superior drug carrier to 
organic materials. This is because apart from being biocompatible and resorbable, the 
carrier material is bioactive. This means that after drug delivery the calcium phosphate 
can act as a bone precursor, supplying raw material for osteogenesis and be
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incorporated into the new bone. This removes the painful and costly procedure of 
surgically removing the drug carrier materials after drug delivery, which at the present 
is the standard procedure for treating patients with osteomyelitis. Calcium phosphate 
bioceramics will also have a greater mechanical strength and stability that organic 
materials cannot match.
The sintered bioceramic microspheres have also been found to have the characteristics 
desired for transdermal needle-free powder injection, namely biocompatibility, physical 
hardness, high density, chemical stability and the correct particle-size. It was found 
that the sintered p-TCP microspheres have a density of ~ 3 g/cm3  and are physically 
robust. The high density allows them to achieve a high momentum, to penetrate deeper 
into the skin and the physical robustness allows the particle to survive the process of 
travelling at sonic speeds and the subsequent impact on the skin. The carriers currently 
used for powder injection are organic polymers and gold particles. Calcium phosphate 
microspheres are mechanically stronger and denser than organic materials, and they do 
not have the toxicity and cost associated with gold.
The depth of particle penetration in needle-free injection is dependent on particle 
momentum, which in turn is related to the velocity, size and density of the particles. 
Various particle penetration depths could be achieved by using microspheres of 
different sizes and densities. This study shows that sintered calcium phosphate 
microspheres of various controlled sizes can be obtained by altering the spray-drying 
process and sintering conditions. With further work, the particle-size distributions can 
be further strictly controlled by sieving. A narrow particle-size range can improve 
ability to target a specific depth of delivery.
The depth of penetration is directly proportional to particle density. Based on the 
calculation that sintered P-TCP microspheres have a density of 3 g/cm3, if a particle of 
x pm in diameter can achieve a particle penetration of y  pm, then, by using a bigger size 
particle of 2x pm, a particle penetration of 2y pm can be achieved. It has been shown 
that particles up to 1 0 0  pm are suitable for needle-free injection without excessively 
damaging the skin. Organic particles (density < 1 g/cm3) of 20 pm -  70 pm have been 
used to achieve extracellular particle delivery, and dense gold particles (density ~
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19.5 g/cm3) of < 3 pm have achieved intracellular delivery. In this experimental work, 
bioceramic particles in range of 10 pm -  20 pm were made. By varying the spray- 
drying process, particles of up to 1 0 0  pm could be produced by spray-drying with the 
present system. Using larger commercial equipment, spray-dried particles of three 
times this size can be made. Thus there is a good range of particle-sizes available for 
achieving controlled depth delivery.
The main challenges of the needle-free powder delivery technology today are:
1) Limited payload - The current system has a restricted skin treatment area of up to 
2  cm2, therefore, doses are generally limited in the low milligram range;
2) Lack of carriers with sustained release properties;
3) Organic carriers do have limited chemical and physical shelf stability;
4) The production should be high yield and a scalable process.
It is envisaged that calcium phosphate bioceramic microspheres could meet these 
challenges because:
1) They are highly porous; therefore a high payload can be achieved.
2) They are inert materials which will have unlimited chemical and physical stability 
giving an extended shelf life. Being inert also infers that they do not react with 
drugs.
3) Their production (spray-drying and sintering) is a high yield, scalable, economic 
process capable of being fully automated.
4) By controlling the pore-size of the microspheres, they could be themselves 
developed into controlled release carriers. Furthermore, they could also be coated 
with a rate-controlling polymer to achieve other levels of controlled release.
Calcium phosphate microspheres could also be used for oral delivery because the 
compound is orally acceptable. Calcium phosphate microspheres may be used as 
carriers for drug or food to mask the bitter taste. This study found that the p-TCP 
microspheres are stable in alkaline conditions, but dissolved completely in strong acidic 
conditions in ~ 20 min. Therefore they can be used as instant release formulations for 
drug release in the stomach. These microspheres can also be further modified into oral 
controlled release systems by coating them with an acid-resistance polymer or rate-
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controlling polymers to achieve enteric coated formulations and controlled release 
formulations. They could also function as a scaffold for subsequent coatings o f control 
release systems, giving greater flexibility to the design o f  control systems.
Model drugs were loaded into sintered microspheres by a vacuum method. It was 
found that using non-concentrated drug loading solutions, drugs were adsorbed as a 
layer on the surface o f  the porous matrix. This study also demonstrates that it is 
possible to grow crystals inside the pores o f  the microspheres. This would be a way to 
pack a larger quantity o f drugs inside the microspheres. It was found that the size and 
the quantity o f crystals growth could be controlled by the degree o f  supersaturation o f 
the drug solution and the incubation time. Therefore, with the correct conditions, it is 
possible to generate microspheres filled with drug crystals in all their pores (Figure 
6.1). The implication is that the depth (length to diameter) o f  the pores could be an 
important control mechanism for controlled release whilst at the same time a high drug 
loading could also be obtained.
Figure 6 .1 Schematic diagram o f a microsphere filled with drug crystals in pores.
Filtration was found to be a crucial step in harvesting microspheres containing drug 
crystals since supersaturated solutions crystallise readily during filtration. It is 
proposed that instant crystallisation could be avoided by surrounding the microspheres 
with a liquid in which the drug is not soluble after the crystal growth, before the 
filtration takes place. Alternatively, a washing experiment that will remove all the 
surface crystals that form during filtration could also be used.




Therefore, with further investigation into the effects of a wider range of degree of 
supersaturation and incubation time, and with an improved filtering technique, it is 
believed that a microsphere densely packed with drug crystals could be achieved.
Dissolution test results show that the flexible delayed release of drugs was not achieved 
solely in the sintered microsphere systems. Model drugs were released quickly (in most 
cases, ~ 50% was released in the first 20 min) and no marked differences were observed 
for microspheres with varying pore-sizes. It is believed that this is because the pores in 
the microspheres are too big to constrain the water movement in and out of the 
microspheres. However, controlled release or targeted release could be achieved by 
coating the microspheres with polymers of various characteristics (e.g., rate-controlled 
and environment sensitive). Furthermore, a standard 900 ml dissolution medium was 
used for the in vitro release in this study. The conditions will be different if the 
microspheres were used as an implant or by transdermal powder delivery. In such 
environments, there is a limited supply of fluid; hence, the microspheres' reservoirs 
might be expected to release their contents more slowly over an extended period of 
time.
An investigation into the use of the microsphere systems in a commercial needle-free 
injectable delivery device, such as the Powderject® device, should be performed to 
explore and assess its practical pharmaceutical value.
In conclusion, in this study it was found that:
1) Microspheres of two calcium phosphates, DCPA and P-TCP, were produced by 
spray-drying high solids content slurries which contained a binder and a dispersant.
2) The spray-dried microspheres are affected by the slurry composition (solids 
content; binder type and binder concentration; dispersant concentration; ceramic 
powder type; and powder particle-size) and spray-drying operation conditions 
(temperature; jet size).
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3) The production of p-TCP microspheres is easier and quicker than DCPA 
microspheres because there are less process steps and therefore more suitable for 
larger scale production.
4) Sintering changes the mechanical hardness, porosity, pore-size, and surface area of 
the DCPA and p-TCP microspheres. The soft agglomerates of spray-dried 
microspheres became mechanically hard and strong after sintering.
5) Sintered microspheres have pores of ~ 0.1 pm - 5 pm in diameter with hardly any 
small pores in the nanometer range.
6 ) The porosity and the specific surface area of the microspheres decrease as the 
sintering temperature increases.
7) Drugs can be loaded into non-sintered microspheres by direct addition of the drug 
into the spray-drying slurry, and then co-spray-drying with the ceramic powder. 
Drugs can be loaded into sintered microspheres by a vacuum method.
8 ) Using a vacuum method for drug loading, the percentage drug loading is closely 
related to the surface area of the microspheres. Microspheres with a lower total 
surface area were found to achieve lower drug loading and vice versa.
9) BP standard dissolution test results showed that drugs were released quickly from 
both non-sintered and sintered drug-loaded microspheres. No marked differences 
were observed among the drug release profiles from microspheres sintered at 
different temperatures.
10) Drug crystals could be grown inside the pores of the microspheres. The size and 
the quantity of the crystals produced were dependent on the degree of 
supersaturation of the drug solution and the incubation time.
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Appendix I Statistical Analysis
(a)True Density
One-way Analysis of Variance
Analysis of Variance for stacked
Source DF ss MS F P
subscrip 7 0,.2310133 0.0330019 1389.11 0.000
Error 16 0 .0003801 0.0000238
Total 23 0 .2313934
Individual 95% CIs For Mean
Based on Pooled StDev
Level N Mean StDev 11+111111111+111111111+111111111+1111
1 3 2.77461 0.00255 (*)
2 3 2.84893 0.00512 (*)
3 3 3.01365 0.00610 (*
4 3 3.04019 0.00685 (*)
5 3 3.04044 0.00755 (*)
6 3 3.02757 0.00295 *)
7 3 3.04072 0.00221 (*)
8 3 3.03757 0.00159 (*
Pooled StDev = 0.00487 2.800 2.880 2.960 3.040
Fisher's pairwise comparisons
Family error rate = 0.443 
Individual error rate = 0.0500
Critical value = 2.120
Intervals for (column level mean) - (row level mean)



























































(b) Sintering Temperature and Surface Area 
Two-way Analysis of Variance
(comparisons for samples which were non-sintered and were sintered at 900°C)
Source DF SS MS F P
temperature 1 13273.19 13273.19 2.3E+04 0.000
batch 1 127.85 127.85 218.98 0.000
Interaction 1 38.17 38.17 65.37 0.000















________________ L ________________________ 1--------------------------------------J ___________________________ 1____________
(*
*
15.00 30.00 45.00 60.00
Individual 95% Cl
30.00 31.50 33.00 34.50
(c) Sintering Temperature and Surface Area 
Two-way Analysis of Variance
(comparisons for samples which were sintered between 900 °C and 1 2 0 0  °C)
Analysis of Variance for 2nova,
Source DF SS MS F P
raOw fac 4 290.2265 72.5566 1.9E+04 0.000
column f 1 12 .3828 12.3828 3221.45 0.000
Interaction 4 7 . 1620 1.7905 465.81 0.000
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Appearance: off-white crystals or powder
Melting point: 127 °C
Boiling point: 288 °C
Density: 1.34 g cm "3
Solubility: 1 g in 74 ml water; 1 g in 6  ml alcohol
Propranolol hydrochloridelv V,V1
Molecular formula: C 16H21NO2.HCI 
Molecular Weight: 295.81 
Appearance: white crystalline powder 
pKa = 9.3
Bulk-density: 0.42 g cm"3
0.55 g cm"3 after 20 tappings 
Melting point: 163-164 °C 
Solubility: 1 g in 20 ml water and alcohol 
Solutions are most stable at pH = 3
and decompose rapidly in alkali.
Paracetamol1* ' * 11
Molecular formula: C 8H9N0 2  
Molecular Weight: 151.17 
Appearance: White crystalline powder.
Melting point: 169-172 °C 
pKa = 9.5
Solubility: 1 g in 67 ml water, 1 g in 5 ml 
Density: 1.29 g cm"3
I The Merck index - an encyclopedia of chemicals, drugs, and biologicals, Merck & Co., Inc., Rahway, 
N.J., USA, 1986.
II http://physchem.ox.ac.uk/MSDS/BE/benzamide.html (15/12/2001), The Physical and Theoretical 
Chemistry Laboratory, Oxford University, Chemical and Other Safety Information for benzamide.
III http://www.jtbaker.com/msds/b0720.htm (15/12/2001), Material Safety Data Sheet, Mallinckrodt 
Baker, Inc., Phillipsburg, NJ, USA.
IV Martindale - The Extra Pharmacopoeia, 30th Edition, Pharmaceutical Press, London, UK, 1993.
v Clarke's isolation and identification of drugs: in pharmaceuticals, body fluids and post-mortem material, 
Pharmaceutical Press, London, UK, 1986.
V1 http://www.chemicals-india.com/propranolol.html (21-4-2002), Propranolol hydrochloride B.P/U.S.P.
v" http://www.chemicalland21 .com/arokorhi/lifescience/phar/PARACETAMOL.htm (20/12/2002) 




Appendix III Model Calculation for % Drug Release
Calculation model for % drug release taking into account the removal of 5 ml sample during each sampling and replace with 5 ml of fresh 
medium.
E.g. If Y = absorbance, X = drug concentration, and Y = 0.0015 + 754.92X
Time
/min






















Yi x 1 =
(Yi-0.0015)/754.92
lOOOOXi = ai 5 x ai 0 900 x ai = ci Ci + 0  = di (di/total drug 
release)xl0 0
y 2 x 2 =
(Y2-0.0015)/754.92
10000X2  = a2 5 x a2 (5 x ai) + 0 = b2 900 x a2  = c2 b2  + c2  = d2 (d2/total drug 
release) x 1 0 0
y 3 x 3 =
(Y3-0.0015)/754.92
10000X3  = a3 5 x a3 (5 x a2) + b2  = b3 900 x a3  = c3 b3  + c3  = d3 (d3/total drug 
release)xl0 0
y 4 X4 =
(Y4-0.0015)/754.92
10000X3  = 3 4 5 x a4 (5 x a3) + b3  = b4 900 x a4  = c4 b4+ c4  — d4 (dVtotal drug 







Appendix IV Calibration Plots
benzamide in buffer, lamda = 225 nm
calibration set 1 
calibration set 2 
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Propranolol in phosphate buffer, lamda = 289 nm
•  c a l i b r a t i o n  s e t  1
O  c a l i b r a t i o n  s e t  2
▼ c a l i b r a t i o n  s e t  3
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Paracetam ol in phosphate buffer, lam da = 2 4 9  nm
•  calibration data set 1
o calibration data set 2
t  calibration data set 3
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Appendix V AAPS 2000 Poster Abstract
Poster presentation at AAPS Annual Meeting and Exposition 2000 at Indianapolis,
Indiana, USA on 30th Oct 2000. 
in AAPS PharmSci Supplement, Volume 2, Number 4.
THE PRODUCTION OF INORGANIC POROUS MICROSPHERES AS 
CARRIERS FOR CONTROLLED RELEASE
Ching Kim Tye*, Michael J. Tobyn*, Ronald Stevens^
^Pharmaceutical Technology Research Group, Department of Pharmacy and 
Pharmacology, University of Bath, Bath BA2 7AY, UK.
2
Department of Engineering and Applied Science, University of Bath,
Bath BA2 7AY, UK.
Purpose. To produce inert porous microspheres for use as controlled release carriers. 
To tailor the characteristics (sizes and porosity) of the calcium phosphate systems by 
spray-drying and sintering. Methods. Aqueous mixtures of tri-calcium phosphate (10, 
20, 30, 40%w/w), binder (Eudragit L100) and dispersant (Dispex A40) were spray- 
dried at various temperatures (160°C-245°C). The products were then sieved to retain 
the bigger microspheres. These microspheres were then sintered at high temperatures 
(900°C-1200°C) to produce carriers having different pore sizes. Results. Spray-drying 
tri-calcium phosphate mixtures produced porous microspheres ranging from 5 pm to 
30pm (microscopic observation). The mean microsphere size increases with increased 
solid concentrations (10-30%w/w). Solid loading lower than 10%w/w and higher than 
30%w/w were not suitable to be spray-dried. Systems prepared at 245°C produced 
microspheres with solid centres while those at 160°C-200°C produced hollow 
microspheres. Sintering produced microspheres with different porosity. It also reduced 
the total surface area (and also pore density) of the microspheres from 50m2/g (before 
sintering) to lm  /g (after sintering at 1200°). Conclusion. By combining spray-drying 
and sintering techniques, tri-calcium phosphate microspheres with various degrees of 
controlled porosity can be produced. These inert microspheres have a potential use as 
controlled release carriers.
Acknowledgements. We thank University of Bath and Overseas Research Students 
Award for funding this studentship (CKT).
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Appendix VI AAPS 2001 Poster Abstract
Poster presentation at AAPS Annual Meeting and Exposition 2001 at Denver, 
Colorado, USA on 23rd Oct 2001. 
in AAPS PharmSci Supplement, Volume 3, Number 3.
THE EFFECT OF SINTERING TEMPERATURE ON A PHARMACEUTICAL
GRADE CALCIUM PHOSPHATE
Ching Kim Tye*, Michael J. Tobyn*, Ronald Stevens^
* Pharmaceutical Technology Research Group, Department of Pharmacy and 
Pharmacology, University of Bath, Bath BA2 7AY, UK.
2
Department of Engineering and Applied Science, University of Bath,
Bath BA2 7AY, UK.
Purpose. To study the effect of sintering temperatures on a pharmaceutical grade tri­
calcium phosphate (Merck, Darmstadt, Germany). Methods. Spray-dried tri-calcium 
phosphate systems were sintered at 900°C, 1000°C, 1100°C, 1150°C and 1200°C 
respectively for one hour. Their morphologies were examined by scanning electron 
microscopy (SEM). The internal structure of these systems was examined by first 
mounting them in resin, then cross-sectioned through with a diamond knife before SEM 
analysis. The change of porosity was measured by mercury intrusion porosimetry. Their 
total surface area was determined by 5-point BET N 2  adsorption. The true density was 
measured by helium pycnometry and tap density was also determined. To determine the 
effect of gastrointestinal conditions on these systems, they were suspended in phosphate 
buffer (pH=6 .8 ) and 0.1 M hydrochloric acid respectively. Results. SEM showed a 
distinct change in tri-calcium phosphate morphology (grain size grew) with increasing 
sintering temperatures. Mercury intrusion porosimetry analysis indicated a decrease in 
total porosity as the temperature increased. The total surface area decreased from 8.3 
m2/g to 1.8 m2/g when temperature increased from 900°C to 1200°C. Density 
measurements illustrated that true density and tap density increased with increasing 
temperature. All sintered tri-calcium phosphate systems were found to retain their 
structure (SEM examination) after suspension in phosphate buffer overnight but totally 
dissolved in diluted acid. Conclusion. Sintering temperature has a marked effect on the 
morphology, porosity, surface area and density of the spray-dried tri-calcium phosphate 
microspheres.
Acknowledgements. We thank University of Bath and Overseas Research Students 
Award for funding this studentship (CKT).
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